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Summary
Most micro-organisms contain an NADP-dependent isocitrate dehydrogenase (ICDH) 
activity. During growth of micro-organisms on acetate as the sole carbon source the two 
enzymes of the glyoxylate bypass, isocitrate lyase (ICL) and malate synthase (MS), are 
induced. These two enzymes are required to generate the intermediates of the TCA cycle that 
are used for biosynthesis. Under these conditions there is competition between the TCA 
cycle enzyme ICDH and the glyoxylate bypass enzyme ICL for available isocitrate. In E. 
coli this competition is overcome by the partial phosphorylation and inactivation of ICDH. 
This mechanism of control has been observed in other enteric bacteria.
In recent years there has been increasing interest in the study of thermophilic bacteria due to 
their possible applications in industrial processes. Despite the interest in these organisms 
very little is known about their central metabolism. This study has concentrated on the 
central metabolic enzyme ICDH from the thermophile Bacillus caldotenax. During the 
course of this study the enzyme has been purified, its regulatory properties studied and the 
gene for ICDH has been cloned and sequenced.
A purification procedure for 5. caldotenax ICDH was developed using ammonium sulphate 
fractionation followed by ion-exchange and dye-ligand chromatography. B. caldotenax 
ICDH is a dimer of subunit molecular weight 46,000 daltons and is similar in size and 
subunit composition to E. coli ICDH. The similarity between these two enzymes was 
further established by the fact that B. caldotenax ICDH cross-reacted with an antibody raised 
to E. coli ICDH.
In vitro phosphorylation studies demonstrated that it was possible to inactivate B.caldotenax 
ICDH, using purified E. coli ICDH kinase, in the presence of ATP. The observed decrease 
in ICDH activity was associated with the phosphorylation of ICDH. The stoichiometry of 
phosphorylation of B. caldotenax ICDH was determined by comparison to be the same as 
that of E. coli ICDH, i.e .lmol of phosphate/mol of subunit.
The possibility that B. caldotenax ICDH was controlled by phosphorylation in vivo, was 
investigated. A 46,000 dalton protein was seen to become phosphorylated in crude extracts 
of B. caldotenax incubated with [y-32P] ATP but immunoprecipitation experiments 
confirmed that the protein was not ICDH. No evidence for phosphorylation of B. caldotenax 
ICDH in intact cells was obtained. However it remains possible that phosphorylation might 
be observed in conditions other than the ones tested.
Amino acid sequence was obtained from peptides of pure B. caldotenax ICDH .The 
sequence was used to design a probe for cloning the ICDH gene by reverse genetics. A 4.5 
kb fragment of B. caldotenax genomic DNA was cloned into the plasmid vector pUC18. 
The fragment contained the complete coding region of ICDH which was sequenced together 
with the flanking regions of DNA. The gene for ICDH consists of an open reading frame of 
1272 bp coding for a protein of 422 amino acids. The amino acid sequence of B. caldotenax 
ICDH was compared with that of E. coli ICDH and the sequences found to be 70% 
identical.
The C-terminus of a second open reading frame was identified upstream to the gene for 
ICDH. The translated open reading frame could be aligned with significant sequence 
similarity to the C-terminal end of the amino acid sequences from a large number of 
bacterial citrate synthases. It was concluded from this alignment that in B. caldotenax the 
gene for citrate synthase lies upstream to that of ICDH. The close proximity of these two 
genes suggested the possibility that they might constitute an operon.
Chapter 1 
Introduction
1.1 Introduction
1 .1 .1  Isocitrate dehydrogenase
Isocitrate dehydrogenase (ICDH) catalyses the oxidative decarboxylation of isocitrate to 
give 2-oxoglutarate and carbon dioxide. The enzyme is found in most micro-organisms, 
plants and animals (Plaut, 1963). There are two types of ICDH, one dependent on NADP, 
the other dependent on NAD. Both types of ICDH have been found in eukaryotes 
(Komberg and Pricer, 1951). The two types of ICDH are distributed differently within the 
cell, NAD-dependent ICDH being found exclusively within the mitochondria, having an 
important role in the TCA cycle (Emster and Navazio, 1956; Sung and Hsu, 1957). The 
NADP-dependent form is largely found within the cytoplasm where it functions to provide 
reducing equivalents for biosynthesis. Studies carried out on a number of species of 
bacteria showed that most prokaryotes only contain the NADP-dependent form of ICDH 
(Ragland et al., 1966).
NADP-dependent isocitrate dehydrogenase (threo-Ds-isocitrate NADP+ oxidoreductase 
(decarboxylating) EC.1.1.1.42, hereafter ICDH) has a requirement for Mn2+ (Adler et al., 
1939; Moyle, 1956). They showed that Mn2+ could be substituted with Mg2+ but this was 
less effective. NADP is the natural coenzyme for this type of ICDH, NAD is not active.
Bacterial NADP-dependent ICDHs seem to fall into two main types. For example, two 
isoenzymes of NADP dependent ICDH, termed IDH-I and IDH-II, have been isolated from 
the psychrophilic bacterium, Vibrio ABE-1 (Ishii et al., 1987). IDH-I is a dimer of 
molecular weight 88,100 daltons, having a similar subunit composition to E. coli ICDH 
which is a dimer of 90,000 daltons. Most other purified bacterial ICDHs also take this 
dimeric form. The second type of ICDH, IDH-II is a monomeric enzyme of molecular 
weight 80,500 daltons; other similar monomeric forms of ICDH have been purified from 
other prokaryotes. These two types of ICDH are discussed further in section 1.9.
1.1.2 The Tricarboxylic Acid Cycle
Cells contain several central metabolic pathways into which all carbon sources are directed 
and from which all constituents are derived. The central metabolic pathways produce 
precursors for biosynthesis, generate energy in the form of ATP and produce necessary 
reducing power. In aerobic organisms or tissues this is achieved by complete combustion 
of nutrients to COz and H20.
The Tricarboxylic acid cycle (TCA cycle) or Krebs cycle is the central metabolic pathway in 
most organisms serving as the terminal pathway of oxidation. In each turn of the cycle 
acetate, as acetyl-CoA, condenses with oxaloacetate (OAA) to form citrate. Subsequent 
reactions result in the stepwise oxidation of citrate to regenerate oxaloacetate with the loss 
of two carbon atoms as C02 (figure 1.1) (Krebs and Johnson 1937). The coenzymes 
NADH, NADPH and FADH2 are generated in the cycle and can be used in reductive 
biosynthesis or to regenerate ATP via oxidative phosphorylation.
Many of the intermediates of the cycle are used as precursors of macromolecular 
constituents of the cell (Roberts et al., 1955; Gilvarg and Davies, 1956). For example OAA 
is used to synthesize aspartate which in turn supplies the amino acids methionine, lysine, 
threonine and isoleucine together with the pyrimidines of nucleic acids. Therefore during 
growth, intermediates of the TCA cycle are constantly being removed for biosynthetic 
purposes. Removal of these intermediates would prevent regeneration of OAA and hence 
cause breakdown of the cycle. If growth is to continue these intermediates must be 
replenished, therefore anaplerotic pathways operate to maintain the levels of intermediates 
of the central pathways (Komberg, 1966).
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Figure 1.1 The glyoxylate bypass and the TCA cycle
The reactions numbered 1-4 are catalysed by the enzymes isocitrate lyase, malatc 
synthase-A, phosphoenolpymvate carboxykinase, and isocitrate dehydrogenase respectively. 
The heavy arrows indicate fluxes to biosynthesis.
1.1.3 The Glyoxylate Bypass
Operation of the TCA cycle results in the loss of both carbon atoms of the acetyl unit as 
CO2, and by itself would allow no net accumulation of carbon. However E. coli is able to 
grow on acetate or fatty acids as the sole carbon source. This is achieved by diverting flux 
from the two C02 evolving steps of the TCA cycle through the glyoxylate bypass (figure 
1 . 1).
The glyoxylate bypass is an anaplerotic sequence which serves to replace the intermediates 
of the TCA cycle which are drawn away for biosynthetic purposes. During growth on 
acetate or fatty acids as sole carbon source the two unique enzymes of the glyoxylate 
bypass isocitrate lyase (ICL) and malate synthaseA (MSA) are induced (Komberg, 1966; 
Vanderwinkel and DeVliegher, 1968). There is a second malate synthase induced during 
growth on glycolate and compounds which are metabolised to glycolate as sole carbon 
source (Falmange et al., 1965 ).
ICL (threo-Ds-isocitrate glyoxylate-lyase EC.4.1.3.1.) was first observed in sonic extracts 
of Pseudomonas aeruginosa which catalysed the reversible formation of succinate and 
glyoxylate on the addition of citrate or cis-aconitate (Campbell et al., 1953). This result was 
later confirmed using several bacteria and fungi, and Ds(+)-isocitrate was established as the 
true substrate (Olsen, 1954; Saz, 1954; Smith and Gunsalus, 1954). The second enzyme 
MSA (EC.4.1.3.2) catalyses the condensation of glyoxylate with acetyl-CoA to generate 
malate (Wong and Ajl, 1956). Later experiments using labelled acetate showed that ICL 
and MSA act together to give the overall reaction shown below (Komberg and Madsen, 
1958; Komberg and Quayle, 1958; Komberg et al., 1960).
acetylCoA + isocitrate + H2O = succinate + malate + CoA
4
As a result of the activity of the glyoxylate bypass there is the net gain of one C4- 
dicarboxylic acid, a TCA cycle intermediate. Since the intermediates of the TCA cycle are 
interconvertible and OAA can be converted to phosphoenolpyruvate (PEP) by PEP 
carboxykinase, the bypass can generate all the precursors required for biosynthesis.
Flux through ICDH is essential to produce 2-oxoglutarate and succinyl-CoA for 
biosynthesis as well as energy and reducing power. Therefore when the glyoxylate bypass 
is in operation a branch point is created at the level of isocitrate. Under these conditions 
there is competition between the TCA cycle enzyme ICDH and the glyoxylate bypass 
enzyme ICL for available isocitrate. In E. coli growing on acetate the maximum catalytic 
activity of ICDH is potentially much greater than that of ICL. In addition the Km of ICDH 
for isocitrate is much lower than that of ICL (Ashworth and Komberg, 1963; Bautista et 
al., 1979). Therefore to allow flux through the glyoxylate bypass to occur there must be a 
method of either activating ICL, inhibiting ICDH or both. The control of this branch point 
has been most extensively studied in E. coli.
1.2 Control of the branchpoint between ICL and ICDH in E. coli
There is no evidence to suggest that ICL from E. coli is allosterically controlled. Likewise 
ICDH from E. coli does not seem to be controlled by any allosteric inhibitors or activators 
(Ragland et al., 1966). It has been suggested that ICDH is subject to concerted inhibition 
by glyoxylate plus OAA. This inhibition is kinetically complex. Inhibition is partly caused 
by the unstable compound oxalomalate which forms non-enzymically from the 
condensation of glyoxylate and OAA. Oxalomalate is a potent competitive inhibitor of 
ICDH but decomposes spontaneously to form 4-hydroxy-2-oxoglutarate, a much less 
potent inhibitor of ICDH (Nimmo, 1986). Several groups have reported the condensation 
of OAA and glyoxylate to be too slow to account for inhibition of ICDH by oxalomalate 
(Shiio and Ozaki, 1968; Man* and Weber, 1968; Johanson and Reeves, 1977).
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Inhibition is also caused by the slow binding of OAA and glyoxylate to the ICDH isocitrate 
binding site (Nimmo, 1986). However this is not thought to be physiologically significant 
as the intracellular concentrations of these inhibitors are probably too low (Nimmo, 1986). 
Moreover, glyoxylate and OAA might be expected to activate ICDH rather than inhibit it as 
these are end products of the glyoxylate bypass.
Holms and Bennett (1971) whilst studying the levels of TCA cycle enzymes in E. coli 
ML308 during growth on different carbon sources, provided the first evidence that ICDH 
may be controlled by a reversible modification. They showed that specific activities of 
ICDH, malate dehydrogenase (MDH) and 2-oxoglutarate dehydrogenase, in crude extracts 
remained constant when growth on limiting glycerol had ceased. However after cessation 
of growth on limiting glucose, although the activities of MDH and 2-oxoglutarate 
dehydrogenase remained constant, the activity of ICDH fell to 20% of its original value 
over a 2 hour period, recovering to 75% over the next 2hours. The reason for this 
observation was that E. coli excretes acetate during growth on glucose but not on glyceroL 
After cessation of growth on glucose the enzymes of the glyoxylate bypass were induced 
and the acetate was oxidised. The specific activity of ICDH decreased during this period of 
adaptation to use of acetate but increased once all available acetate had been utilised.
The specific activity of ICDH in cells growing on acetate as carbon source was 30% of the 
corresponding value for cells growing on glucose or glycerol. When cells were removed 
from the acetate medium, or on addition of compounds such as pyruvate which made the 
operation of the glyoxylate bypass unnecessary, a 3-4 fold increase in ICDH activity was 
observed. The specific activity of ICDH decreased again on restoration to an acetate 
medium or when the added carbon source, e.g. pyruvate had been exhausted. Changes in 
activity were rapid, independent of protein synthesis and not caused by low molecular 
weight effectors. Bennett and Holms (1975) concluded that a reversible covalent 
modification might be involved. In addition they showed that this mechanism was not
6
unique to E. coli but could be observed in at least one strain each of Salmonella 
typhimurium, Klebsiella aerogenes and Serratia marcescens.
1.3 Phosphorylation in the control of ICDH activity
1.3.1 Early studies
Phosphorylation was first implicated in the control of ICDH activity by Gamak and Reeves 
(1979 a, b). E. coli was grown on limiting glucose in a low phosphate medium. At the 
beginning of stationary phase 32P and acetate were added to the culture. A 51,000 dalton 
radiolabelled protein was extracted from these cells which co-purified with ICDH and was 
found to be immunologically identical to ICDH The radioactive band corresponded with 
ICDH activity in native gels suggesting the protein was phospho-ICDR In retrospect, the 
material was probably a mixture of phosphorylated and dephosphorylated forms. The 
phosphorylated residue was found to be serine by using anion-exchange chromatography 
followed by acid hydrolysis.
Borthwick et al. (1984 a) purified active ICDH from cells grown on glycerol and inactive 
and partially active ICDH from cells grown on acetate. These three proteins had identical 
mobilities on SDS polyacrylamide gels corresponding to a subunit molecular weight of
45,000 daltons. Non-denaturing gel electrophoresis, however, did show differences 
between the three proteins. Active ICDH gave a single band when stained either for protein 
or for activity. Partially active ICDH showed two bands when stained for protein. The 
higher mobility band did not appear on gels stained for ICDH activity. Protein staining of 
inactive ICDH showed one band of the same mobility as the higher mobility band of the 
partially active ICDH. It was shown that these differences in mobility were due to charge 
and not size differences. In addition alkali-labile phosphate measurements showed that 
active and inactive ICDH correspond to dephosphorylated and phosphorylated forms 
respectively, differing in one phosphate/ subunit.
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1.3.2 Phosphorylation of ICDH in vivo
Phosphorylation of ICDH was established to be of physiological significance by Borthwick 
et al. (1984 b). These workers correlated changes in the phosphorylation state of ICDH 
with changes in the activity of the enzyme.
When pyruvate was added to cells growing on acetate, in the presence of 32Pi, ICDH 
activity rose 4 fold over 20-30 min, declining to its basal level after 50 min. Denatured cell 
pellets were run on SDS gels. A 32P containing band of protein of the same molecular 
weight as ICDH was identified. Addition of pyruvate resulted in a loss of 32P from this 
band but there was an increase in 32P in this band after 40-60 min. This observation was 
not due to changes in the amount of ICDH present which remained constant throughout the 
experiment. It was evident that there is an inverse correlation between the phosphorylation 
state of ICDH and its activity in intact cells.
Cell extracts were prepared during the same experiment and incubated in the presence of 
purified ICDH kinase/phosphatase, under conditions promoting dephosphorylation. For 
samples with a low initial ICDH activity (e.g. before addition of pyruvate) this treatment 
caused an increase in ICDH activity to the value seen in extracts after addition of pyruvate. 
It was concluded therefore that the reversible inactivation of ICDH observed in vivo is 
solely due to reversible phosphorylation. Borthwick et al., (1984 b) isolated chymotryptic 
peptides from ICDH labelled in vivo and in vitro. The same serine residue was found to be 
phosphorylated both in vivo and in vitro.
This work confirmed that changes in the activity of ICDH could be interpreted in terms of 
changes in its phosphorylation state and thus must reflect control of the activities that 
interconvert the phosphorylated and dephosphorylated forms of ICDH.
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1.4 Isocitrate dehydrogenase kinase/phosphatase
1.4.1 The bifunctional nature of ICDH kinase/phosphatase
The phosphorylation and dephosphorylation of ICDH are carried out by a single 
bifunctional kinase/phosphatase enzyme. The first indication that this enzyme was 
bifunctional came during the development of a purification protocol for this enzyme. 
LaPorte and Koshland (1982) found that the two activities were eluted together from a 
variety of chromatographic media. The purified protein gave a single band with SDS 
electrophoresis and catalysed both reactions efficiently.
The bifunctional nature of the kinase/phosphatase was confirmed when the locus encoding 
the protein was cloned. The gene encoding ICDH kinase/phosphatase (<aceK) was cloned 
by complementation of an aceK mutation (LaPorte and Chung, 1985) which restored the 
host's ability to grow on acetate. The clone expressed both ICDH kinase and ICDH 
phosphatase activities and was shown to encode a polypeptide with the same molecular 
weight (65,000 daltons) as the purified protein.
The nucleotide sequence of the gene for ICDH kinase/phosphatase has been established 
independently by two groups (Klumpp et al., 1988 and Cortay et al., 1988) which 
confirmed that the kinase and phosphatase were expressed from the same gene.
A number of workers have studied the organisation of the active site (or sites) in ICDH 
kinase/phosphatase and there is now a considerable amount of evidence suggesting that 
there is only a single active site within ICDH kinase/phosphatase. The activity of ICDH 
kinase/phosphatase has an unusual requirement for either ATP or ADP (LaPorte and 
Koshland, 1982). Examination of the sequence of ICDH kinase/phosphatase showed that 
it contained only a single region which matched the consensus for ATP binding sites 
(Klumpp et al., 1988). This site contains an invariant lysine residue which has been found 
in the ATP binding site of every protein kinase sequence to date. Stueland et al. (1989)
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carried out site directed mutagenesis converting this lysine to a methionine residue; the 
allele produced was refered to as aceK(lys>met). This lys>met mutation inhibited both 
ICDH kinase and phosphatase activities by at least 500 fold. The possibility of proteolytic 
degradation was ruled out by Western blotting, the protein was present at wild type levels 
but was inactive. A single mutation had abolished both kinase and phosphatase activities 
indicating that the kinase and phosphatase may share the same ATP binding site and 
therefore probably the same active site.
Affinity labelling of ICDH kinase/phosphatase with the ATP analogue P 2P]azido-ATP also 
gave evidence for a single ATP binding site. This analogue inactivated both activities in 
parallel presumably because of its covalent attachment at, or near, the active site.
Proteolysis of the labelled protein followed by chromatography yielded a single peak of 
radioactivity again confirming the existence of only a single ATP binding site (Varela and 
Nimmo 1988).
Random mutagenesis of aceK resulted in several mutants which retained their kinase 
activity but not their phosphatase activity (Stueland et al., 1987). It was discovered that 
these mutants suffer a drastic loss in their affinity for phospho-ICDH. These mutations had 
the same effect on the kinase. The mutant kinase, unlike the wild type enzyme, was not 
subject to product inhibition by phospho-ICDH. As a result of the mutation both the kinase 
and the phosphatase had simultaneously lost their ability to bind phospho-ICDH suggesting 
that the two reactions occur at the same active site.
Stueland et al. (1987) showed that ICDH kinase/phosphatase had ATPase activity, 
catalysing the hydrolysis of ATP even in the absence of ICDH. In addition they found that 
this activity was greater than that of the phosphatase and kinase and was retained even 
when the enzyme was complexed with either ICDH or phospho-ICDH.
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In an attempt to combine all these pieces of evidence with regards to the mechanism of 
ICDH kinase/phosphatase LaPorte et al. (1989) put forward a working model for this 
protein. The model proposes that ICDH kinase/phosphatase has a single active site and that 
the) phosphatase reaction results from the kinase back reaction tightly coupled to 
hydrolysis of ATP. The phosphatase reaction would require the formation of a ternary 
complex involving ICDH kinase/phosphatase, ADP and phospho-ICDH. The phosphate 
would then be transferred from phospho-ICDH to ADP and then to water the net result 
being dephosphorylation (figure 1.2). This model is only speculative but it satisfactorily 
explains all the evidence produced to date.
1.4.2 Molecular organisation and control of the gene for ICDH 
kinase/phosphatase and enzymes of the glyoxylate bypass
In E. coli the genes encoding the enzymes of the glyoxylate bypass, malate synthase A 
(aceB ) and isocitrate lyase (aceA) together with the gene for ICDH kinase/phosphatase 
(iaceK)y in this order, comprise an operon called the glyoxylate bypass operon (Malloy and 
Nunn, 1982; LaPorte et al., 1985). This operon is located at 90 min on the E. coli 
chromosomal map.
Expression of the ace operon is negatively controlled at the transcriptional level by two 
genes iclR and fadR (Malloy and Nunn, 1982) which code for repressors. The gene for 
iclR has been cloned (Negre et al., 1991) and overexpressed and the repressor has been 
purified to homogeneity (Cortay et al., 1991). Studies using the purified IclR protein 
showed it to bind to the promoter region of the ace operon. The fadR gene has also been 
cloned and is known to participate in the regulation of fatty acid degradation (fad) regulon 
(Simons e ta l., 1980).
It has been suggested by Malloy and Nunn (1982) that the iclR and fadR repressors can act
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E.ATP — E.ATP.IDH
Figure 1.2 Model for the mechanism of ICDH kinase phosphatase
The model proposes that the ICDH kinase and ICDH phosphatase reactions are catalysed 
at the same active site and that the ICDH phosphatase reaction results from the ICDH 
kinase reaction tightly coupled to ATP hydrolysis. Taken from LaPorte et a/.(1989).
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independently to cause partial repression of the ace operon or together to cause complete 
repression. The operon could therefore be activated to different levels depending on the 
carbon source.
Expression of the glyoxylate bypass is induced during growth on acetate, however addition 
of acetate to E. coli growing on glucose did not induce ICL (Komberg, 1963). This 
suggests that neither acetate nor acetylCoA act directly as inducers. Komberg (1966) 
proposed that PEP or a metabolite close to PEP was more likely to be the inducer. In 
support of this view experiments with purified IclR and the promoter /operator region of 
the ace operon showed reduced binding in the presence of PEP but not in the presence of 
acetate, acetylCoA, pyruvate or OAA (Cortay et al., 1991).
The mechanism of control of the ace operon is complex and the metabolites which regulate 
its expression have yet to be identified. Further research in this area is required before the 
regulatory mechanism is fully elucidated.
1.4.3 Biochemical regulation of ICDH kinase/phosphatase activity
In vitro and in vivo studies have identified a large number of effectors which can alter the 
activity of ICDH kinase and/or phosphatase, (LaPorte and Koshland, 1983; Nimmo and 
Nimmo, 1984). These effectors and their actions are summarised in figure 1.3. Isocitrate, 
3-phosphoglycerate, pyruvate, AMP, ADP, oxaloacetate, 2-oxoglutarate and PEP activate 
ICDH phosphatase and inhibit ICDH kinase, whereas NADP, citrate, fmctose-6-phosphate 
and glyoxylate inhibit the kinase having little effect on the phosphatase. Considering the 
intracellular concentrations of these metabolites (Lowry et al., 1971; Bautista et al., 1979; 
Morikawa et al., 1980; El-Mansi et al., 1985) the effectors most likely to be significant in 
vivo are isocitrate, PEP, 3-phosphoglycerate, AMP, ADP and NADPH (Nimmo and 
Nimmo, 1984).
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ICDH ac tive
ATP
ICDH Phosphatase ICDH Kinase
ADP
ICDH - ®  Inactive
I s o c l tr a te , AMP, ADP, Pyruvate, 
Phosphoenol pyruvate, Oxaloacetate 
2-0xog1u fcarate,3-Phosphog1ycera te
NADPH
Figure 1.3 Control of ICDH kinase/phosphatase
Taken from Nimmo (1984). + and - represent stimulatory and inhibitory effects 
respectively.
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The metabolite isocitrate plays a key role in controlling the phosphorylation state of ICDH. 
The Km of ICDH for isocitrate has been estimated in intact cells to be 5|iM whereas that of 
ICL was estimated to be >260pM (Nimmo et a l ., 1988), much higher than the usual 
intracellular concentration of isocitrate (Bautista et al., 1979; El-Mansi et al. , 1985). It was 
proposed by Nimmo (1984) that during growth on acetate phosphorylation renders the 
ICDH rate limiting in the TCA cycle, resulting in an increase in the intracellular 
concentration of isocitrate. This increase in the isocitrate concentration facilitates flux 
through the glyoxylate bypass. A similar mechanism to explain how phosphorylation 
affects the division of flux between the TCA cycle and glyoxylate bypass was also 
proposed by Walsh and Koshland (1985).
There is a substantial amount of evidence, both experimental and theoretical, in support of 
these proposed mechanisms. Support for the role of isocitrate was provided by El-Mansi et 
al., (1985; 1986). These workers showed the intracellular concentration of isocitrate in 
E.coli to be much higher during growth on acetate than during growth on glucose or 
glycerol. Moreover the addition of pyruvate to cells growing on acetate caused a transient 
2-fold increase in the intracellular concentration of isocitrate. The role of phosphorylation 
seems to be to maintain the intracellular concentration of isocitrate at a level such that it can 
sustain the necessary flux through the glyoxylate bypass to produce biosynthetic 
precursors. The other effectors of ICDH kinase/phosphatase (figure 1.3) can also be 
explained in terms of metabolic control.OAA, pyruvate, 3-phosphoglycerate, 2- 
oxoglutarate and PEP are all precursors of biosynthesis. One would expect high levels of 
these to promote flux through the TCA cycle rather than the glyoxylate bypass. All these 
effectors are capable of completely inhibiting the kinase and activating the phosphatase 
(Nimmo and Nimmo, 1984). High concentrations of AMP and ADP represent a decrease in 
the energy charge of the cell and therefore also favour flux through the TCA cycle, 
activating the phosphatase and inhibiting the kinase. In addition NADPH acts to inhibit the 
phosphatase (Nimmo and Nimmo, 1984). NADPH is one of the end products of the TCA 
cycle and this effect may be thought of as feedback inhibition.
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Further amplification of the sensitivity of the ICDH phosphorylation cycle is the result of 
"zero-order ultrasensitivity" (LaPorte and Koshland, 1983) which refers to the situation 
where one or both converter enzymes are saturated with their substrates. The 
phosphorylation system can also respond to changes in the ICDH concentration in vivo 
(LaPorte et al., 1985).
In conclusion the system acts to integrate a variety of information in the form of metabolite 
concentrations. This information is used to adjust the phosphorylation state of ICDH so as 
to optimise the division of flux between the TCA cycle and glyoxylate bypass.
1.5 Mechanism of inactivation of ICDH by phosphorylation
1.5.1 Inactivation is a result of the negative charge of the phosphate
Many eukaryotic enzymes regulated by phosphorylation are allosteric proteins and 
phosphorylation often results in changes in the affinity of the target enzyme for a substrate 
or allosteric factor rather than changes in Vmax. In contrast ICDH is not an allosteric 
protein and the phosphorylated form is almost totally inactive. The unusual nature of this 
phosphorylation event has led a number of groups to investigate molecular mechanisms for 
the way in which phosphorylation causes inactivation of ICDH.
ICDH kinase transfers the y-phosphoryl group of ATP to the serine 113 residue of ICDH 
and this causes complete loss of enzyme activity when measured under Vmax conditions. 
Thorsness and Koshland (1987) showed that the inactivation of ICDH by phosphorylation 
was a result of introduction of the negative charge of the phosphate. They determined the 
complete nucleotide sequence of the gene for ICDH and then carried out site directed 
mutagenesis of the serine residue at position 113. Substitution of serine with aspartate 
resulted in complete inactivation of ICDH suggesting that it was the introduction of a 
negative charge in this position, when phosphorylated, which causes loss of activity.
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1.5.2 Phosphorylation inactivates ICDH by preventing isocitrate binding
Two proposed mechanisms for the inactivation of ICDH by phosphorylation have been 
suggested. Garland and Nimmo (1984) proposed that phosphorylation inactivated ICDH 
by preventing NADP from binding. However more recent results obtained by Dean et al. 
(1989) indicate that phosphorylation inactivates ICDH by preventing isocitrate from 
binding. Garland and Nimmo suggested that the NADP-binding site contained one or more 
positive charges that interact with the phosphate group of the co-enzyme and that this 
charge-charge interaction could trigger a conformational change which would block NADP 
binding. A certain amount of evidence was available in favour of this idea. Firstly inactive 
ICDH was unable to bind to a Procion red-Sepharose column whereas active ICDH bound 
to the column and could be eluted with NADP (Borthwick et al., 1984 a). It was therefore 
suggested that ICDH bound to the column via its NADP binding site. Garland and Nimmo 
also provided support for their idea from fluorescence studies which showed enhanced 
fluorescence of NADPH in the presence of native enzyme but not in the presence of the 
phosphorylated enzyme. Finally experiments by Garland and Nimmo using limited 
proteolysis showed that binding of NADP to the active enzyme significantly increased 
resistance to proteolysis, whereas it did not protect the phosphorylated form of the enzyme. 
The interpretations made from these experiments were that inactive enzyme cannot bind 
NADP and that binding of NADP and phosphorylation cause similar conformational 
changes.
Dean et al. (1989) carried out equilibrium binding studies which showed active ICDH to 
bind to a-ketoglutarate, NADP, NADPH and isocitrate at 1:1 ratios of enzyme to substrate 
monomer. In contrast phosphorylated ICDH was unable to bind isocitrate but maintained 
the ability to bind NADP and NADPH. These studies indicated that phosphorylation 
inactivates ICDH by preventing isocitrate from binding. Dean et al. (1989) correctly 
pointed out that the earlier evidence was indirect and that the failure of phospho-ICDH to 
bind to Procion-red Sepharose could be explained by other reasons. However, it is still true
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that the binding of NADP and phosphorylation of ICDH have similar effects on the 
enzyme. Further evidence of this was provided by McKee and Nimmo (1989). They 
showed the arginine specific reagent phenylglyoxal to inactivate ICDH by reacting with one 
arginine per subunit. This residue was protected from attack by either the presence of 
NADP or phosphorylation of ICDH. A mutant (R112Q) of ICDH was constructed (G.A. 
Nimmo personal communication) in which the arginine residue at position 112 was 
replaced by glutamine. This mutant was completely resistant to attack by phenylglyoxal 
confirming Argl 12 to be the site of attack.
1.5.3 Steric hindrance and electrostatic effects due to phosphorylation
As mentioned previously in section 1.5.1 variants of ICDH have been made, using site 
directed mutagenesis, in which Seri 13 was replaced with either aspartate or glutamate 
(Thorsness and Koshland, 1987; Dean and Koshland, 1990). The structures of these two 
mutant enzymes were determined using X-ray crystallography and compared to those of 
active ICDH and inactive ICDH (Hurley et al., 1990). Such comparisons showed the 
structure of the mutant enzymes to be be more similar to that of the active form of ICDH 
than that of the phosphorylated form. There were only slight structural shifts due to the 
presence of a negatively charged residue at position 113. Slight conformational changes 
were evident in phospho-ICDH as compared to the active, dephosphorylated form of the 
enzyme. However, as both mutant enzymes were also inactive it was apparent that 
inactivation is not a result of conformational changes.
Calculations made on the observed structures indicated that the change in electrostatic 
potential due to the introduction of a negative charge, either by site directed mutagenesis or 
phosphorylation is sufficient to inactivate ICDH. This prediction, based on structural and 
kinetic data, was confirmed by Dean and Koshland (1990) using a combination of site 
directed mutants and a substrate analogue of 2R, 3S-isocitrate (2R-malate) which lacks the
18
carboxyl group. The use of mutants in which Seri 13 had been substituted with aspartate or 
glutamate enabled the importance of electrostatic effects as a result of phosphorylation to be 
established. Similarly substitution with bulky residues such as tyrosine allowed for 
analysis of the steric effects of the phosphate group. Measurements of kinetic parameters of 
these mutant proteins were made in conjunction with the use of the isocitrate analogue, 2R- 
malate. The results indicated that the inactivation of ICDH by phosphorylation results from 
electrostatic repulsion and steric hindrance between the phosphoryl moiety and the y- 
carboxyl group of isocitrate and to a lesser extent from the loss of the hydrogen bond 
between the y-carboxyl group of isocitrate and serinel 13.
1.6 Other molecular mechanisms of phosphorylation
The regulation of enzymic activity by protein phosphorylation results from structural 
changes at the active site. There are known to be at least three different molecular 
mechanisms through which this control is mediated (Reviewed by Barford, 1991).
a) Control by allosteric interactions; studies on glycogen phosphorylase showed 
phosphorylation of this enzyme to occur at a site distinct from the active site which results 
in long range conformational changes causing the enzyme’s activity to increase (Sprang et 
aU 1988).
b) Control by direct interaction; the molecular mechanism of control of bacterial ICDH by 
phosphorylation falls into this category. As described in previous sections inactivation of 
the enzyme by phosphorylation at the active site results in the direct inhibition of substrate 
binding.
c) Control by phosphorylation of pseudo-substrate auto-inhibitory domains; this 
mechanism was proposed to explain the activation of pp70 ribosomal S6 protein kinase 
(Baneijee et al., 1990). The model proposes that the enzyme has a low basal activity as a 
result of a pseudo-substrate binding to the catalytic site. Phosphorylation of the pseudo- 
substrate domain causes it to dissociate from the active site thus activating the enzyme.
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1.7 The structure of E. coli ICDH
X-ray crystallography has been used to determine the structure of E. coli ICDH (Hurley et 
al., 1989). The structure was found to consist of three domains, a large a+B domain a 
small a  /B domain and an a/B clasp domain involving both subunits. Two pockets line the 
cleft between the large and small domains.
With the exception of the recendy determined structure of Thermus thermophilus 
isopropylmalate dehydrogenase, the E. coli ICDH structure was found to be topologically 
different from all other known dehydrogenase structures. The best known dehydrogenase 
structure is that of the lactate dehydrogenase-like class which includes lactate 
dehydrogenase, malate dehydrogenase, alcohol dehydrogenase and glyceraldehyde-3- 
phosphate dehydrogenase. The structure of the catalytic domains of these dehydrogenases 
vary, however the structure of their nucleotide binding domains are similar. This structure 
is termed the Rossmann or LDH fold after the enzyme it was first described for (Rossman 
et al., 1974) (figure 1.4). ICDH was found to contain a nucleotide binding fold which had 
not previously been characterised.
The phosphorylated residue serl 13 was found to lie in the front pocket on the protein's 
surface, presumably accessible to ICDH kinase /phosphatase. The position of the residue 
within the pocket was compatible with there being a direct phosphoserine-substrate 
interaction. Within this pocket there were a number of conserved residues including 
argl 19, argl29, argl53, tyrl60 and lys230. The conservation of these positive charges 
suggest a binding site for a negatively charged substrate and maybe a means of stabilising 
the oxyanion intermediate believed to occur in the ICDH reaction.
Comparisons of the amino acid sequence of ICDH with the known amino acid sequences 
of other proteins showed it to only have significant homology to isopropylmalate 
dehydrogenase (IMDH) (Thorsness and Koshland, 1987). The structure of T. thermophilus
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Figure 1.4 Schematic diagram of the LDH fold
An NAD+ molecule is shown in the position in which it is bound to the Spiny dogfish 
M-lactate dehydrogenase (LDH). From Wierenga et al.,(1986).
□= basic or hydrophobic amino acids.
A= small and hydrophobic amino acids.
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IMDH has recently been determined (Imada et al., 1991) and was found to have a similar 
nucleotide binding fold to that of ICDH.
1.8 Protein phosphorylation in prokaryotes
The control of ICDH by phosphorylation in E. coli was the first example of prokaryotic 
phosphorylation to be well characterised. It is now widely accepted that phosphorylation
plays an important role as a regulatory control mechanism in prokaryotes, however this has
/
not always been the case. For many years it was thought that protein phosphorylation did 
not occur in prokaryotic cells (e.g. Rubin and Rosen, 1975). Protein kinase activity had 
been detected in cells infected with bacteriophage T7 however kinase activity in uninfected 
cells was negligible. In addition U-V irradiation of the phage genome prevented appearance 
of the protein kinase whereas irradiation of the host genome did not. It was therefore 
concluded that the kinase activity was a phage gene product (Rahmsdorf et al., 1974; Zillig 
et al., 1972). However in 1978, Wang and Koshland used pulse labelling experiments to 
demonstrate the existence of at least four 32P containing proteins in Salmonella 
typhimurium. These proteins were labelled in vitro by the addition of [y-32P] ATP to 
crude cell extracts; 32P was incorporated as either phosphoserine or phosphothreonine 
residues.
Likewise Manai and Cozzone (1979) observed similar results in E. coli. Cortay et al. 
(1986) showed it was possible to resolve over 100 phosphorylated proteins from E. coli, 
much more than observed in previous studies, although few of these have been identified. 
Similar studies in other micro-organisms, such as Salmonella typhimurium (Ferro-Luzzi 
Ames and Nikaido, 1981) and Clostridium sphenoides (Antranikian, 1985 a) gave similar 
results although in these cases fewer phosphorylated proteins were detected than in E. coli. 
Contrary to original belief protein phosphorylation in prokaryotes is now believed to be a 
common occurrence.
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Evidence has been obtained from prokaryotic studies for examples of phosphorylation in 
metabolic control (e.g. the regulation of citrate lyase ligase (Antranikian, 1985 b )) and in 
the control of transport processes (the regulation of the phosphotransferase system in 
Streptococci (Reizer, 1983)). There is also evidence that phosphorylation controls gene 
expression e.g. the transcription of the gene for glutamine synthase, glnA (Ninfa and 
Magasanik, 1986).
Glutamine synthetase is the central enzyme in bacterial nitrogen metabolism and under 
limiting conditions mediates the entry of ammonia into anabolic metabolism. When cells are 
starved of nitrogen expression of the gene for glutamine synthetase (glnA ) is induced. This 
response to nitrogen starvation is one of a number of examples of a prokaryotic response 
system which uses a phospho-transfer network to convey an environmental signal to a 
range of response elements. These response elements control cell motility and regulation of 
gene expression. Other examples are reviewed in Stock et a l . (1990).
In all these examples two families of signal transduction proteins are employed to produce a 
response. One of these proteins is a histidine protein kinase (HPK) which uses ATP to 
phosphorylate itself at a histidine residue. The phosphoryl group is then transferred from 
the HPK to an aspartic acid side chain of the second protein, known as a response regulator 
which can control a wide variety of cellular activities including gene expression.
The full implications of protein phosphorylation in prokaryotes are as yet unclear as so few 
target proteins have been identified. However it is clear that phosphorylation functions as 
an important regulatory control mechanism.
1.9 The control of ICDH in other prokaryotes
As described in previous sections the control of ICDH by phosphorylation in E. coli has
23
been intensively studied and both the molecular details and physiological role are well 
established. It is likely that this mechanism is not unique to E. coli but operates in other 
prokaryotes. As a result of the early work of Bennett and Holms (1975) (section 1.2) it 
was thought likely that ICDH was controlled in a similar manner in other enteric bacteria 
including Klebsiella aerogenes, Salmonella typhimurium and Serratia marsescens.
ICDH has been purified from a large number of prokaryotic species including species of 
Bacillus, Thermus and cyanobacteria. ICDH from all these species was of a comparable 
size to E. coli ICDH and had the same subunit composition. However this is not the case 
in all prokaryotes. Studies on the micro-organism Acinetobacter calcoaceticus showed it 
to contain two isoenzymes of NADP linked ICDH. The two forms were termed isoenzyme- 
I and isoenzyme-II (Self and Weitzman, 1972). The two isoenzymes were originally 
separated by ion exchange chromatography or zonal ultracentrifugation. More recently 
f.p.l.c. MonoQ chromatography has been utilised in separating the two forms.
The two isoenzymes differ in the pH dependence of their activity, kinetic parameters, 
stability to heat or urea and molecular size. Isoenzyme-I has a molecular weight under
100,000 daltons resembling the NADP linked ICDH from E. co li. Isoenzyme-II resembles 
the NAD linked ICDH of eukaryotes in that it is a much larger enzyme of approximate 
molecular weight 300,000 daltons. In addition isoenzyme-II is allosterically controlled as is 
the NAD linked ICDH of higher organisms. The activity of the eukaryotic enzyme is 
dependent on the intracellular isocitrate concentration and enzyme activity is stimulated by 
AMP or ADP. Likewise the activity of A. calcoaceticus isoenzyme-II is also stimulated by 
AMP or ADP. A high concentration of AMP and ADP reflect a low energy charge within 
the cell and one might expect high levels of these to promote activity of the TCA cycle. In 
addition isoenzyme-II activity is increased by low concentrations of glyoxylate or 
pyruvate. Kinetic studies showed this stimulation to result from an increase in Vmax and a 
decrease in the apparent Km for both substrates. ICDH competes with the glyoxylate 
bypass enzyme, ICL, for available isocitrate and a balance has to be achieved at this branch
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point. The stimulation of ICDH by glyoxylate, a product of the glyoxylate bypass, may 
help to maintain the balance by partitioning isocitrate appropriately between the two 
pathways. There is some evidence to suggest that isoenzyme-II has two distinct regulatory 
sites, one for adenylate regulation and one for regulation by glyoxylate and pyruvate. 
Interaction of these sites with their specific effectors is thought to cause conformational 
changes leading to an increase in enzyme activity (Self et a l ., 1973).
Reeves et al. (1986) showed ICDH of A. calcoaceticus to exhibit unique behaviour during 
growth on acetate. These workers reported the specific activity of NADP dependent ICDH 
to increase whilst growing on acetate. This is in contrast to other bacterial ICDFTs 
studied which show a decrease in activity under these conditions. As mentioned previously
A. calcoaceticus contains two isoenzymes of ICDH. During growth on acetate an increase 
in the relative proportion of isoenzyme-II and a corresponding decrease in the amount of 
isoenzyme-I was observed. The increase in the allosterically controlled enzyme might have 
implications in the control of the branchpoint between the TCA cycle and the glyoxylate 
bypass, however, precisely how regulation is achieved is unsure.
Isoenzymes of NADP-dependent ICDH have been identified in other prokaryotes. Studies 
of the bacterium Vibrio ABE-I showed this micro-organism to contain two isoenzymes 
of ICDH termed IDH-I and IDH-II (Ishii et al.t 1987). IDH-I is a dimeric form of the 
enzyme with a subunit molecular weight of approximately 50,000 daltons; this form is 
similar to that of E. coli ICDH. The second form of ICDH, IDH-II, is a monomer of 
subunit molecular weight approximately 80,000 daltons. The N-terminal amino acid 
sequence of the two forms have been determined and show no similarity, the two forms 
are immunologically distinct The two isoenzymes were found to be differentially 
regulated in vivo under varying growth conditions. IDH-I was induced during growth on 
acetate whereas levels of IDH-II remained almost unchanged. The biological significance 
of this induction is uncertain but again may have implications in the control of the branch 
point.
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ICDH has recently been purified from Streptomyces coelicolor (R.D. Taylor personal 
communication) and also from Rhodomicrobium vannielii (Leyland and Kelly, 1991). Both 
these enzymes are monomeric proteins of approximate molecular weight 80,000 daltons.
On the basis of this information and on the immunological properties and N-terminal 
sequence of these enzymes it was proposed that these two types of ICDH could be 
grouped, with IDH-II from Vibrio spp. ABE-1, into a seperate class of enzymes (R.D. 
Taylor personal communication). It was proposed to call this class of enzymes the type n  
IDHs.
1.10 Thermophilic micro-organisms
1.10.1 Introduction
Most organisms which have been studied in great depth are adapted to growth at moderate 
temperatures and operate within a relatively narrow temperature range. In recent years there 
has been increasing interest in thermophilic micro-organisms which are adapted to 
environments of extreme temperature, such as thermal springs.
Thermophiles have been classified according to their maximum and optimum growth 
temperatures. The classification is somewhat imprecise but in general organisms which 
have optimum growth temperatures between 50-85°C are termed moderate thermophiles. 
Micro-organisms with optimum growth temperatures above 85°C are termed extreme 
thermophiles, some archaebacteria have been isolated with optimum growth temperatures 
as high as 110°C. (Wiegel and Ljungdahl, 1986; Stetler, 1982).
In order to survive at these temperatures the cellular constituents of thermophiles such as 
enzymes, nucleic acids and lipids and organised structures of this material, such as 
ribosomes and membranes also function at these high temperatures. How they are able to 
do this, in many cases, is as yet unknown.
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1.10.2 Advantages of thermophiles
Thermophiles are industrially important micro-organisms that offer a number of advantages 
over mesophiles for use in biotechnology processes. Because of their ability to grow at 
high temperatures their enzymes have a greater thermostability than those of mesophiles. In 
addition they are often extremely stable towards denaturing agents (Kristjansson, 1989). It 
is generally accepted that the increased thermostability of the enzymes is the result of an 
increase in the number of hydrophobic bonds, ionic interactions and disulphide bridges 
which stabilise all proteins. A considerable number of such enzymes have been purified 
from thermophiles and are commercially available. Examples of these are the DNA 
polymerases obtained from Thermus aquaticus (Taq polymerase) and more recently from 
Pyrococcus. DNA polymerase is employed in several molecular biology techniques, 
including nucleotide sequencing and the polymerase chain reaction (PCR). The extreme 
thermostability of these enzymes allows them to withstand the high temperatures often 
required for these procedures.
In addition to being a source of thermostable enzymes thermophiles have other advantages. 
When micro-organisms are grown on an industrial scale a considerable amount of cost is 
incurred by cooling processes for maintenance of the correct growth temperature. If 
thermophiles are used in place of mesophiles then these costs will be reduced. One such 
example of an industrial processes which uses thermophiles is starch hydrolysis for the 
production of high fructose syrup.
1.10.3 Bacillus caldotenax
Bacillus caldotenax was the micro-organism used in this study. First isolated in 1969 by 
Epstein and Grossowicz it is a moderate thermophile having an optimum growth
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temperature of between 55-60°C. A slender gram positive bacillus, it is 4-6|im long, 
0.2|im wide and actively motile. Studies of this micro-organism by Epstein and 
Grossowicz showed it to be very similar to the moderate thermophile Bacillus 
stearothermophilus, differing only in its ability to | hydrolyse starch.
B. stearothermophilus has been studied in considerable depth by many researchers. A 
wide variety of enzymes have been isolated from this organism including isocitrate 
dehydrogenase (Howard and Becker, 1970). In addition other aspects of B. 
stearothermophilus have been researched such as physiology and genetics, while 
comparatively little research has been carried out on B. caldotenax. Researchers in the past 
have found the growth requirements of B. caldotenax to be less fastidious than those of 
B .stearothermophilus. For this reason B. caldotenax was used in this study in preference 
to B. stearothermophilus. Although some aspects of thermophilic micro-organisms are 
fairly well documented very little is known about the regulation of their metabolism or how 
it compares to that of mesophiles.
1.11 Aims of this study
As explained in section 1.10 thermophiles are industrially important micro-organisms yet 
relatively little is understood about the regulation of their metabolism. In order to make any 
rational approaches to improving microbial biotechnological processes involving 
thermophiles it will be necessary to make use of or manipulate the regulation of enzyme 
activities.
The regulation of the TCA cycle enzyme ICDH and the control of isocitrate metabolism in 
E. coli have been well established. The aim of this project was to carry out a comparative 
study using the moderate thermophile B. caldotenax. It was thought that B. caldotenax
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would be a good model system for studying the control of central metabolic pathways and 
for the isolation of key genes in thermophiles.
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Chapter 2
Materials and methods
2.1 Materials
2.1.1 Chemicals and biochemicals
General chemicals of analytical reagent grade were obtained from BDH Ltd., Poole, 
U.K.; Boehringer Mannheim, Lewes, U.K.; Formachem Ltd, Strathaven, U.K.; FSA 
Laboratory Supplies, Loughborough, U.K.; Koch-Light Ltd, Haverhill, U.K.; May and 
Baker, Dagenham, U.K..
Ampicillin, dithiothreitol (DTT), ethidium bromide, Ficoll, Mops buffer, benzamidine 
hydrochloride, bovine serum albumin (for Bradford's protein determination), Coomassie 
Brilliant Blue G250, DL-isocitrate (trisodium salt), Tris buffer and Triton X-100 were obtained 
from Sigma (London) Chemical Co., Poole, Dorset, U.K..
Acrylamide, ammonium sulphate (enzyme grade), HC1 (Aristar), 2-mercaptoethanol, 
N,N’-methylenebisacrylamide, N,N,N’,N1-tetramethylenediamine, ATP, and NADH were 
obtained from Boehringer Mannheim, Lewes, U.K..
Amberlite MB3, bromophenol blue, caesium chloride and SDS were obtained from 
BDH Chemicals Ltd., Poole, Dorset, U.K..
Xylene cyanol was obtained from IBI Ltd., Cambridge, U.K..
Agarose, 5-bromo-4-chloro-3-indoyl-p-galactoside (X-gal), HI), isopropyl-p- 
thiogalactoside (IPTG), phenol (ultrapure), urea (ultrapure) and lkb ladder were obtained from 
Gibco, BRL Ltd., Paisley, U.K..
Bactotryptone, yeast extract and bactoagar (agar) were obtained from Difco, Detroit, 
USA. Oxoid No. 1 agar and trypticase soy broth were obtained from Oxoid Ltd., London, 
U.K..
Oligonucleotides were synthesised on an Applied Biosystems Model 280A DNA 
synthesiser using phosphoramidate chemistry by Dr. Veer Math (Department Of 
Biochemistry).
[y-32P]ATP and [a-35S]-dATP (code SJ.304) were obtained from Amersham 
International pic., Amersham, U.K..
The Sequenase version 2.0 sequencing kit was obtained from United States
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Biochemical Corporation (distributed by Cambridge BioScience, Cambridge, U.K.).
2.1.2 Enzymes and proteins.
The following enzymes were obtained from Boehringer Mannheim, Lewes, UK 
rabbit muscle aldolase (EC 4.1.2.13) 
pig muscle lactate dehydrogenase (EC 1.1.1.27) 
pig heart malate dehydrogenase (EC 1.1.1.37) 
rabbit muscle pyruvate kinase (EC 2.7.1.40) 
lysozyme (EC 3.2.1.17) 
calf intestine alkaline phosphatase 
A kit for molecular weight determination and the following enzymes and proteins were 
obtained from Sigma Chemical Co., Poole, UK. 
bovine albumin 
egg albumin
rabbit muscle glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12)
bovine erythrocyte carbonic anhydrase (EC 4.2.1.1)
bovine pancreas trypsinogen (EC 3.4.21.4)
soybean trypsin inhibitor
bovine milk a-lactalbumin
Escherichia coli p-galactosidase (EC 3.2.1.23)
rabbit muscle phosphorylase b (EC 2.4.1.1)
ribonuclease A (RNase A)
Normal goat serum and peroxidase conjugate goat anti rabbit IgG were from the Scottish 
Antibody Production Unit Ltd., Carluke, Lanarks, U.K..
Staphylococcus aureus V8 protease was obtained from Miles, Slough, U.K..
All restriction enzymes, T4 DNA ligase, and T4 Polynucleotide kinase were obtained from 
BRL, Gibco Ltd., Paisley, UK..
2.1.3 Chromatography media
Sephadex G-50 was supplied by Pharmacia, Milton Keynes, UK.
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Procion-red Sepharose was a gift from Dr H.G. Nimmo.
2.1.4 Pre-packed media
Pre-packed Mono Q, and Superose 12 columns were obtained from Pharmacia and utilised on a 
Pharmacia f.p.l.c. system. Genpak FAX and 11 Bondapak C18 reverse phase columns were 
purchased from Waters Chromatography, Watford, U.K. and attached to a Beckman System 
Gold h.p.l.c. apparatus ( Beckman Instruments Inc., High Wycombe, U.K.).
2.2 General biochemical methods
2.2.1 pH measurements
All pH measurements were made with a Radiometer pH probe calibrated at room temperature 
using standards of pH 7.0 and pH 4.0 prepared from tablets obtained from the manufacturer.
2.2.2 Conductivity measurements
Conductivity measurements were made on a Radiometer conductivity meter, type CDM2e 
(Radiometer, Copenhagen, Denmark).
2.2.3 Glassware and plastics
Glassware was washed in Haemo-sol solutions (Alfred Cox (Surgical) Ltd., U.K.), rinsed 
with tap water and then distilled water and dried in an oven. Plastic tips for micropipettes and 
Eppendorf tubes were taken from a newly opened bag.
2.2.4 Distilled water
Glass distilled water stored in polythene containers was used in all experiments.
2.2.5 Protein estimations
Protein concentrations were determined by the method of Bradford (1976). This method is
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based on the binding of Coomassie Brilliant Blue to the protein. The reagent was prepared by 
dissolving lOOmg Coomassie Brilliant Blue G250 in 50ml of 95% (v/v) ethanol and 85% (w/v) 
orthophosphoric acid. The reagent was made up to 1 litre with distilled water and filtered. For 
each of the assays, a standard curve in the range 0-25 fig protein was obtained using a 1 mg/ml 
BSA solution which was made up assuming that a lmg/ml BS A solution has an absorbance of 
0.62 at 280nm. To each sample, 2.5ml of Bradford Reagent were added, the samples vortexed 
and allowed to stand for 2 min. The absorbances were recorded at 595nm. The amount of 
protein present in the unknown samples was estimated from the standard curve. Protein 
concentrations of the fractions eluted from columns were monitored at 280nm.
2.2.6 Dialysis
Dialysis membranes (Scientific Instruments Centre Ltd., London), were boiled for 5 min in 1% 
(w/v) EDTA, pH7.0, stored in 20% ethanol and rinsed in distilled water prior to use.
2.2.7 Preparation of chromatographic media
All columns were poured at room temperature and packed at higher flow rates than would be 
used during a run, then moved to a 4°C cold room. Columns were stored in 0.02% (w/v) 
sodium azide and equilibrated with starting buffer before use.
2.2.8 Spectrophotometric determination of nucleic acid concentrations
Nucleic acid concentrations were determined spectrophotometrically at 260nm (Sambrook et 
al.t 1989). In a 1 cm path length quartz cuvette an absorbance of 1.0 corresponds to 50 |ig/ml 
for double stranded DNA, 40 fig/ml for single stranded DNA and approximately 20 |ig/ml for 
single stranded oligonucleotides.
2.2.9 Sterilisation
Solutions for the preparation of growth media and solutions used in manipulation of nucleic 
acids were autoclaved in a B&T Autoclave 225E (Laboratory Thermal Equipment U.K.) at 15 
p.s.i. for 25 min, except carbon sources which were autoclaved at 5 p.s.i. for 50 min.
Because of their probable heat lability, the following compounds were sterilised by filtration
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through 0.22 p.m pore-sized Millex G.V. filters (Millipore Ltd., U.K.) into sterile bottles: 
ampicillin, methionine and IPTG.
2.2.10 Gel drying and autoradiography
Polyacrylamide gels were dried onto Whatman 3MM paper using a Biorad Laboratories Gel 
Drier model 1125 connected to an Aquavac Junior multi-purpose vacuum unit (Uniscience 
Ltd., London).
32P in polyacrylamide gels or on filters was detected by exposure to FujiRX film using 
intensifying screens at -70°C. 35S was detected by exposure to film in the absence of 
intensifying screens at room temperature. Films were developed by a Kodak X-OMAT 
processor Model ME-3.
2.3 Microbiological techniques:
2.3.1 Bacterial strains and plasmids
The E. coli strains are derivatives of E. coli K12. The bacterial strains used in this study are 
shown below;
Bacterial strain Relevant characteristics Reference /source
E. coli DS941 rec Flac Iqlac ZdelM15 Gift from Prof. D. Sherratt
(Institute of Genetics, Glasgow 
University)
E. coli XLl-blue supE hsdR lac- Bullock et al. (1987)
FprnAB+lacIQ/acZAMl 5
Bacillus caldotenax was obtained from The Public Health Laboratory Service, Centre for 
Applied Microbiology and Research (P.H.L.S. C.A.M.R.), Porton, Wilts.
The plasmid pUC18 was obtained from Pharmacia and the plasmid pBluescript ™  IIKS+ was
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obtained from Stratagene Ltd. (La Jolla, CA, USA).
2.3.2 Growth Media
Unless otherwise stated, all media were sterilised by autoclaving at 15 p.s.i. for 25 min. 
al Bacillus caldotenax growth media:
Solid growth media (per litre) trypticase soya broth 30g
Difco agar 15g
Liquid culture media (per litre) NH4C1 2.14g
KH2P 04 0.3g
yeast extract l.Og
tryptone 1 .Og
The remaining constituents were added by filtration, post sterilisation.
MgQ2 0.03g
CaCl2.6H20  0.005g
FeS04.7H20  0.004g
Kuhns salts 1.5ml
methionine 0.15g
biotin 0.0015g
In addition 5ml of a 50% solution of a carbon source were added to the media, this was 
generally glutamate. The pH of the media was adjusted to pH7 with Na0H/H3P04 The growth 
temperature was 60°C.
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K) Escherichia coli growth media:
L-Broth (per litre)
L-Agar (per litre)
bactotryptone lOg
yeast extract 5g
NaCl lOg
(+5ml 20% (w/v) glucose) 
pH7.5 with NaOH
As for L-broth, +15g Difco-agar.
2xTY Medium (per litre) bacto-tryptone 16g
yeast extract lOg
NaCl 5g
2.3.3 Selection supplements
The following supplements were added to rich media to select and identify recombinant 
organisms:
a") antibiotics
Ampicillin (Amp) was used at a final concentration of 50 pg/ml. A stock solution of 25 mg/ml 
was filter sterilised and stored at -20°C. Hot L-agar was cooled to 55°C before ampicillin was 
added. L-Amp plates were stable for at least 4 weeks if stored at 4°C.
b) chromogenic substrates
X-gal and IPTG were used at a final concentration of 20 ng/ml. A stock solution of IPTG of 
20 mg/ml was filter sterilised and stored at -20°C. A stock solution of X-gal (20 mg/ml) was 
made up in DMF and stored at -20°C.
2.3.4 Growth of bacteria
a) Bacillus caldotenax
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For general purposes cells were grown on a large scale using an 8 litre fermenter at the Public 
Health Laboratory Service, Centre for Applied Microbiology and Research (P.H.L.S. 
C.A.M.R.), Porton, Salisbury. For the purpose of phosphorylation studies cells were grown 
on a small scale in 250ml conical shake flasks on an orbital shaker at 60°C.
b) Escherichia coli
10ml of media in a 20ml universal bottle was inoculated from a loop of a single colony from a 
plate or from lOpl of a glycerol stock. 100ml of media in a 250ml conical flask was inoculated 
with 500[il of an overnight 10ml L-broth culture. Cultures were grown on an orbital shaker at 
37°C.
2.3.5 Measurement of growth
Bacterial cell density was measured as an apparent absorption at either 420nm or 600nm. The 
measurements were carried out in 1 cm light path cuvettes using a Unicam SP500 
spectrophotometer (Pye Unicam Instruments Ltd., U.K.) equipped with a Gilford photoelectric 
detector and digital read out If necessary, the culture samples were diluted 1:10 to give an 
absorbance of less than 0.5.
2.3.6 Harvesting of bacteria
Cells were harvested by centrifugation at 6,000g for 15 min at 4°C (MSE 18 with an 8x250ml 
rotor).
2.3.7 Disruption of bacteria
a) Ultrasonic Disruption
A sample of culture (2.5ml) was placed in a 2-dram vial within a brass holder (Holms and 
Bennett, 1971) surrounded by an ice/water slurry. The sample was ultra-sonicated (Dawe 
Soniprobe type 1130A from Dawe Instruments Ltd., London) for six 30 sec periods alternating 
with five 30 sec cooling periods.
b) French pressure cell disruption
37
Bacterial cell pellets were gradually resuspended in 2 volumes of 50mM potassium phosphate 
pH7, ImM EDTA, 2mM MgC^, ImM benzamidine, ImM DTT at 4°C and disrupted by 2 
passages through a French pressure cell (Cat No. 4-3398A, American Instruments Company, 
Maryland, U.S.A.) at a pressure of 98 MPa (14,300 p.s.i.). The pressure cell, capacity 40ml, 
was cooled on ice before use.
2.4 Enzyme assays
2.4.1 Equipment
Unless otherwise stated all spectrophotometric assays were performed at 50°C using a Gilford 
Unicam SP 500 spectrophotometer equipped with a Gilford photoelectric detector and recorder. 
Quartz cells with a path length of 1cm were used. One unit of enzyme activity is defined as the 
amount of enzyme required to catalyse the disappearance of lpmol of substrate, or the 
appearance of lpmol of product /  min. For the purpose of kinetic measurements a Perkin- 
Elmer LS-5 luminescence spectrometer was used with an excitation wavelength of 340nm and 
a detection wavelength of 460nm (slit width lOnm for both).
2.4.2 Assay for isocitrate dehydrogenase
ICDH activity was assayed by a method based on that of Reeves et al. (1972). The assay 
contained in a total volume of 1ml, 0.15 M Tris/HCl buffer pH7.5, 0.5mM MnCl^ 0.4mM 
NADP+, 2.5mM DL-isocitric acid and enzyme suitably diluted. The reaction was initiated by 
the addition of the enzyme and the reduction of NADP+ was monitored at 340nm.
2.4.3 Assay for isocitrate dehydrogenase kinase/phosphatase
ICDH kinase/phosphatase activity was measured essentially by the method of Nimmo et al. 
(1984). The incubation was contained in a total volume of 90pl consisting of, 25|il 50mM 
Mops-NaOH pH7.3,45|il 50mM Bicine/NaOH pH 9 containing 2mM DTT, 9|Xl 50mM ATP, 
lpl 1M MgCl2. A suitable concentration of purified ICDH from either E. coli or B.
38
caldotenax and E. coli ICDH kinase/phosphatase were also present in the assay mixture. 
Incubations were carried out at 37°C the reactions being initiated by the addition of the ATP 
solution. Samples were removed over a time course to assess ICDH activity (section 2.4.2 
above) hence any change in ICDH activity was monitored.
2.5 Polyacrylamide gel electrophoresis of proteins
2.5.1 Denaturing electrophoresis
Protein samples were analysed by discontinuous slab gel electrophoresis in the presence of 
SDS according to Laemmli (1970). Glass plates were separated by 1.5mm spacers and sealed 
with 1.0% (w/v) agarose. Gels were prepared from the volumes of stock solutions shown in 
table 2.1. The acrylamide, Tris buffer and distilled water were mixed and degassed; SDS, 
ammonium persulphate and TEMED were added and the gel was poured into the cast 
immediately. Isopropanol was layered onto the separating gel and rinsed off upon 
polymerisation. The stacking gel was then made up and poured around a well-forming 
template. The wells were rinsed with distilled water after polymerisation. The electrophoresis 
buffer consisted of 25mM Tris/192mM glycine, pH8.8, 0.1% (w/v) SDS. Electrophoresis was 
carried out at a constant current of 50mA.
Protein samples were mixed with at least an equal volume of sample buffer, consisting of 
50mM Tris/HCl pH6.8, 1% (w/v) SDS, 10% (v/v) glycerol, 0.01% (w/v) bromophenol blue 
and 1% (v/v) 2-mercaptoethanol. For the purpose of phosphorylation experiments, where 
larger sample volumes were involved, 5x concentrated sample buffer was used.
2.5.2 Protein staining
Protein was routinely localised on gels by staining with Coomassie blue. The Coomassie 
reagent was 0.1% Coomassie brilliant blue G250 in 10% (v/v) glacial acetic acid, 50% (v/v) 
methanol and destain reagent was 10% acetic acid, 10% methanol. These procedures were 
carried out at 40°C. When a more sensitive detection method was required gels were silver
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Table 2.1 Preparation of polyacrylamide gels
Quantities and stock solutions used:
stock solution stacking gel (ml) separating
10%
30% (w/v) acrylamide/ 1.5 10
0.8% (w/v) bisacrylamide
1.5M Tris/HCl pH8.8 - 7.5
0.5M Tris/HCl pH6.8 3.75
H20  9.45 12.05
10% (w/v) SDS 0.15 0.3
10% ammonium persulphate 0.15 0.15
(freshly prepared)
TEMED 0.01 0.01
gel (ml) 
15%
15
7.5
7.05 
0.3 
0.15
0.01
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stained. The silver reagent was 0.8% (w/v) AgN03, 0.08% (w/v) NaOH, in 200 mM 
(NH4)OH. The developer reagent was 0.02% (v/v) formaldehyde, in 0.24 mM sodium citrate. 
The method was adapted from Wray et al. (1981). Gels were first soaked in 50% (v/v) 
methanol for at least 8 hours, then incubated for 8 minutes in freshly prepared silver reagent. 
After washing with distilled H20  for one hour the gel was developed with fresh developer until 
protein bands appeared. The reaction was then terminated by washing with distilled H20  and 
the gels stored in 10% (v/v) acetic acid, 10% (v/v) methanol.
2.6 Purification buffers
The buffers used in the purification of ICDH from B. caldotenax were as follows: 
buffer A 50mM KH2P04, ImM EDTA pH7
buffer B lOmM KH2 P04 ImM EDTA, 5mM potassium citrate, 5mM MgCL^ 10% 
glycerol, pH7 
The pH of these buffers was adjusted with KOH
2.7 Peptide mapping (Cleveland Mapping).
Peptides were generated from ICDH by the method of Cleveland (1977). Homogenous ICDH 
was run on a 10% polyacrylamide gel by the system of Laemmli (section 2.5.1), stained with 
Coomassie Brilliant Blue (section 2.5.2) and rapidly destained. The bands of protein were 
excised from the gel and rinsed several times in 0.125M Tris/HCl pH 6.8 containing ImM 
DTT and 0.1% SDS. The gel chips containing ICDH were loaded onto a 15% polyacrylamide 
gel and overlayered with 20}il of buffer (0.125M Tris/HCl pH 6.8, ImM DTT, 0.1% SDS, 
20% glycerol) followed by 50ng of protease in a volume of 20|il. The gel was run at 45mA 
until the dye front was nearing the end of the stacking gel, the current was then switched off 
for 30 min to allow digestion to occur. After this time the gel was run to completion. Peptides 
for protein sequence analysis were electroblotted (section 2.9.3). Otherwise peptides were 
visualised by silver staining (section 2.5.2).
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2.8 Immunoblotting techniques
The method is based on that described by Towbin et al. (1970) as modified by Batteigner et 
al. (1982).
Stock solutions:
Buffer A (transfer buffer) 20mM Tris/HCl pH 7.2
150mM NaCl 
0.5% (w/v) tween 20
Buffer B (blocking buffer) 20mM Tris/HCl pH 7.2
150mM NaCl
Buffer C (chloronapthol stain) 50ml lOmM Tris/HCl pH 7.4
30mg chloronapthol in 10ml methanol 
150|il 4% (v/v) H20 2 
H2O2 was mixed immediately before use.
Experimental procedure:
SDS PAGE was carried out as in section 2.5.1. When electrophoresis was complete the 
proteins were transferred to 0.45M nitrocellulose paper (Adderman and Co., Kingston-upon- 
Thames) using a Bio-Rad trans-blot cell containing bufferA with 16.6% methanol. The current 
was run at 350 mA for 4 hours, after which the nitrocellulose paper was placed in buffer B 
containing 5% normal donkey serum at 4°C for at least 16 hours. The nitrocellulose paper was 
then rinsed twice in buffer B. The paper was then soaked in Buffer A containing 5% (v/v) 
normal donkey serum and 0.5% (v/v) antiserum at 25°C for 90 min, after which the 
nitrocellulose paper was washed 4x12 min in Buffer A then 1x12 min in Buffer B. The 
nitrocellulose paper was then soaked in Buffer B containing 5% (v/v) normal donkey serum 
and 0.05% (v/v) peroxidase conjugate donkey anti rabbit IgG at 23°C for 90 min, washed 
5x12 min in Buffer B and developed by soaking in Buffer C at 23°C. The final product was 
then washed in distilled water dried and stored.
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2.9 Protein sequencing
2 .9 .1  Preparation of intact B. caldotenax ICDH for protein sequencing
Approximately 1 nmol of homogenous B. caldotenax ICDH in a volume of lOOpl 0.5% (w/v) 
ammonium bicarbonate (pH7.5) was loaded onto a Waters bondapak C l8 reverse phase 
column (section 2.1.4). The column was equilibrated with milliQ grade distilled water 
containing 0.15% TFA at a flow rate of lml/min. The protein was eluted with h.p.l.c. grade 
acetonitrile containing 0.1% TFA, a linear gradient was run over 45 min and the eluant 
monitored at 280 nm. ICDH was eluted as a sharp peak at 77% acetonitrile and collected in a 
volume of 1ml. Sequencing was carried out as described in section 2.9.4.
2.9.2 Preparation of peptides for protein sequencing
Peptides were generated from 120|ig of purified protein by the method of Cleveland (section
2.6). Digestion of the protein was carried out using V8 protease, the peptides were resolved in 
a 15% polyacrylamide gel which was electroblotted.
2.9.3 Electroblotting
For the purpose of sequencing all reagents used were of the highest available purity, solutions 
and buffers were made using milliQ grade water. A 15% polyacrylamide gel containing 
peptides (section 2.6 )was soaked for 5min in transfer buffer (lOmM CAPS pH ll, 10% (v/v) 
methanol). A piece of Problott™ (Applied Biosystems) membrane wetted in 100% methanol, 
and soaked in transfer buffer was placed on top of the gel. The gel and membrane were 
sandwiched between two pieces of 3MM paper and two abrasive pads, also soaked in transfer 
buffer, and the whole was supported in a cassette. The cassette was placed in a Bio-Rad trans- 
blot cell with transfer buffer. Blotting was carried out for lhour at 50V. The Problott 
membrane was washed in milliQ water, dipped in 100% methanol and stained for lmin with 
Coomassie Brilliant Blue R-250 (CBBR 0.1%, 50% methanol, 50% water). The blot was 
destained in several changes of destain (50% methanol, 50% water), rinsed in water and air 
dried. Protein staining bands were excised from the blot and used for sequencing.
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2.9.4 Liquid-phase sequencing
Electroblotted peptides of B. caldotenax ICDH and a sample of intact protein were sequenced 
on an Applied Biosystems model 4774 pulsed liquid phase sequencer with on-line detection of 
amino acid thiohydantoins by a model 120A analyser. The instrument was operated by Dr s. M. 
Cusack and G.B. Curry, Department of Geology, University of Glasgow.
2.10 Molecular weight determinations
2.10.1 Subunit M r
SDS PAGE was used to estimate the subunit Mr of the purified protein. A Sigma Chemical Co. 
molecular weight marker kit was used to calculate subunit Mr. The proteins used to produce 
standard curves of Rf against log Mr are listed below:
Protein Subunit M r (daltons)
bovine albumin 66 000
egg albumin 45 000
rabbit muscle glyceraldehyde-3-phosphate 36 000
bovine erythrocyte carbonic anhydrase 29 000
bovine pancreas trypsinogen 24 000
soybean trypsin inhibitor 20 100
bovine milk -lactalbumin 14 200
Values for subunit molecular weights were taken from Weber and Osborn (1969) and Mousdale 
etal. (1987).
2.10.2 Native M r
Gel permeation chromatography on a Superose 12 column was used to estimate the native Mr 
of the purified protein. This was carried out at room temperature using a Pharmacia f.p.Lc. 
apparatus. The column was eluted with 50 mM potassium phosphate pH 7,0.4 mM DTT (flow 
rate = 0.3 ml/min, fraction size 0.3 ml). The eluate was monitored at 280nm and the column
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calibrated with the following proteins :
Protein Native Mr (daltons)
pig heart malate dehydrogenase 
pig muscle lactate dehydrogenase 
rabbit muscle aldolase
70 000
140 000
160 000
rabbit muscle pyruvate kinase 
horse apoferritin
232 000
440 000
2.11 Phosphorylation studies
2.11.1 In vitro phosphorylation studies
a'l Detection of changes in B. caldotenax ICDH activity 
Changes in B. caldotenax ICDH activity as a result of the action of E. coli ICDH 
kinase/phosphatase activity were detected using the ICDH kinase/phosphatase assay described 
in section 2.4.3. A suitable concentration of B. caldotenax ICDH was used in the assay in 
place of E. coli ICDH.
fr) Detection of 32P incorporation into ICDH
To measure the incorporation of 32P into ICDH the ICDH kinase/phosphatase assay (section 
2.4.3) was used. 5mM ATP was replaced in the assay with 2mM [y-32P]ATP (20|iCi/|imol). 
Samples were removed from the assay for analysis by gel electrophoresis (section 2.5.1). Gels 
were stained for protein with Coomassie Brilliant Blue, dried and autoradiographed (sections
2.5.2 and 2.2.10).
2.11.2 Phosphorylation studies in crude extracts
a) Preparation of the crude extract
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Approximately 0.5g of B. caldotenax cells were resuspended in 3ml 50mM KH2P04, ImM 
EDTA pH 7. Cells were broken open by sonication (section 2.3.7 a). Cell debris was 
precipitated by 5min centrifugation in a microfuge, to obtain a cell free extract
bl Phosphorylation in crude extracts
[y-32P] ATP was added to the crude extract to give a final concentration of 2mM ATP 
(20|iCi/|imol). Incubations were carried out at 50°C and samples removed over a time course 
for analysis by one of the two following methods:
i) Analysis by gel electrophoresis:
20|il samples were removed and the reaction stopped by boiling for 2min with 5|il 5x normal 
sample buffer. Samples were analysed by SDS PAGE, stained with Coomassie Blue, dried 
and autoradiographed (sections 2.5 and 2.2.10).
ii) Immunoprecipitation of ICDH:
30p.l samples were removed, mixed gently with 50|il anti E. coli ICDH antiserum and 
incubated on ice for 60 min. The sample was then microfuged for 2 min and the supernatant 
discarded. The pellet was washed in 1ml 1.5M NaCl, 2mM EDTA pH 7. The sample was 
microfuged for a further 2 min and the supernatant discarded. The pellet was resuspended in 
20jil normal sample buffer and boiled for 2min prior to analysis by SDS PAGE followed by 
autoradiography (sections 2.5 and 2.2.10).
2.11.3 Phosphorylation in vivo
A 10ml culture of B. caldotenax was grown overnight using the liquid culture media described 
in section 2.3.2 and acetate as the carbon source. The culture was grown in the presence of 
32Pi with a final specific activity of 20(iCi/[imoLCells were harvested by 5min microfugation 
in 10 x 2.5ml microfuge tubes and washed extensively with buffer (50mM KH2P04, lOmM 
pyrophosphate, ImM EDTA) to remove free 32Pi. The cells were broken open by sonication 
(section 2.3.7 a).
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2.12 General recombinant DNA techniques
2.12.1 Small scale plasmid purification
The method employed for small scale plasmid DNA preparation was based on the method of 
Bimboim and Doly (1979). 5ml of L-broth, containing the appropriate antibiotic, were 
inoculated with a single colony of plasmid transformed cells and grown overnight 1.5 ml of 
the overnight culture was harvested in a microfuge and the cell pellet resuspended in 100 pi 
GTE (50mM glucose, 25mM Tris/HCl, pH8.0, lOmM EDTA). 10 pi freshly prepared 
lysozyme (lOmg/ml) was added and incubated at room temperature for 5 min. 200 pi freshly 
prepared 0.2M NaOH, 1% (w/v) SDS was added, mixed gently and incubated on ice for 5 
min. 150 pi ice cold 5M potassium acetate (pH4.8) was added and the lysate incubated on ice 
for 5-15 min. Cell debris was removed by micro-centrifugation. The supernatant was removed 
to a fresh microfuge tube and the plasmid DNA phenol/chloroform extracted (section 2.12.8). 
The supernatant was placed into a fresh tube and the DNA precipitated by the addition of 2 
volumes ethanol at room temperature. After incubation at room temperature for 2 min, the 
plasmid DNA was recovered by micro-centrifugation at 4°C (cold room) for 5 min. The pellet 
was washed with 200 pi 70% (v/v) ethanol, air dried for 5-15 min and resuspended in 30 pi 
TE (lOmM Tris/HCl, pH8.0, ImM EDTA). A 5 pi sample was sufficient for digestion by 
restriction enzymes. During the digestion, lpl boiled RNase A (lOmg/ml) was added to the 
digest for the last 15 min of the incubation at 37°C.
2.12.2 Large scale plasmid purification
The method employed was based on the alkali lysis method of Bimboim and Doly (1979) and 
was used to purify milligram quantities of plasmid DNA.
100 ml of L-broth, containing the appropriate antibiotic, were inoculated with a single colony 
of plasmid transformed cells. The culture was incubated at 37°C overnight (16 hours) on an 
orbital shaker. The bacterial cells were harvested by 10 min centrifugation at 4000g, 4°C (MSE 
18,6x250ml rotor). The cell pellet was resuspended in 5ml GTE containing a concentration of 
5mg/ml lysozyme and the suspension incubated at room temperature for 5min. 10 ml of 0.2M 
NaOH, 1% (w/v) SDS were added, gently mixed by swirling and incubated on ice for 10 min
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Lysis was achieved by addition of 7.5 ml of ice cold 5M potassium acetate, pH4.8, followed 
by rocking to mix and incubation on ice for 10 min. Bacterial cell debris was removed by 
centrifugation (12,000g, 15 min, 4°C, MSE 18, 8x50ml rotor). The supernatant was filtered 
through gauze to remove floating cell debris and nucleic acids precipitated by the addition of 
0.6 volumes of isopropanol. After incubation at room temperature for 15 min, the nucleic acid 
was recovered by centrifugation (MSE 18 8x50 ml rotor, 12,000g, 10 min, 25°C). The pellet 
was washed with 70% (v/v) ethanol, air dried for 10-20 min and resuspended in 5ml 50mM 
Tris/HCl, pH8.0, lOmM EDTA.0.5 ml ethidium bromide, 10mg/ml., was added together with 
CsCl to a final concentration of lg/ml. The gradient was then set up by centrifugation at 
289,000g for 16 hours at 25°C in a Beckman Ti70.1 rotor in polycarbonate tubes. The DNA 
bands were usually visible, however if the bands were not visible, long wavelength U.V. light 
was used to visualise the plasmid band which migrates in front of the host chromosomal DNA. 
The plasmid band was removed by gently inserting a sterile pipette tip to just below the plasmid 
band. Ethidium bromide was removed by extracting several times with TE (lOmM Tris/HCl, 
pH8.0, ImM EDTA) saturated 1-butanol. The DNA was diluted to double the volume with 
distilled water, precipitated twice with ethanol (section 2.12.9) and resuspended in 0.2 ml TE. 
The DNA concentration and purity C^260/A28o) was measured spectrophotometrically.
2.12.3 Preparation of B. caldotenax genomic DNA
Total DNA of B. caldotenax was prepared essentially as described by Saito and Miura (1963).
2.12.4 Digestion of DNA with restriction enzymes
The methods used were as described in Sambrook et al. (1989). Restriction digests were 
carried out using the BRL React buffers which were provided with each batch of enzyme.
There are ten different React buffers with a range of salt concentrations, each one suitable for a 
range of enzymes. Analytical digests were carried out in a volume of 10 or 20 pi at 37oC. 
Preparative digests were carried out in larger volumes. When DNA was digested with two 
restriction enzymes, the endonuclease requiring the lower salt buffer was used first. After the 
recommended duration of digestion the salt concentration was adjusted and the second enzyme
48
added.
2.12.5 Agarose gel electrophoresis
DNA was separated at room temperature on horizontal submerged agarose gels as described by 
Sambrook et al. (1989). The Tris-borate (TBE) buffer system was employed. A 0.8% (w/v) 
agarose gel was used to size restriction fragments accurately in the range of 0.8-10 kb.
Samples for agarose gels were prepared by addition of 0.2 volumes of 10 mM Tris/HCl 
pH7.2, 20% (w/v) ficoll, 0.5% (w/v) bromophenol blue and 10 mg/ml ethidium bromide. 
Ethidium bromide (0.5 |ig/ml) was added to both gel and buffer,, and stained DNA bands 
visualised on a long wave U.V. transilluminator (U.V. Products Inc.). Restriction fragment 
markers of known size were run alongside the unknown fragments, usually X DNA digested 
with HindJlI, or with EcoRl+HindEl. For restriction mapping a lkb ladder was used.
2.12.6 Size fractionation of restriction fragments
In order to construct a sub-library of B. caldotenax genomic DNA, restriction fragments 
within a particular size range were selected. This selection was achieved by use of a Waters 
GenPak FAX column (section 2.1.4). Approximately 20fig of genomic DNA were digested 
with an appropriate restriction enzyme. The restriction fragments were loaded onto the column 
which was equilibrated in buffer A (25mM Tris/HCl, ImM EDTA pH7.5). Restriction 
fragments were eluted with a gradient produced using buffer B(buffer A+1M NaCl). The 
gradient was run from 0-75% NaCl over 40min, kept constant for lOmin, and then increased to 
100% over a further 20min period.The flow rate was 0.5ml/min. Fractions of 125pl volume 
were collected and DNA recovered by ethanol precipitation. Test samples from the fractions 
were analysed by agarose gel electrophoresis (section 2.12.5) to establish which fraction 
contained DNA of the required size.
2.12.7 Recovery of DNA from agarose gels:
The DNA band of interest was visualised by ethidium bromide staining and a long wave U.V. 
transilluminator (U.V. Products Inc.). The desired DNA band was excised from the gel. A 
hole was pierced in the base of a sterile 0.5ml Eppendorf using a sterile syringe needle and then
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plugged with a small amount of sterile, siliconised glass wool. The agarose gel chip containing 
DNA was placed into the Eppendorf which in turn was placed inside a 1.5 ml Eppendorf and 
microfuged for lOmin at 6,500 rpm. The 1.5 ml Eppendorf was then removed and the buffer, 
containing DNA, retained. The smaller Eppendorf was microfuged once more collecting any 
remaining DNA in a fresh Eppendorf. The two DNA containing fractions were pooled and 
microfuged at 12,000 rpm, at 4°C for 30min to remove any traces of agarose. The supernatant 
was decanted and DNA recovered by ethanol precipitation. DNA obtained in this way was 
sufficiently pure for cloning purposes.
2.12.8 Phenol/chloroform extraction of nucleic acids:
Restriction digests and other solutions containing DNA were deproteinised by extracting with 
phenol and chloroform. The volume of the sample was measured and an equal volume of TE- 
saturated phenol:chloroform:isoamyl alcohol (25:24:1) was added. This mixture was vortexed, 
allowed to stand until the two layers separated and vortexed again. The two layers were 
separated by centrifugation in a microfuge for 5 min. The top layer was removed into a fresh 
tube and an equal volume of TE added to the bottom, phenol layer. The mixture was vortexed 
and the two layers separated as in the first extraction. The two aqueous , top, layers were 
pooled and extracted in an identical manner with an equal volume of TE-saturated 
chloroform/isoamyl alcohol (24:1) to remove any residual traces of phenol. The DNA was 
recovered from the aqueous layer by ethanol precipitation (section 2.12.9).
2.12.9 Ethanol precipitation
Sodium acetate was added to the DNA solution to a final concentration of 0.3M by adding 0.1 
volumes of a 3M solution. 2.5 volumes of cold ethanol (-20°C) were added and mixed. The 
mixture was then incubated at -20°C overnight or alternatively, at -80°C for 1 hour and the 
precipitated DNA recovered by centrifugation in a microfuge at 4°C for 30 min or for larger 
volumes, centrifugation at 10,000 rpm for 30 min at 4°C (MSE 18, 8x50ml rotor). The DNA 
pellet was washed in 70% (v/v) ethanol and resuspended in a suitable volume of TE.
An alternative to the addition of sodium acetate was to add 0.5 volumes of 7.5M ammonium
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acetate, however, when the DNA was to be treated with T4 polynucleotide kinase, sodium 
acetate was used since ammonium ions inhibit this enzyme.
2.13 Ligations
The insert DNA was digested with the appropriate restriction enzymes, purified using the 
Genpak FAX column (2.12.6) and ethanol precipitated (2.12.11). Plasmid vector pUC18 
DNA was supplied linearised by digestion with the appropriate restriction enzymes and treated 
with bacterial alkaline phosphatase to yield DNA ready to use. Bluescript KS+ vector was 
linearised by digestion with the appropriate restriction enzymes and treated with calf intestinal 
s alkaline phosphatase to yield DNA ready to use. This treatment prevented self-ligation of the
[ vector and resulted in a low background of false positive clones.
For ligation reactions where the insert size was similar to the vector size an equal concentration 
of foreign DNA to vector DNA was employed. For those reactions where the insert size was 
much greater than the vector size, at least a four-fold excess in concentration of foreign DNA to 
vector DNA was typical. Depending on the size of insert, ligation mixtures contained 25 ng 
vector and between 25 and 400 ng insert in a final volume between 5 and 10 pi.
Vector plus insert were pre-incubated at 45°C for 5 min to melt any cohesive termini that had 
reannealed. The ligations were performed overnight in 66 mM Tris/HCl pH 7.6,6.6 mM 
: MgCl2, 0.5 mM ATP, 10 mM DTT at 16°C using 0.5 Units (Weiss et al., 1968) of
bacteriophage T4 DNA ligase.
2.14 Transformation of E. coli with plasmid DNA
2.14.1 Preparation of competent cells
A single colony of E. coli DS941 or E. coli XL 1-blue from a stock minimal media plate was
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used to inoculate 10 ml of 2 x YT which was incubated overnight at 37°C. 0.3 ml of overnight 
culture was used to inoculate 30 ml of 2 x YT which was grown at 37°C for about 2 hours to 
an OD at 600 nm of 0.4-0.6. The cells were cooled on ice for 10 min and gently harvested 
(12,000g, 5min, 4°C).
When being prepared by the CaCl2 method (Cohen et al., 1972) the cells were resuspended in 
one half of the original culture volume of ice-cold, sterile 50 mM CaCl2, 10 mM Tris/HCl pH 8 
and placed in an ice bath for 15 min. Following centrifugation (12,000g, 5min, 4°C) the cells 
were resuspended in l/15th original culture volume 50 mM CaCl2, 10 mM Tris/HCl pH 8 and 
mixed in the ratio 3:1 culture to glycerol and cells dispensed into chilled microfuge tubes in 
200-400 pi aliquots. These cells were stored at -70°C.
For high transformation efficiency cells, the following steps were carried out (Hanahan, 1983). 
Cells were prepared and harvested as above but were then resuspended in 2.5 ml of ice cold 
TFB (10 mM MES/KOH pH 6.3,100 mM RbCl, 45 mM MnCl2, 10 mM CoCl2, 3 mM 
hexaminecobaltic chloride) and incubated on ice for 15 min. 100 pi of DMSO were added and 
the cells were incubated on ice for 5 min. 100 pi of 2.25 M DTT, 40 mM potassium acetate pH 
6.0 were added and the cells further incubated on ice for 10 min. Finally, 100 pi of DMSO 
were added, the cells were kept on ice and used on the day of preparation.
2.14.2 Transformation of competent cells
Transformations were carried out in sterile 1.5 ml microfuge tubes. Ligation mix refers to any 
DNA being used in the transforming process and usually was a ligation mixture. An aliquot of 
ligation mix containing up to 25 ng plasmid DNA was added to 100 pi aliquots of competent 
cells and the mixture was incubated on ice for at least 30 min. The DNA/cell mix was then heat 
shocked at 42°C for 2 min. 1 ml of L-broth was added to the tubes which were incubated 
without shaking at 37°C for 1 hour. The cells were then plated onto appropriately prepared 
antibiotic/chromogen containing LB plates and incubated overnight at 37°C.
2.14.3 Selection of pUC derived recombinant clones
The pUC plasmids have been constructed as cloning vectors using p-galactosidase activity as
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the basis of selection (Messing, 1983; Norrander et a i, 1983; Yanisch-Perron etal., 1985). 
The vector carries a segment of E. coli DNA that contains the regulatory sequences and the 
coding information for the first 146 amino acids of the P-galactosidase gene {lacZ). Vectors 
of this type are used in host cells (e.g. E. coli DS941) that code for the carboxy-terminal 
portion of p-galactosidase, therefore though neither the host-encoded nor the plasmid-encoded 
fragments are themselves active, they can associate to form active enzyme. A polycloning site 
has been inserted, in-frame, within the coding region of the plasmid which does not affect the 
complementation, however insertion of additional DNA into the polycloning site generally 
destroys the complementation. Active P-galactosidase cleaves the chromogenic substrate X-Gal 
to produce a blue chromophore, when transformed cells are grown in the presence of the non- 
metabolisable lac operon inducer IPTG. However in recombinant plasmids the ability for 
complementation is lost, the enzyme is inactive, and consequently the colonies appear white. 
False positive white colonies appear at low frequency, probably due to incorrect self-ligation of 
the vector (Yanisch-Perron et al., 1985).
2.15 DNA transfer to nylon membranes (Southern blotting)
This method is based on that of Southern (1975). After electrophoresis the agarose gel was 
placed in 250 ml of 0.25 M HC1 and soaked for 15 min. The gel was then placed in 250 ml of 
denaturing solution (1.5 M NaCl, 0.5 M NaOH) for 30 min and then into neutralising solution 
(1M Tris, 1.5M NaCl) for 60min. The DNA was blotted onto a nylon (Hybond-N, Amersham) 
membrane using 20xSSC transfer buffer (SSC = 0.15 M NaCl, 15 mM sodium citrate pH 7.3) 
overnight After blotting the membrane was washed in 2 x SSC as described in detail in 
Sambrook et al., (1989). The filters were air dried and then baked at 80°C for 2 hours.
2.16 32P labelling of the 5' terminus of the oligonucleotide
Bacteriophage T4 polynucleotide kinase can catalyze the transfer of the y-phosphate group from 
ATP to the free hydroxyl group on the 51 terminus of DNA. In a total reaction volume of 10 jil 
the mixture contained; 8 pmoles of purified oligonucleotide, kinase buffer (50 mM Tris/HCl
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pH8, 10 mM MgCl2, 5 mM DTT, 1 mM spermidine), 8 pmoles (y-32P) ATP and 10 units of 
T4 polynucleotide kinase. The reaction was carried out at 37°C for 30 min by which time it had 
gone to completion.
2.17 Hybridisation of filter bound nucleic acid
The temperature of hybridisation and the salt concentration and temperature of washing 
solutions were dependent on the particular experiment being canied out and precise details are 
given in the text. Hybond-N filters were not pre-wetted, but were placed directly into a 
polythene bag containing prehybridisation solution (6 x SSC, 0.05% (w/v) sodium 
pyrophosphate, 200 }ig/ml heparin, 0.05% (w/v) SDS); the volume of prehybridisation fluid 
was determined by filter surface area x 0.2. The bag was placed in an agitating waterbath and 
the filter prehybridised for at least 4 hours at 60°C. After prehybridisation the bag was opened, 
two thinls of the fluid were removed and labelled oligonucleotide (section 2.16) added. The 
bag was resealed and the hybridisation carried out for 2 hours in a shaking waterbath at the 
appropriate temperature.
The hybridised filters were washed in large volumes of buffer appropriate in ionic strength for 
different experimental conditions. The temperature of this buffer varied experimentally. After 
washing, the filters were autoradiographed damp (under Saran wrap) as described in section 
2 .2 .10.
2.18 Screening of plasmid clones by colony hybridisation
Recombinant pUC clones were screened using a modification of the method described by 
Nygaard and Hall (1963). Nylon filters (Hybond-N, Amersham) were placed on duplicate agar 
plates containing the selective antibiotic. Bacterial colonies were crossed onto a master plate 
(containing antibiotic) then onto the filter containing plates. The plates were inverted and grown 
overnight at 37°C. Alignment marks were made on the filters. The filters were removed and
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placed colony side up on piece of 3MM paper soaked in 10% SDS and left for 3 min. The 
filters were then removed, using blunt ended forceps, to a second piece of 3MM paper soaked 
in denaturation solution (1.5 M NaCl, 0.5 M NaOH) and left for 5 min. Finally, the filters 
were transferred, colony side up, to 3MM paper soaked in neutralising solution (1.5 M NaCl, 
0.5 M Tris/HCl pH 8 ) for 5 min. The filters were then transferred to dry filter paper and 
allowed to air dry, colony side up. Filters were baked at 80°C for 2 hours prior to being 
hybridised with a nucleic acid probe (section 2.17).
2.19 Nucleotide sequencing
2.19.1 Sequencing by the chain termination method
Sequencing was carried out using the United States Biochemical Corporation (USB) 
sequencing kit and protocols described in 'Step-By-Step Protocols For Sequencing With 
Sequenase Version 2.0’ were strictly adhered to.
Sequenase Version 2.0 is a site directed mutant of bacteriophage T7 DNA polymerase which 
carries no 3-5' exonuclease activity and gives a high rate of polymerisation of nucleotides 
(Tabor and Richardson, 1989).
al Preparation of sequencing template
Sequencing was carried out using double stranded DNA. In order to use double stranded DNA 
as a template for sequencing it must be denatured. The alkaline denaturation method described 
in 'Step-By-Step Protocols For Sequencing With Sequenase Version 2.0' was used for this 
purpose. The DNA was denatured in 0.2M NaOH, 0.2mM EDTA (30min at 37°C) and the 
mixture neutralised by the addition of 0.1 volumes of 3M sodium acetate (pH5.5). The DNA 
was precipitated with 2-4 volumes ethanol and the pelleted DNA washed with 70% ethanol, air 
dried and resuspended in 7|il distilled water before use in sequencing.
b) Annealing primer to template:
7 |il of prepared template was annealed for 2 hours at 55°C in a mixture also containing:
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1 pi primer, -40 primer (3ng/ pi) or designed oligonucleotide
2 pi 200mM Tris/HQ, pH7.5, lOOmM MgCl2,250mM NaQ (5xSequenase Buffer)
The-40 primer has the sequence:
5’-GTT TTC CCA GTC ACG AC-3’.
Other primers are described inthe text
c) Sequencing reactions:
To the annealed primerAemplate mix, the following were added; 1 pi DTT (lOOmM), 2 pi 
| labelling mix (1.5 pM dGTP, 1.5pM dCTP, 1.5pM dTTP), 0.5 pi (5pCi) [<x35S]-dATP<xS at
| >600Ci./mmol. (Amersham SJ.304) and 1.5 units of Sequenase Version 2.0. After mixing,
the labelling reaction was incubated at room temperature for 2-5 min. After this incubation, 3.5 
pi of the labelling reaction were transferred to each of four microfuge tubes labelled A, C, G, 
and T, in which 2.5 pi of the appropriate termination mix (80 pM dATP, 80pM dCTP, 80pM 
dGTP, 80pM dTTP, 8pM ddNTP (appropriate analogue), 50mM NaCl) had been spotted at 
the bottom of the tube.The contents of the tubes were mixed well and incubated at 37°C. After a 
5 min incubation at 37°C, 4 pi of stop mix (95% (v/v) formamide, 20mM EDTA, 0.05% (w/v) 
Bromophenol Blue, 0.05% (w/v) Xylene Cyanol FF) was added to each tube and mixed with 
the reaction by a brief spin in a microfuge. The sequencing reactions were then stored at -20°C. 
For sequencing areas which were particularly G/C rich, the labelling mix contained (3.0 pM 
dTTP, 1.5pM dCTP, 1.5pM dTTP) and the termination mixes were (80 pM dATP, 80pM 
dCTP, 80pM dTTP, 80pM dTTP, 8pM ddNTP (appropriate analogue), 50mM NaQ) except 
the ddGTP termination mix (80 pM dATP, 80pM dCTP, 160pM dITP, 80pM dTTP, 8pM 
ddNTP (appropriate analogue), 50mM NaQ).
2.19.2 Polyacrylamide gel electrophoresis
The nested set of primer extended fragments produced by the sequencing reactions described 
above were resolved by electrophoresis on thin polyacrylamide gels using the BRL S2
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sequencing gel apparatus (BRL-Gibco).
Gels were composed of the following constituents:
40% acrylamide 15ml.
(38% acrylamide, 2% bisacrylamide) 
lOxTBE 10ml
urea 50g
distilled water 35ml
10% (v/v) ammonium persulphate 350pl
TEMED 50pl
(N, N, N\ N', tetramethylethylenediamine)
Gels were pre-run in TBE for at least 30 min at 50mA constant current before loading samples. 
Samples were prepared by heating to 75-80°C for 2 min before loading, during which the top 
of the gel was thoroughly cleared of any unpolymerised acrylamide or urea and the lanes 
formed using a sharkstooth comb. The heat-denatured samples were loaded immediately onto 
the gel and electrophoresis carried out at 60W (constant power), 50mA, 2000V. The duration 
of electrophoresis depended on the length of sequence required. DNA close to the primer 
extending 250bp away from the primer was obtained from gels run for 2-5 hours, or until the 
dye front reached the anode, while sequence from 200-400bp from the primer was obtained 
from gels run for 6 hours. Routinely, 5 pi of each sample was run until the dye front reached 
the anode and 5 pi run for 8 hours in order to obtain the maximum sequence from each 
reaction.
All gels were fixed in 10% (v/v) acetic acid, 10% (v/v) methanol for 30 min following 
electrophoresis and were then dried onto a sheet of Whatman 3MM paper and autoradiographed 
as described in section 2.2.10.
2.19.3 Preparation of oligonucleotides
The oligonucleotides used were supplied in a solution of 35% (w/w) NH4OH. The
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oligonucleotides were precipitated with ethanol (section 2.12.9) and resuspended in TE. The 
oligonucleotide concentration was measured and adjusted to a final concentration of 
20nmol/ml.
2.20 Computer programs used in the analysis of DNA and amino acid 
sequences
A number of programs for the manipulation and analysis of DNA sequences of the UWGCG 
(University Of Wisconsin Genetics Computer Group) package (Devereux et al., 1984) were 
run on a VAX computer. This package contains programs for the comparison of DNA 
sequences with those in GenBank and EMBL (European Molecular Biology laboratory, 
Heidelberg, Germany) databases. The following UWGCG programs were used:
SeqEd is an interactive editor which allows entering and modification of sequences.
Mao displays both strands of a DNA sequence with a restriction map shown above the 
sequence and possible protein translations shown below.
j  BestFit makes an optimal alignment of the best segment of similarity between two
I sequences and inserts gaps if necessary (Smith and Waterman, 1981).
I
FastA searches for sequences similar to the query sequence in any group of sequences, 
using a Pearson and Lipman search (Pearson and Lipman, 1988).
TFastA Does a Pearson and Lipman search as for FastA, but first translates the query 
sequence in all six reading frames.
Strings finds sequences by searching sequence documentation for character patterns 
e.g. citrate.
LineUp is a screen editor for editing multiple sequence alignment
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CodonPreference is a frame specific gene finder which tries to recognise protein coding 
sequences by comparison to a codon frequency table, or by their composition in the 
third position of each codon.
TestCode identifies protein coding sequences by plotting a measure of the non- 
randomness of the composition at every third base.
Translate translates nucleotide sequence into peptide sequence.
Peptidesort shows the peptides from a digest of an amino acid sequence, shows the 
amino acid composition of each peptide and gives a summary of the composition of die 
whole protein.
CodonFrequencv tabulates codon usage from sequences and/or existing codon usage 
tables.
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Chapter 3
The Purification and characterisation 
of Bacillus caldotenax ICDH
3.1 Introduction
NADP-dependent ICDHs have been isolated from a number of different micro-organisms 
including, Salmonella typhimurium (Marr and Weber, 1968), Thiobacillus novellus 
(Charles, 1970), Bacillus stearothermophilus (Howard and Becker, 1970) and E.coli 
(Reeves et al., 1972). The methods of isolation used by these workers used salt 
fractionation of cell free extracts followed by chromatography on ion exchange and gel 
filtration media. These methods were developed before the techniques of f.p.l.c. and dye 
ligand chromatography became widely available for protein purification. The original 
methods were generally lengthy and gave relatively low yields. An improved method for the 
isolation of ICDH from E. coli was developed (Borthwick et al., 1984 a) which utilised dye 
ligand chromatography giving higher yields and improved specific activities. Similarly, 
more recent purifications have been developed for ICDH from a number of thermophilic 
bacteria; Bacillus stearothermophilus (Nagaoka et al., 1977) using chromatography on blue 
dextran sepharose and Thermus thermophilus HB8 (Eguchi et al., 1989).
In this chapter I report the purification of ICDH from a moderately thermophilic bacterium 
Bacillus caldotenax, using f.p.l.c. and dye ligand chromatography, and some properties of 
the purified enzyme.
60
3.2 Results
3.2.1 Procedure for Purification of ICDH from Bacillus caldotenax
In this procedure steps a) to c ) were carried out at 4°C.
a) Preparation of a cell free crude extract
5-10g of B. caldotenax, grown as described in section 2.3.4a), were resuspended in 25ml 
of buffer A, as defined in section 2.6, containing ImM benzamidine and ImM DTT. The 
cells were disrupted by two passages through a French pressure cell as described in section
2.3.7 b). Cell debris and unbroken cells were removed by centrifugation at 30,000g for 
20min in a MSE 18 refrigerated centrifuge and the supernatant was decanted.
b) Ammonium sulphate fractionation.
Powdered ammonium sulphate was added gradually to the supernatant to give 35% 
saturation whilst the pH of the solution was maintained in the range 6.5-7.0 by the addition 
of 5M ammonia. The temperature was kept at 0°C by use of an ice-water bath. After the 
addition of all the ammonium sulphate the solution was stirred for 30min at 0°C and then 
centrifuged at 20,000g for 15min. The pellet was discarded and the supernatant fraction was 
brought to 50% saturation with ammonium sulphate, stirred and centrifuged as before. This 
second pellet was also discarded and the supernatant brought to 70% saturation, stirred and 
centrifuged as before. The supernatant from this final fractionation was discarded and the 
pellet was resuspended in 2ml of buffer A.
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c) Desalting by gel filtration on Sephadex G-50
The resuspended pellet was loaded onto a column of Sephadex G-50 (20ml bed volume) 
equilibrated with buffer A. Fractions of 2ml were collected. Fractions containing a 
significant amount of protein but no ammonium sulphate, as determined by conductivity 
readings (section 2.2.2) were pooled.
d) f.p.l.c. ion-exchange chromatography on MonoQ
This and subsequent steps were carried out at room temperature. The desalted enzyme was 
filtered and then loaded on to a 10/10 MonoQ column equilibrated in buffer A at a flow rate 
of 4ml/min. The column was washed with 24ml of the same buffer and developed with a 
linear gradient of 50mM to 250mM KH2PO4 over 30 min. ICDH activity eluted at 70mM 
KH2PO^(figure 3.1). Fractions containing significant ICDH activity were pooled and 
dialysed overnight into buffer B.
e) Dye ligand chromatography on Procion-red Sepharose.
The dialysed material was applied to a column of Procion-red dye HE-3B immobilised on 
cross-linked Sepharose 6B which had been equilibrated in buffer B (as defined in section
2.6). The column was washed exhaustively with buffer B until the A28O °f the effluent 
returned to baseline. The ICDH was then eluted as a sharp peak by washing the column 
with buffer B containing 0.5mM NADP+. A typical elution profile is shown in figure 3.2. 
The purity of ICDH throughout the purification procedure was monitored by polyacrylamide 
gel electrophoresis (section 2.5.1) (figure 3.3). A typical purification table is shown in table 
3.1.
62
A
28
0
1001.0
0.6
0.4
02
0.0
3 02520150
Fraction number
----------  A28O
— • -----  ICDH activity (units/ml).
----------- KH2 PO4  gradient
Figure 3.1 Ion exchange chromatography on Mono Q
Enzyme from (NH4>2S04 fractionation was loaded onto a Mono Q column and eluted 
with a phosphate gradient, as described in section 3.2.1 d). The units of the gradient are 
arbitrary.
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Figure 3.2 Dye ligand chromatography of Bxaldotenax ICDH on 
Procion-red Sepharose
Elution profile from a cross-linked Procion-red Sepharose column. Details of the 
procedure are described in section 3.2.1 e).
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1 2 3  4 5 6 7  8
Figure 3.3 Purification gel of B.caldotenax ICDH
A 10% polyacrylamide gel was run in the presence of SDS to monitor the purification of ICDH. Marker 
proteins were selected from those listed in section 2.1.2.
Track Sample
1 Markers.
2 Crude extract.
3 0-35% ammonium sulphate supernatant.
4 35-50% ammonium sulphate supernatant.
5 50-70% ammonium sulphate pellet
6 Mono Q pool.
7 Procion-red Sepharose pool.
8 Markers.
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Table 3.1 Purification of B.caldotenax ICDH
Theresults are presented for a typical purification starting from 5g of 
B.caldotenax cells.
step total total specific yield purification
protein activity activity .(%) (fold)
(mg) (units) (units/mg)
a) crude extract 270 757 2.8 100 1
b ) ( N H 4 ) 2 S 0 4  35 418 12.0 55 4
fractionation
(50-70% pellet)
c) gel filtration 25 300 12.0 40 4
d) monoQ 4 220 55 29 10
chromatography
e) dye ligand 0.6 100 167 13 60
chromatography on
Procion red Sepharose
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3.2.2 Purity and molecular weight
ICDH isolated from B. caldotenax was judged to be homogenous by the criterion of 
polyacrylamide gel electrophoresis. The purified enzyme gave a single protein staining band 
on a 10% polyacrylamide gel run in the presence of 0.1% (w/v) SDS (figure 3.3).
The subunit molecular weight of ICDH was estimated by SDS gel electrophoresis using the 
method of Laemmli (1970) as described in section 2.10.1. The electrophoretic mobility of 
marker proteins of known molecular weight were measured and used to construct a standard 
curve of electrophoretic mobility against log subunit molecular weight (figure 3.4). 
Comparison of the electrophoretic mobility of ICDH with these markers gave a value of
46.000 daltons for the subunit molecular weight of B. caldotenax ICDH.
The molecular weight of native, undissociated ICDH was estimated using a Superose 12 gel 
filtration column which was run on a Pharmacia f.p.Lc. system as described in section 
2.10.2. Standard proteins of known molecular weight were used to calibrate the column. A 
standard curve was constructed of elution volume against log molecular weight (figure 3.5). 
The measured elution volume for ICDH corresponded to a native molecular weight of
93.000 daltons indicating that the native enzyme is a dimer.
3.2.3 Immunological cross-reaction.
Varying concentrations of purified B . caldotenax ICDH were run on a 10% polyacrylamide 
gel in the presence of 0.1% SDS using the method of Laemmli (1970) (section 2.5.1). The 
gel was Western blotted (section 2.8) using an antibody raised to E. coli ICDH. The B. 
caldotenax ICDH was found to cross-react with this antibody (figure 3.6) suggesting 
appreciable structural homology between these two types of ICDH. This usually indicates > 
60% identity.
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SDS PAGE (10%) was performed as described in section 2.5.1. The Rf values of standard proteins were 
calculated and plotted against the log Mr. The Rf of purified B.caldotenax ICDH is shown (■). The 
standard curve was fitted by eye. A list of the standard proteins used is given below.
pro tein  
bovine albumin 
egg albumin
glyceraIdehyde-3-phosphate dehydrogenase
carbonic anhydrase
trypsinogen
trypsin inhibitor
a-Iactalbumin
molecular weight (Daltons) 
66 000 
45 000 
36 000 
29 000 
24 000 
20 000 
14 000
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Figure 3.5 Superose 12 gel filtration standard curve
A Superose 12 gel filtration column was calibrated and run as described in section 2.10.2. Peak elution 
volume (ml) was plotted against log Mr. The standard curve was fitted by eye. The elution volume of 
purified B.caldotenax ICDH is shown (•). The proteins used to calibrate the column are listed below.
Protein
pig heart malate dehydrogenase 
pig muscle lactate dehydrogenase 
rabbit muscle aldolase 
rabbit muscle pyruvate kinase 
horse apofemtin
molecular weight (Daltons) 
70 000 
140 000 
160 0 0 0  
232 000 
440 000
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Figure 3.6 Western blot of B.caldotenax ICDH using an antibody 
raised to E .coli ICDH
Serial dilutions of B.caldotenax ICDH woe run on a 10% polyacrylamide gel in the 
presence of 0.1% SDS (section 2.5.1). The gel was Western blotted using an antibody 
raised to E.coli ICDH by the method described in section 2.8.
The tracks were loaded as follows:
1) 2pg B.caldotenax ICDH.
2) 0.4pg B.caldotenax ICDH.
3) 0.08j_ig B.caldotenax ICDH.
4)0.016pg B.caldotenax ICDH.
3.2.4 Determination of Km values for B. caldotenax ICDH
Km values were determined for B.caldotenax ICDH at 37°C. The activity of ICDH was 
measured, varying concentrations of one substrate with the concentration of the other being 
fixed and saturating. Km values were established by constructing Lineweaver-Burk plots 
for each substrate (figures 3.7 and 3.8). The Km values of ICDH for isocitrate and NADP+ 
were determined to be 2.4 |iM and 1.6 |J.M respectively.
3.2.5 Amino acid sequence analysis of B . caldotenax ICDH
a) N-terminal amino acid sequence analysis
B. caldotenax ICDH was prepared for N-terminal sequence analysis by passage down a 
Waters Bondapak p,C18 reverse phase column as described in section 2.9.1. This served to 
clean the protein and transferred it to acetonitrile containing 0.1% TFA, an ideal solvent for 
sequencing purposes. The sample was loaded directly onto an Applied Biosystems Protein 
sequencer (section 2.9.4). No sequence was obtained from this sample and it was suggested 
that the protein was N-terminally blocked.
b) Amino acid sequence analysis of a V8 peptide of ICDH
Peptides were obtained from ICDH by digestion with V8 protease (section 2.9.2) and 
electroblotted onto PVDF membrane as described in section 2.9.3. A number of peptide 
bands were visible on the blot, one of which was particularly intense. This intense band was 
excised from the blot and used for amino acid sequence analysis on an Applied Biosystems 
Protein sequencer (section 2.9.4).
Two sets of sequence data were obtained simultaneously. The yields of each residue
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Figure 3.7 Determination of the Km of ICDH for isocitrate
The activity of ICDH was measured at 37°C using the assay described in section 2.4.2. 
The concentration of isocitrate was varied whilst that of NADP+ was kept constant and in 
excess (0.4mM). A Lineweaver-Burk plot was constructed to determine the apparent Km 
for isocitrate.
72
10 -I
o
>
2 ~
• 0.8 -0 .6 -0 .4  -0 .2  0 .0 0.2  0 .4  0 .6  0.8 1.0 1.2
1/[NADP]
Figure 3.8 Determination of the Km of ICDH for NADP+
The activity of ICDH was measured at 37°C using the assay described in section 2.4.2. 
The concentration of NADP+ was varied whilst that of isocitrate was kept constant and 
in excess (2.5mM). A Lineweaver-Burk plot was constructed to determine the apparent 
Km for NADP+.
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Table 3.2 Sequence data obtained from V8 peptides of 
B.caldotenax  ICDH
Cycle PTH-amino pmol PTH-amino pmol
number acid recovered acid recovered
1 M 62.2 T 40.83
2 T 37.52 Q 47.69
3 Q 59.63 G 74.80
4 G 97.51 E 37.90
5 E 40.61 K 40.11
6 K 49.93 I 66.16
7 I 79.67 T 28.16
8 T 30.66 V 44.92
9 V 53.91 Q 49.13
10 Q 63.99 N 34.19
11 N 40.95 G 61.25
12 G 67.3 V 36.48
13 V 42.52 L 45.68
14 L 55.84 N 32.96
15 N 42.26 V 37.54
The yields of PTH-amino acids during sequencing of V8 peptides of ICDH. Two species of 
peptide were sequenced simultaneously producing the two sets of data shown above. The 
initial amount of peptide sequencing was lOOpmol.
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Figure 3.10 Comparison of the amino acid sequence obtained from 
B. caldotenax ICDH with the E. coli ICDH amino acid 
sequence
The results are shown of a Bestfit computer analysis (section 2.20) between the amino 
acid sequence of B. caldotenax ICDH and the amino acid sequence of E. coli ICDH 
(Thorsness and Koshland, 1987). The numbers relate to the position of the amino acids 
within the sequence as a whole. Identical matches are marked with a line ( I). Matches 
were scored using the table provided with the GCG package.Matches with a score of 
greater than 0.5 are marked with a colon ( : )  and matches with a score of greater than or 
equal to 0.1 are marked with a full stop (.).
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recovered from each cycle of sequencing are shown in table 3.2. The two sets of data 
resulted from two types of peptide being sequenced in unison. The two types of peptide had 
an identical sequence but one was a single residue shorter. The derived amino acid sequence 
is shown in figure 3.9. Sequence was obtained for the first fifteen amino acid residues. This 
was judged to be sufficient sequence for designing a probe for use in cloning the ICDH 
gene. Sequencing was therefore terminated after fifteen residues.
3.2.6 Comparison of B. caldotenax ICDH sequence with that of 
E. coli
Amino acid sequence was obtained from a peptide of B. caldotenax ICDH. Comparison of 
the sequence of B. caldotenax ICDH with that of E. coli ICDH, determined from the 
nucleotide sequence by Thorsness and Koshland (1987), showed considerable homology 
between the two (figure 3.10). Bestfit computer analysis was used to find the optimal 
alignment between the two sequences (section 2.20). The amino acid sequence of 
B.caldotenax ICDH lined up with 78% identity to a region very close to the N-terminus of 
E. coli ICDH (figure 3.10).
3.3 Discussion
This chapter reports the purification to homogeneity of an NADP-dependent ICDH from the 
moderate thermophile Bacillus caldotenax. Typical purifications gave yields of between 10 
and 15%. The purified enzyme had a specific activity of approximately 150 units/mg at 
50°C giving a purification factor of 60 fold over the initial extract
The purification procedure involves (NH^SC^ fractionation, anion exchange 
chromatography and dye ligand chromatography on Procion-red Sepharose and is very
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similar to that developed by Borthwick et al. (1984a) for the purification of ICDH from 
E.coli.
Similar procedures for the purification of NADP-dependent ICDH from a number of 
thermophilic bacteria have been reported including Bacillus stearothermophilus (Nagaoka et 
al., 1977), Thermus thermophilus (Eguchi et al., 1989) and Thermus aquaticus ( Ramaley 
& Hudock, 1973). At the start of this study no purification had been reported for ICDH 
from the moderate thermophile Bacillus caldotenax. Recently Edlin and Sundaram (1989) 
reported a procedure for the purification of ICDH from several different micro-organisms 
including B. caldotenax. Their method of purification uses selective elution of ICDH from a 
Procion-red Sepharose HE3B column with a mixture of NADP+ and isocitrate followed by 
anion exchange chromatography. The method gives ICDH in high yield but with a low 
specific activity (4 units/mg protein at 37°C). In contrast the purification reported here gives 
a r e l a t i v e l y  low yield of between 10 and 15%. I intended to purify ICDH in order to obtain 
pure protein for enzyme characterisation, N-terminal sequence analysis and phosphorylation 
studies. Although the yield was low, enough protein was obtained to satisfy these 
requirements.
Characterisation of the ICDH isolated from B. caldotenax showed that its undissociated 
molecular weight was 93,000 daltons (figure 3.5) and its subunit molecular weight 46,000 
daltons (figure 3.4). This suggests that the native protein exists as a dimer. This subunit 
molecular weight is in good agreement with that obtained for B. caldotenax ICDH by Edlin 
and Sundaram (1989) of 46,000 daltons (table 3.3). B. stearothermophilus is a thermophile 
known to be extremely similar to B. caldotenax (Epstein and Grossowicz 1969). The 
subunit molecular weight of B. stearothermophilus has been reported as being 45,000 
daltons (Howard and Becker, 1970) which also agrees with our value for B. caldotenax 
ICDH. Table 3.3 shows subunit molecular weights of ICDH from E. coli, B. subtilis and 
two extremely thermophilic Thermus strains for comparison. All the ICDHs documented in 
table 3.3 are dimers and with the exception of T. aquaticus and T. thermophilus, there is
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Table 3.3 Molecular weight estimations of various bacterial ICDH s
source subunit native study
molecular weight molecular weight 
(Daltons) (Daltons)
E.coli ML308 45 756
B.subtilis nd
B.subttlis 47 000
B stearothermophilus 45 000
B.caldotenax 46 000
B.caldotenax 46 000
T.aquaticus 33 000
T. thermophilus 57 500
Synechocystis sp. 57 000
92 000 
75-80 000 
nd
92 500
93 000 
nd
66 000
120000 
108 000
Thorsness and 
Koshland (1987)
Ramaley and 
Hudock (1973)
Edlin and Sundaram 
(1989)
Howard and 
Becker (1970)
This study
Edlin and Sundaram 
(1989)
Edlin and Sundaram 
(1989)
Eguchi et al.(1989)
Muro-Pastor and 
Florencio (1991)
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little variation in size. As previously mentioned in chapter 1 there are two classes of NADP- 
dependent ICDH, enzymes being classified according to size and composition. Class I 
includes dimeric forms of ICDH and class II monomeric forms of the enzyme. ICDH from 
B. caldotenax is a class I ICDH.
Km values were determined for B. caldotenax ICDH. These values together with the Km 
values of several other purified ICDHs are summarised in table 3.4. It is not possible to 
draw a comparison of these different Km values due to the variability of assay conditions 
used by different workers. However, it is evident that the Km values determined for B. 
caldotenax ICDH are of a similar order of magnitude to those established for ICDH from 
other species.
Amino acid sequence was obtained from B. caldotenax ICDH and found to align with 78% 
identity to a region close to the N-terminus of of E. coli ICDH. It seems likely from the 
alignment that the amino acid sequence obtained from B. caldotenax was in fact N-terminal 
sequence. Initial attempts to gain N-terminal sequence from B. caldotenax ICDH proved 
unsuccessful. This observation may have resulted from a sequencing error or it is possible 
that the process of electroblotting has removed impurities from ICDH which had previously 
prevented sequence analysis. If this sequence is N-terminal, the two species of peptide 
observed during sequencing may have resulted if the N-terminal methionine residue was 
post-translationally cleaved from some, but not all of, the ICDH.
In conclusion, B. caldotenax ICDH has been shown to be both similar in size and 
composition to that of E. coli. Western blotting has shown B. caldotenax ICDH to cross- 
react with an antibody raised to the E. coli ICDH. Finally, amino acid sequence analysis of 
B. caldotenax ICDH has demonstrated considerable sequence homology with E. coli 
ICDH. Therefore, although from two quite different organisms, these two types of ICDH 
exhibit remarkable similarity. A further approach in the comparison of these two enzymes 
would be to clone the gene for B. caldotenax ICDH and to determine the complete
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Table 3.4 The Km values for NADP+ and isocitrate determined for
various different bacterial ICDHs under different conditions
organism
E.coli
B.subtilis
B .steamthermophilus
B.caldotenax
T.aquaticus
T. thermophilus
Synechocystis
(cyanobacterium)
S.typhirmurium 
Azotobacter vinelandii 
Thiobaciilus novelus
assay Km
conditions NADP+
(M-M)
Tris pH 7.5 5
[Mn2+] 37°C
Hepes pH 7.4 27.4
[Mn2+] 25°C
Triethanolamine 4.4
buffer pH 7.5 
[Mg2+] 50°C
Tris/HCl pH 7.5 1.6
[Mn2+] 37°C
Hepes pH 7.5 31
[Mn2+] 70°C
Hepes-Na pH 7.8 6.3
[Mn2+] 70°C
phosphate pH 7.5 6
[Mn2+] 30°C
Tris/HCl pH 7.7 11.5
[Mn2+] 25°C
phosphate pH 7 23
[Mg2+] 30°C
phosphate pH 7.8 13
[Mn2+] 25°C
Km study
isocitrate
(liM )
10 Nimmo
(1986)
9.1 Ramaleyand 
Hudock (1973)
6 Howard and Becker
(1970)
2.4 this study
18.1 Ramaleyand 
Hudock (1973)
8.8 Eguchi et al. (1989)
5.7 Muro-Passtor
Florencio (1991)
1.9 Marr and Weber
(1968)
20 Chung and Franzen
(1969)
8.3 Charles (1969)
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nucleotide sequence of the gene. It would be possible to deduce the entire amino acid 
sequence of ICDH, from the nucleotide sequence, and use this for more detailed comparison 
with E. coli ICDH. This approach has been used in the course of this study and the results 
are reported in chapter 5.
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Chapter 4
Phosphorylation studies using 
Bacillus caldotenax ICDH
4.1 Introduction
As mentioned in chapter 1 during the growth of E. coli on acetate or fatty acids, as the sole 
carbon source, most of the precursors for biosynthesis are generated by means of the 
glyoxylate bypass (Komberg, 1966). During growth under these conditions there is 
competition between the TCA cycle enzyme ICDH and the glyoxylate bypass enzyme ICL 
for available isocitrate. It has been found in E. coli that this competition is overcome by the 
partial phosphorylation and inactivation of ICDH (Gamak and Reeves, 1979a,b).
Bennett and Holms (1975) reported some of the early work to suggest the existence of a 
covalent modification in the control of this branch point in E. coli. In addition they showed 
that this mechanism was not unique to E. coli but was also seen to exist in at least one strain 
each of Klebsiella aerogenes, Salmonella typhimuriwn and Serratia marcescens. In view of 
this, together with the fact that B. caldotenax ICDH has been shown to be structurally 
similar to E. coli ICDH (section 3.2.3), it would not be unreasonable to suggest that the 
ICDH of B. caldotenax might also be controlled by phosphorylation.
In this chapter I report results of in vitro phosphorylation studies which indicate that B. 
caldotenax ICDH is under the control of phosphorylation. I also report experiments in 
which I have looked for evidence of phosphorylation in vivo, although within the limits of 
this study I have been unable to confirm that phosphorylation is physiologically important in 
B. caldotenax.
4.2 Results
4 .2 .1  Inactivation of B. caldotenax ICDH by E. coli ICDH kinase
Homogenous ICDH purified from B. caldotenax was incubated in the presence of E. coli 
ICDH kinase/phosphatase (purified by the method of Nimmo et al., 1984) in the assay 
described in section 2.4.3. Samples were removed from the incubation, to assay for ICDH
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activity, over a time course of 0-30 min. A progressive decrease in activity was observed 
over this period of time (figure 4.1). Appropriate controls were carried out which showed 
that this decrease was only observed when E. coli ICDH kinase was present in the 
incubation. In addition no decrease in activity was observed in the absence of ATP or if 
ATP was substituted with 0.5mM AMP-PCP, a non-hydrolysable analogue of ATP (figure 
4.1).
4.2.2 Phosphorylation of ICDH in vitro
Purified B. caldotenax ICDH was incubated with E. coli kinase in the presence of [y-32P] 
ATP as described in section 2.11.1 b). Samples were taken over a time course of 0-60 min 
for estimation of the activity of ICDH (section 2.11.1 a) and analysis of 32P incorporation 
into protein as shown by electrophoresis followed by autoradiography. Over a 60 min 
period a progressive decrease in ICDH activity was observed (figure 4.2) which 
corresponded to a progressive increase in 32P incorporation into ICDH (figure 4.3). Two 
control assays were performed one in the absence of E. coli ICDH kinase and the other in 
the absence of B. caldotenax ICDH. Samples were taken from each control assay after 60 
min for estimation of 32P incorporation into protein. Neither control showed any evidence 
of 32P incorporation (figure 4.3). It was confirmed from these control results that 
phosphorylation is dependent on the presence of the kinase and that 32P is incorporated into 
B. caldotenax ICDH and not into any contaminating E. coli ICDH present in the E. coli 
ICDH kinase preparation.
4.2.3 The stoichiometry of phosphorylation of ICDH
E. coli ICDH is known to be phosphorylated with a stoichiometry of 1 mol of phosphate 
/mol of subunit (Laporte and Koshland, 1983; Nimmo et al., 1984, ). The stoichiometry of
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Figure 4.1 Inactivation of B.caldotenax  ICDH in vitro
Purified B.caldotenax ICDH was incubated with E.coli ICDH kinase in the assay 
described in section 2.11.1 a). ICDH activity was measured over a 30 min time course. 
Control assays were also performed 1) in the absence of E.coli ICDH kinase, 2) ATP 
was substituted with AMP-PCP and 3) in the absence of ATP.
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Figure 4.2 Inactivation and phosphorylation of B. caldotenax ICDH 
in vitro
Purified B. caldotenax ICDH was incubated with E. coli ICDH kinase in the 
presence of [y-32P]ATP as described in section 2.11.1. The activity of ICDH and the 
incorporation of 32P into the protein (figure 4.3) were followed.
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Figure 4.3 SDS PAGE of ICDH during in vitro inactivation and 
phosphorylation
40|il samples were removed from the incubation in figure 4.2 at the times shown. 
The reaction was stopped by heating the sample to 100°C for 2 min with 10|il 5x 
normal sample buffer. SDS PAGE of these samples was carried out as described 
in section 2.5.1. The gel was stained for protein, dried and autoradiographed 
(sections 2.5.2 and 2.2.10).
A 10% polyacrylamide gel was loaded as follows:
Track Time (min)
1 0
2 5
3 10
4 25
5 60
6 60 control containing no ICDH
60 control containing no ICDH kinase7
The dried gel was autoradiographed for 48 hours.
 
-
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phosphorylation of B. caldotenax ICDH was determined by comparing the degree of 
phosphorylation of B. caldotenax ICDH with that of E. coli ICDH under the same 
conditions. Two parallel assays were performed in the presence of [y -32P] ATP as 
described in section 2.11.1 b). One of the assays contained B. caldotenax ICDH whilst the 
other contained an equal concentration of ICDH purified from E. coli. The enzymes were 
incubated in the presence of equal amounts of E. coli ICDH kinase. Samples were removed 
from both assays over a 60 min time course for estimation of 32P incorporation into ICDH 
as shown by gel electrophoresis followed by autoradiography (section 2.2.10). Duplicate 
assays were performed using non-radioactive ATP in order to estimate ICDH activity over 
the same time course. Control assays were carried out in the absence of ICDH and in the 
absence of kinase.
The resiults showed that E. coli ICDH was phosphorylated to completion within the first 
5min off incubation (figures 4.4 and 4.5). No E. coli ICDH activity remained after 5min and 
no further incorporation of 32P was observed after this time (figure 4.5). In contrast the 
incorporation of 32P into B. caldotenax ICDH occurred more slowly being only complete 
after 60) min incubation when no ICDH activity remained (figures 4.4 and 4.5). The 
intensity of the autoradiograph band corresponding to fully inactivated B. caldotenax ICDH 
(i.e. the; 60 min sample) was equal to that for the fully inactivated E. coli ICDH samples 
(figure 4.5). As both types of ICDH were present in equal concentrations this would 
suggest that the inactivation of B. caldotenax ICDH by phosphorylation proceeds with the 
same stoichiometry as phosphorylation of E. coli ICDH, i.e. lmol of phosphate /mol of 
subunit- However it is possible that more 32P might be incorporated during a longer 
incubation.
4.2.4 Phosphorylation of ICDH in crude extracts of B. caldotenax 
A crude extract was made from B. caldotenax grown on glutamate as described in section
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Figure 4.4 Comparison of the inactivation of B .caldotenax  ICDH to 
that of E.coli ICDH using E.coli ICDH kinase
Two parallel incubations were performed using either B.caldotenax ICDH or E.coli ICDH 
in the presence of [y-^PJATP. Samples were removed at the time intervals shown for 
analysis of ICDH activity (above) and the incoiporation of 32p into ICDH (figure 4.5).
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Figure 4.5 SDS PAGE to compare the stoichiometry of
phosphorylation of E.coli ICDH to that of B.caldotenax  
ICDH
Two parallel incubations were performed containing purified ICDH from either 
E.coli or B.caldotenax. Samples (40|il) were removed from the incubations 
(figure 4.4) at the times indicated. The reaction was stopped by heating the sample 
to 100°C for 2min with lOpl 5x normal sample buffer. SDS PAGE was carried out 
as described in section 2.5.1. The gel was stained for protein, dried and 
autoradiographed (sections 2.5.2 and 2.2.10).
A 10% polyacrylamide gel was loaded as follows:
track time (min)
1 0 E.coli ICDH
2 5
3 10
4 25
5 60
6 0 B.caldotenax ICDH
7 5
8 10
9 25
10 60
11 60 control containing no ICDH kinase
12 60 control containing no ICDH
The dried gel was autoradiographed for 48 hours.
90
2.11.2 aa) and incubated in the presence of [y-32P]ATP (section 2.11.2b). Samples were 
removecd, over a time course of 60 min, for analysis of any 32P incorporation into protein by 
gel electrophoresis followed by autoradiography (section 2.11.2 b)i) (figure 4.6). The 
autoradiiograph showed incorporation of 32P into a number of proteins including a 46kDa 
protein: i.e. a protein of the same molecular weight as B. caldotenax ICDH.
4.2.5 Ilmmunoprecipitation of phosphorylated B. caldotenax ICDH
As described in section 3.2.3 cross-reaction was observed between anti-£. coli ICDH 
antitxxhy and B. caldotenax ICDH. I therefore developed a procedure for 
immuncoprecipitation of B. caldotenax ICDH in order to investigate if the 46kDa protein 
observecd to be phosphorylated in crude extracts was ICDH. Trial experiments with purified 
B. ccddcotenax ICDH were used to define conditions for immunoprecipitation. B. caldotenax 
ICDH aind E. coli ICDH were then both phosphorylated with E. coli ICDH kinase for 
lhour ass described in figure 4.5. After this time samples were removed for analysis by 
immuncoprecipitation by the method described in section 2.11.2 b)ii. The results showed it 
was posssible to immunoprecipitate phosphorylated B. caldotenax ICDH from the 
incubatiion mixture using anti-E. coli ICDH antibody (figure 4.7).
4.2.6 Ilmmunoprecipitation of B. caldotenax ICDH from crude extracts
Crude extracts were made from B. caldotenax, as described in section 2.11.2 a), from cells 
grown omi either glutamate or acetate. Both extracts were incubated at 50°C in the presence 
of [y-32PP]ATP and samples removed over a 30 min time course. Duplicate samples were 
taken at < each time point and analysed in one of two ways;
a) Incorpporation of 32P into total protein was analysed by gel electrophoresis followed by 
autoradiiography (section 2.11.2 b)i).
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Figure 4.6 SDS PAGE of phosphorylated crude extracts made 
from B .caldotenax
A crude extract was made from B.caldotenax grown on glutamate as described in 
section 2.11.2 a) and incubated in the presence of [y-32P] ATP (section 2.11.2 b). 
Samples were removed over a time course for analysis by gel electrophoresis 
(2.11.2 b i).
A A 10% polyacrylamide gel was loaded as follows: 
track time (min)
1 0
2 5
3 10
4 25
5 60
6 purified B.caldotenax ICDH
B 48 hour autoradiograph of the above gel
B— 46 k Da
1 2 3 4 5 6
Figure 4.7 Immunoprecipitation of B.caldotenax  ICDH 
phosphorylated in vitro
Samples of purified B.caldotenax ICDH were phosphorylated with 32P in vitro by 
the method described in 2.11.1b. ICDH was immunoprecipitated from the assay by 
the method described in section 2.11.2 b ii. The same experiment was also carried 
out using E.coli ICDH for comparison.
A A 10% polyacrylamide gel was loaded as follows:
track sample
1 immunoprecipitated E.coli ICDH
2 immunoprecipitated B.caldotenax ICDH
B Autoradiograph of the above gel
Am £
ICDH —
— ICDH
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b) Incorporation of 32P into ICDH was estimated by immunoprecipitation of ICDH from the 
sample prior to gel electrophoresis and autoradiography (section 2.11.2 b)ii).
Within the first 5 min in both types of extract a 46 kDa protein was phosphorylated (figure 
4.8B). A number of other proteins were also seen to incorporate 32P. The pattern of 
phosphorylation was similar in the two extracts. ICDH was immunoprecipitated from both 
extracts (figure 4.8A) but the corresponding autoradiograph showed no incorporation of 32P 
into ICDH (figure 4.8B). The immunoprecipitated protein was confirmed to be ICDH by the 
method of Cleveland (1977 ) as described in section 2.7 (figure 4.9).
4.2.7 Immunoprecipitation of B. caldotenax ICDH from crude extracts 
incubated in the presence of phosphatase inhibitors
An identical experiment to that described in section 4.2.6 was carried out with phosphatase 
inhibitors present in the extracts. Extracts of B. caldotenax grown on glutamate or acetate 
were incubated in the presence of either lOnM okadaic acid or 25mM sodium fluoride. 
Aliquots were removed at 5 and 30 min intervals for analysis as described in section 4.2.6 
(figure 4.10). A similar phosphorylation pattern was obtained to that when phosphatase 
inhibitors were absent from the incubations. As in the previous experiment no detectable 32P 
was incorporated into immunoprecipitated ICDH.
4.2.8 Phosphorylation of B . caldotenax ICDH in vivo
A culture of B. caldotenax was grown on acetate in the presence of 32Pi for lhour (section 
2.11.3). A cell free extract was made from these cells as described in section 2.11.2 a) and 
samples were removed for analysis of 32P incorporation into protein by gel electrophoresis 
followed by autoradiography. In addition ICDH was immunoprecipitated from duplicate
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Figure 4.8 Cleveland map to confirm immunoprecipitated protein to
be ICDH
Immunoprecipitations were performed on crude extracts of B.caldotenax using anti-E.coli ICDH antibody 
(section 4.2.6)and the immunoprecipitated protein resolved in a 10% poly acrylamide gel (section 2.5.1). 
The gel was rapidly stained and destained in Coomassie Brilliant Blue (section 2.5.2). The band of 
immunoprecipitated protein was excised from the gel and Cleveland mapping performed as described in 
section 2.7. Purified B.caldotenax ICDH was mapped alongside in order to compare the patterns of 
digestion.
track
1 purified B.caldotenax ICDH
2 " " digested with 50ng V8 protease
3 " " digested with 50ng trypsin
4 " " digested with 50ng chymotrypsin
5 immunoprecipitated protein (uncut)
6 immunoprecipitated protein digested with 50ng V8 protease
7 " " " 50ng trypsin
8 " " " 50ng chymotrypsin
Tracks 9 andl3, 10 and 14, 11 and 15,12 and!6 are duplicates of 5, 6, 7, and 8 respectively.
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Figure 4.9 SDS PAGE of B.caldotenax ICDH immunoprecipitated 
from crude extracts
Two incubations were performed, one using a crude extract made from B.caldotenax 
grown on glutamate the other from B.caldotenax grown on acetate. Samples (20|il) were 
removed over a 30min time course for analysis by gel electrophoresis (section 2.11.2a). 
Duplicate samples (30pl) were used in immunoprecipitations prior to electrophoresis as 
described in section 2.11.2.b. The gel was stained for protein, dried and autoradiographed 
(sections 2.5.2 and 2.2.10).
A A
track 
1 
2
3
4
5
6
7
8
9
10 
11 
12
13
14
15
16 
17
B A 48 hour autoradiograph of the above gel.
10% polyacrylamide gel was loaded as follows:
extract 
grown on glutamate
time (min) treatment
grown on acetate
sample used direcdy for 
gel electrophoresis.
grown on glutamate
grown on acetate
ICDH immunoprecipitated 
prior to gel electrophoresis.
Purified B.caldotenax ICDH
3 4 5 6 7 8 10 11 12 13 14 15 16 17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
%
Figure 4.10 SDS PAGE of B.caldotenax ICDH immunoprecipitated 
from crude extracts incubated in the presence of 
phosphatase inhibitors
Four incubations were performed, two using crude extracts made from B.caldotenax 
grown on glutamate and two using extracts made from B.caldotenax grown on acetate. 
Each type of extract was incubated either in the presence of 25mM sodium fluoride or 
lOnM okadaic acid Samples (20|il) were removed over a 30 min time course for 
analysis by gel electrophoresis (section 2.11.2a). Duplicate samples (30|il) were used 
in immunoprecipitations prior to electrophoresis as described in section 2.11.2.b. The 
gel was stained for protein, dried and autoradiographed (sections 2.5.2 and 2.2.10).
A A 10% polyacrylamide gel was loaded as follows:
track extract time (min) phosphatase treatment
inhibitor
1 grown on glutamate 5 okadaic acid \
2 " " 30 okadaic acid I
3 " 5 NaF I
4 " M 30 NaF I  sample used
5 grown on acetate 5 okadaic acid |  directly for
6 " " 30 okadaic acid I gel
7 " 5 NaF I electrophoresis
8 " " 30 NaF J
9 grown on glutamate 5 okadaic acid \
10 " " 30 okadaic acid I
11 " 5 NaF J
12 " " 30 NaF I  ICDH
13 grown on acetate 5 okadaic acid I  immunoprecipitated
14 " " 30 okadaic acid I prior to gel
15 " 5 NaF I electrophoresis
16 " " 30 NaF J
17 Purified B.caldotenax ICDH
B A 48 hour autoradiograph of the above gel.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
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Figure 4.11 Immunoprecipitation of B.caldotenax ICDH from cells 
grown in the presence of 32Pi
A cell free exract was prepared from B.caldotenax grown in the presence of 32Pi 
(20fiCi /|imol) as described in section 2.11.3. ICDH was immunoprecipitated from 
samples of the extract (section 2.11.2 b ii) for analysis by gel electrophoresis 
followed by autoradiography.
A A 10% polyacrylamide gel was loaded as follows:
track sample
1 30|il of cell free extract denatured in normal sample buffer
2 ICDH immunoprecipitated from 25|il of extract
3 ICDH immunoprecipitated from 50|il of extract
4 ICDH immunoprecipitated from 100|il of extract
5 Purified B.caldotenax ICDH
B 48 hour autoradiograph of the above gel

samples, prior to analysis of 32P incorporation. 32P was incorporated into a number of 
proteins when grown in the presence of labelled inorganic phosphate (figure 4.11) however 
no detectable 32P was incorporated into immunoprecipitated ICDH.
4.3 Discussion
The data presented here shows that B. caldotenax ICDH can be phosphorylated and 
inactivated by E. coli ICDH kinase, albeit more slowly than is E. coli ICDH. The 
stoichiometry of the two phosphorylations seems to be the same namely 1 mol phosphate 
/mol subunit. The slow rate of phosphorylation of the B. caldotenax enzyme may reflect 
differences in the sequence and/or conformation between it and E. coli ICDH. 
Phosphorylation was carried out at 37°C, well below the optimum growth temperature of B. 
caldotenax. The conformation of B. caldotenax ICDH may be dependent on temperature 
which could explain the slow rate of phosphorylation observed.
There are two possible explanations for the results obtained in these in vitro phosphorylation 
studies. The acquisition of the complete nucleotide sequence of the B. caldotenax gene for 
ICDH is reported in chapter 5. The amino acid sequence was deduced from this which 
allowed comparison of the sequence with that of E. coli ICDH. As a result of this 
comparison we now know that there is immense similarity between the amino acid 
sequences of E. coli and B. caldotenax ICDHs (approximately 70% identity). In 
consequence there would be expected to be much structural homology, as was originally 
suggested by immunological cross-reaction between B. caldotenax ICDH and an antibody 
raised to E. coli ICDH (section 3.2.3). The phosphorylation observed in vitro might be 
explained by the fact that B. caldotenax ICDH is so similar to that of E. coli it merely acts 
as a suitable substrate for the E. coli ICDH kinase and therefore becomes phosphorylated. 
Although the phosphorylation is genuine and results in a decrease in activity it is possible 
that the phosphorylation is not used as a control mechanism in vivo and is not of any
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physiological significance. This would explain why it was not possible to show evidence of 
phosphorylation in vivo.
Alternatively the sequence of ICDH is highly conserved between the two genera Escherichia 
and Bacillus, the sequence of amino acids at the phosphorylation site having 100% identity 
(chapter 5). It could be argued that the reason for this extreme level of conservation is to 
maintain the ability to be controlled by phosphorylation, as in E. coli. It was reported by 
Kuhn et al. (1980) that the activity of ICL in B. caldotenax was seen to increase during 
growth on acetate as sole carbon source. It would not therefore be unreasonable to expect 
some form of control mechanism at the branch point between the TCA cycle and the 
glyoxylate bypass in this micro-organism.
The results from in vitro phosphorylation studies kept open the possibility that B. 
caldotenax ICDH might be, like that of E. coli, under the control of phosphorylation. I 
therefore investigated whether phosphorylation occured in intact cells. A 46kDa protein was 
shown to be phosphorylated in crude extracts of B. caldotenax. Immunoprecipitation of 
ICDH from such extracts demonstrated that the phosphorylated protein was not ICDH but 
another protein of the same subunit molecular weight The experiments carried out in the 
presence of phosphatase inhibitors go some way to eliminating the possibility that the action 
of phosphatases in the crude extract was preventing us from seeing ICDH phosphorylation. 
However in retrospect it might have been better to phosphorylate ICDH in vitro, add this to 
the extract, and look for loss of 32P.
It was of course possible that ICDH could be phosphorylated in intact cells but not in crude 
extracts. This possibility was investigated by immunoprecipitating ICDH from 32P labelled 
cells, however this experiment gave no evidence of phosphorylation.
The rate of turn over of isocitrate and other metabolites in the cell is likely to be very high.
In addition, in E. coli it has been reported that anaerobiosis can cause activation of ICDH in
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cells grown on acetate (Holms and Nimmo, 1982). Any process which alters the cell's 
environment prior to stopping metabolism might result in the dephosphorylation of ICDH. 
The method chosen to investigate phosphorylation in vivo was a relatively lengthy process 
and it is possible that if B. caldotenax ICDH was phosphorylated in vivo it may have 
reverted to the dephosphorylated state during these manipulations. This was shown not to 
be the case when similar experiments were carried out with E. coli ICDH (Borthwick et 
a/., 1984 b) although these experiments employed different conditions. Within the limits of 
this study it would seem likely that we have not chosen quite the correct experimental 
conditions in which to observe phosphorylation. The negative data that we have obtained 
here do not prove that phosphorylation does not occur in vivo only that we did not see it.
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Chapter 5
Cloning and sequencing the gene for 
Bacillus caldotenax ICDH
5.1 Introduction
Only a small number of genes have been cloned from the thermophile B. caldotenax 
including those genes for lactate dehydrogenase (Zulli et al.y 1987), isopropylmalate 
dehydrogenase (Sekiguchi et a i, 1986a), and tyrosyl tRNA synthetase (Jones et al., 
1986). Therefore the characterisation of any gene encoding an enzyme of central 
metabolism from this micro-organism would be important
The gene which codes for ICDH in E. coli has been cloned and its complete nucleotide 
sequence determined (Thorsness and Koshland, 1987). Similarities between the E. coli 
and B. caldotenax ICDHs were previously reported in chapter 3 as a result of 
immunological cross-reaction and comparisons of some amino acid sequence. A much 
more detailed comparison of these two enzymes could be carried out if the nucleotide 
sequence of the B. caldotenax icd gene were to be determined and the complete amino 
acid sequence inferred from this.
In this chapter I report the use of the amino acid sequence of B. caldotenax ICDH (see 
section 3.2.5) to design an oligonucleotide probe which has been used to clone the gene 
for B. caldotenax ICDH by reverse genetics. The complete nucleotide sequence of the 
ICDH coding region was determined and compared to that of the E. coli icd gene. Some 
analysis of the DNA peripheral to the gene has also been performed.
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5.2 Results
5.2.1 Design of a probe for cloning the B. caldotenax ICDH gene
The amino acid sequence derived from B. caldotenax ICDH (figure 3.9) has been used to 
design an oligonucleotide probe for use in cloning the gene for this enzyme. The 
sequences of very few genes of B. caldotenax are known and no codon preference table 
has been constructed for this micro-organism. Bacillus stearothermophilus is a moderately 
thermophilic bacillus very similar to B. caldotenax, differing only in its ability to hydrolise 
starch ( Epstein and Grossowicz, 1969). Unlike B. caldotenax, B.stearothermophilus has 
been extensively studied and sequence data has been obtained for a number of genes. A 
codon preference table had been constructed for B.stearothermophilus (Hawkins et al., 
1990) using sequence obtained from seven different genes. Zulli et al. (1987) compared 
codon usage within the B.stearothermophilus and B. caldotenax genes for LDH and 
showed there was considerable similarity in the codon preference of these two micro­
organisms. Therefore the codon usage table of Hawkins was used to design a probe for 
cloning the icd gene of B. caldotenax (figure 5.1). The designed probe is a 35mer 
deoxyoligonucleotide which is the reverse of the coding strand.
5.2.2 Southern blot analysis of digests of B. caldotenax genomic DNA
Samples of B. caldotenax genomic DNA were digested with a series of restriction 
enzymes and the fragments resolved in agarose gels (sections 2.12.4 and 2.12.5) (figure
5.2). The DNA was transferred to nylon filters (section 2.15) and probed with the 35mer 
oligonucleotide which was end labelled with y-32P (sections 2.16 and 2.17). Probed filters 
were washed under increasingly stringent conditions of temperature and ionic strength, air 
dried and autoradiographed for 24 hours. Adjusting the temperature and salt concentration 
of the washes enabled optimum conditions to be established, under which the probe was
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Figure 5.2 Agarose gel electrophoresis of restriction digests of 
B.caldotenax genomic DNA
A gel was run as described in section 5.2.2. 5|ig samples of DNA were digested 
(section 2.12.4) with the following enzymes.
track restriction enzyme
1 Sail
2 Clal
3 £a?RI
4 Bam HI
5 Hin dm
6 markers X/Hin dill +£a?RI
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seen to hybridise to a single restriction fragment in each digest (figure 5.3). Optimum 
conditions were found to be at an ionic strength of lxSSC and a temperature of 55°C.
5.2.3 Choice of an appropriate restriction fragment and vector
The sizes of the hybridising fragments, seen in figure 5.3, are summarised in table 5.1. In 
choosing an appropriate size of restriction fragment to clone a number of criteria were 
employed. The fragment must be sufficiently large that is likely to contain the complete 
coding sequence for ICDH together with some DNA peripheral to the gene. It was 
reported that the subunit molecular weight of B. caldotenax ICDH is 46kDa (section
3.2.2). Using this value it is possible to estimate the size of the gene for ICDH to be 
approximately 1.4 kb. Conversely the fragment must be small enough to allow for its 
successful purification and be of an appropriate size to insert into a cloning vector. 
Applying these criteria any of the hybridising fragments would have been suitable. It was 
decided to use the Sal I digest which gave a fragment of approximately 4.2 kb. It was 
thought that while this fragment was large enough to be likely to contain the entire coding 
region for ICDH it was nevertheless sufficiently small for purification and ligation to be 
straightforward.
For cloning a relatively small piece of DNA, as in the Sal I digest, a plasmid vector should 
be suitable and simple. It was decided to use the plasmid vector pUC18. This vector 
contains a selectable antibiotic marker, for ampicillin resistance, and it possesses IPTG- 
inducible histochemical selection when used in an appropriate host (section 2.14.3). This 
property allows recombinants to be easily identified. The polylinker of pUC18 contains a 
number of restriction sites including a Sal I site, the restriction enzyme chosen above.
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Figure 5.3 Autoradiograph of a Southern blot of digested B.caldotenax  
genomic DNA probed with labelled oligonucleotide
DNA was digested with a range of restriction enzymes and the fragments separated in an 
agarose gel (figure 5.2). The restriction fragments were transferred to a nylon filter by the 
method of Southern (section 2.15). The filter was probed using the oligonucleotide shown 
in figure 5.1 and washed with lxSSC at 55°C (as described in section 2.17).
track restriction enzyme
1 Sal I
2 Cla I
3 Eco RI
4 B am HI
5 Hin dill
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Table 5.1 Size of hybridising restriction fragments obtained from 
digests of B .caldotenax genomic DNA
!
i
: Restriction enzyme
Sal I 
Clal 
Eco RI 
Bam HI 
Hin dm
Fragment size (kb)
4.2
4.4
6.3
9.3
6.5
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5.2.4 Construction of a B. caldotenax genomic sub-library in pUC18
a) Size fractionation of Sal I restriction fragments of genomic DNA
The oligonucleotide probe designed to hybridise to the B. caldotenax icd gene was 
shown to hybridise specifically to a 4.2 kb Sal I restriction fragment of B. caldotenax 
genomic DNA (figure 5.3). By size selecting for fragments of approximately 4.2 kb and 
constructing a library with these it was possible to enrich for the presence of the icd gene.
Originally attempts were made to size select fragments using the conventional methods of 
low melting point agarose and electroelution. These methods repeatedly gave 
unsatisfactory low yields and difficulties were experienced with ligations. Successful size 
fractionation of Sal I digested genomic DNA was achieved using a Waters Gen-pak FAX 
column capable of producing high resolution of DNA restriction fragments. B. caldotenax 
genomic DNA was digested with Sal I as described in section 2.12.4 and fragments 
resolved using the Gen-pak FAX column (section 2.12.6). Restriction fragments were 
eluted from the column with a gradient of increasing NaQ concentration; a typical elution 
profile is shown in figure 5.4. Fractions were collected and DNA precipitated by the 
addition of ethanol. Precipitated DNA was resuspended in TE buffer and test samples 
analysed by gel electrophoresis (section 2.12.5) (figure 5.5) to establish which fraction 
contained DNA of the required size. DNA was transferred to nylon membranes, probed, 
washed and autoradiographed as with genomic digests in section 5.2.2. This process 
identified precisely the fraction containing DNA of interest (figure 5.5). Once identified 
remaining DNA from this fraction was used in subsequent ligations to construct a sub- 
library of B. caldotenax genomic DNA.
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35 45 55
time (min)
Figure 5.4 h.p.I.c. purification of restriction fragments generated by a 
S a il  digest of B.caldotenax  genomic DNA
A Waters Genpak FAX column was equilibrated in 25mM Tris/HCL,lmMEDTA pH7.5 
and a gradient developed with 1M NaCl. The flow rate was 0.5 ml/min and 125|il fractions 
were collected across the peak.
Gradient: 0-75% (v/v) NaCl in 40 min.
75-75% (v/v) NaCl in 10 min.
75-100 % (v/v) NaCl in 20 min.
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Figure 5.5 Agarose gel electrophoresis and Southern blotting of Sal I 
restriction fragments purified by h.p.l.c.
A Fractions were collected across the h.p.l.c. peak (figure 5.4) and the DNA recovered 
by ethanol precipitation. DNA was resuspended in TE buffer (lOmM Tris,lmM EDTA 
pH8) and analysed by agarose gel electrophoresis (section 2.12.5.)
B The gel in figure 5.5 A was Southern blotted (section 2.15) and probed using 
labelled oligonucleotide (figure 5.1). The autoradiograph showed which fraction 
contained the DNA of interest.
5  fractions collected across the k
^  h.p.l.c. peak (figure 5.4)
§  ^
^ 2 3 k b
 ^ 9 .4 k b
— 6.5kb
— 4.4kb
— 2.3kb 
2.0kb
V\
4.2 kb —
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b) Ligation of Sail fragments into pUC18
Purified Sal I fragments, prepared as described in section 5.2.6 a), were ligated into the 
plasmid vector pUC18 as described in section 2.13. This process was facilitated by the 
purchase of pUC18 ready cut with Sal I and treated with bacterial alkaline phosphatase. 
Appropriate control ligations were performed and agarose gel electrophoresis was used to 
confirm that ligations were successful.
c) Transformation of E. coli DS941 with plasmid DNA
Competent cells were produced by the method of Hanahan (1983) as described in section 
2.14.1 and transformed with plasmid containing insert by the method described in section 
2.14.2. Suitable transformation controls were also performed. White colonies were likely 
to contain insert; these were picked and screened for the presence of the B. caldotenax icd 
gene by colony hybridisation.
5.2.5 Screening recombinants for the presence of the B. caldotenax 
gene for ICDH by colony hybridisation
Forty recombinant clones were screened by the method described in section 2.18, using 
oligonucleotide probe labelled as in section 2.16. Hybridisation reactions were carried out 
using the optimum conditions established during Southern blot analysis (section 5.2.2). 
Under these conditions the probe was seen to hybridise strongly to DNA from two 
recombinants (figure 5.6). Plasmid DNA was prepared from these two recombinants 
(section 2.12.1), digested with Sal I and analysed by gel electrophoresis (section 2.12.5). 
Digestion of both recombinant plasmids with Sal I produced a 2.7kb vector fragment and a
4.5 kb insert fragment (figure 5.7 A); the recombinants appeared to be identical. The use of 
lkb DNA Ladder as a marker allowed the size of the insert to be determined accurately to
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Figure 5.6 Colony hybridisation of recombinant clones
Recombinant pUC clones were screened with labelled oligonucleotide (figure 5.1) using 
colony hybridisation as described in section 2.18. Duplicate filters were made and 
screened, these are shown above.
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B4.5kb — 
2.7kb —
— 5.1kb
— 4kb
— 3kb
— 2kb
— X.6kb
— Ikb 
— 0.5kb
4.5kb —
Figure 5.7 Digestion of plasmid pCWl with Sal I
A 5pg of pCWl were digested with Sal I as described in section 2.12.4. The restriction 
fragments obtained were resolved in a 0.8% agarose gel (section 2.12.5). Markers (lkfc 
ladder) were run alongside to estima te the size of the restriction fragments.
B The gel was Southern blotted (section 2.15), probed using the 35mer oligonucleotide 
(section 2.17) and autoradiographed. The probe hybridised strongly to the 4.5 kb insen 
fragment.
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be 4.5kb, larger than the previous estimate of 4.2kb. Agarose gels were blotted and 
probed as in section 5.2.2. The probe was found to hybridise strongly to the 4.5 kb 
fragment figure (5.7B). The two recombinant plasmids were named pCWl and pCW2.
5.2.6 Restriction mapping of pCWl
Plasmid DNA was prepared from the clone on a large scale by the method described in 
section 2.12.2. The plasmid obtained was either singly or doubly digested with a series of 
restriction enzymes, (section 2.12.4). Restriction fragments were analysed by gel 
electrophoresis and their sizes determined by comparison of their relative mobilities to 
those of molecular weight markers. Analysis of the fragments produced by single and 
double digests enabled the positions of several restriction sites within the plasmid pCWl 
to be mapped (figure 5.8).
Southern blot analysis and probing of restriction digests indicated that the probe 
hybridised somewhere within the Sal 1/EcoRl 1.1 kb fragment.
5 .2 .7  Confirmation that pCWl contains the complete coding sequence for 
ICDH
A preliminary sequencing experiment confirmed that pCWl contained the complete 
coding sequence iorB. caldotenax ICDH. Double stranded template was prepared from 
pCWl for sequencing by alkaline hydrolysis (Sambrook et al., 1989) ( section 2.19.1 a). 
Nucleotide sequence was determined from the double stranded template using the chain 
termination sequencing method developed by Sanger (1977) as described in section 
2.19.1. Two primers were used in these preliminary sequencing reactions;
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a)The 35mer oligonucleotide probe designed from the ICDH amino acid sequence (figure 
5.1).
The probe, originally designed to isolate the gene for ICDH, hybridises specifically to a 
region within it sufficiently well to be used as a primer for sequencing. Because the 
oligonucleotide probe is the reverse of the coding strand, sequence obtained using it as 
primer was also the reverse of the coding strand. It is likely (as explained in section 3.3) 
that the probe is homologous to the N-terminus of the ICDH coding sequence. If this is 
the case then sequence obtained would be just upstream to the gene for ICDH.
b) The -40 primer.
This is a universal primer homologous to a region of the pUC18 plasmid vector close to 
the polylinker. This primer was used to sequence into the plasmid insert
The two sequences obtained were complementary over almost their entire lengths, i.e. 
sequencing in this manner gave the sequence of both strands of the same region of DNA. 
As explained previously this region of DNA is likely to be upstream to the icd gene. The 
size of the icd gene was calculated from the size of the protein to be approximately 1.4 kb, 
whereas the cloned insert is 4.5 kb in length. As a result of these sequencing experiments 
the 35mer oligonucleotide was found to hybridise approximately 300 base pairs from one 
of the Sal I sites with the icd gene lying in the direction leading into the insert. It was 
therefore concluded that the insert of pCWl almost certainly contained the complete coding 
sequence for ICDH together with some DNA peripheral to the gene.
5.2.8 Determination of the complete nucleotide sequence of the 
B. caldotenax gene for ICDH
The gene for B. caldotenax ICDH was sequenced using the chain termination method of 
Sanger (1977), as described in section 2.19.1. Sequencing was carried out using double
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stranded templates made by the method described in section 2.19.1 a) and 17mer 
oligonucleotides.
Nucleotide sequence obtained as described in section 5.2.9 was used to design an 
oligonucleotide primer. This was constructed in the correct orientation for sequencing into 
the icd gene. Successive oligonucleotide primers were designed as sequencing proceeded. 
Sequencing was facilitated by the construction of subclones from pCWl.
5.2.9 Construction of subclones from pCW l
Restriction mapping (figure 5.8) showed the presence of an EcoRl restriction site within 
the pCWl insert, approximately 1.1 kb from one Sal I site. Knowing the size and location 
of the ICDH gene within the insert it could be concluded that this EcoR I site must fall 
inside the gene.
Plasmid pCWl was digested as described in section 2.12.4 with both Sail and EcoRl and 
the three fragments produced resolved in a 0.8% agarose gel (section 2.12.5 ). Two Sal 
1/EcoR I fragments were produced of l.lkb and 3.4 kb in size. These two fragments were 
excised from the gel and the DNA was recovered by the method described in section 
2.12.7. The two DNA fragments were subcloned into pBluescript KS+ and transformed 
into XL 1-blue (section 2.14). Plasmid isolated from the subclones and digested with Sail 
and EcoRl confirmed the presence of either a l.lkb ( pCW3) or a 3.4 kb insert (pCW4).
The cloning vector pBluescript KS+ contains a universal priming site complementary to 
the commercially available primer T7. Sequence was obtained from both subclones using 
this primer. Further oligonucleotides were designed to the sequence obtained so that 
sequencing could proceed in both directions. The sequencing strategy used is summarised 
in figure 5.9.
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Figure 5.9 The strategy used to sequence icd
The complete region of 1555 nucleotides sequenced is outlined by the box. The arrows 
indicate the direction of second strand synthesis and length of readable sequence 
obtained. The clone or subclone used for sequencing is given together with the reference 
number of the oligonucleotide or commercial primer.
primers : T7 primer 5'-TAATACGACTCACTATAGGG-3'
-40 primer S’-GTTTTCCCAGTCACGAC-T
oligonucleotides: 01 S’-ACGCCGTTTTGGACCGTGATTTTTTCGCCTTGCAT- 3'
02 5’- CGCCCGCATGCACGGCT- 3’
03 5'- GAGGGGGATGGAACCGG -3'
04 5’- GACATCTTCCTGCAACA- 3'
05 5'- TTGCGCACGCCCATTTC -3'
06 5'- GACATCTTCCTGCAACA -3’
07 5’- GAAGCAGCGAAATTGAT -3'
08 5'- GCCATTAAAGGGCCGTT - 3'
09 5 - TGCCGTGCGTCGCTTCG -3’
10 5'- CGCCCCCGTGAATCCGG -3’
11 5’- GTTCAGCGAGCGGATGC -3*
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The complete coding sequence for ICDH was obtained on both strands of DNA together 
with some sequence of the flanking regions (figure 5.10). An open reading frame of 1272 
nucleotides was evident, commencing with a GTG start codon and finishing with a TAA 
stop codon. The gene encodes a protein of 422 amino acids with a calculated molecular 
weight of 46,438 daltons.
5.2.10 Analysis of the nucleotide sequence
The nucleotide sequence of the region encoding B. caldotenax ICDH has been compared 
to that of E. coli ICDH using bestfit computer analysis (section 2.20). The two sequences 
aligned with 69.6% identity over their complete lengths. The total G+C content in the 
coding region of B. caldotenax ICDH was higher than in E. coli, 54.8% compared to 
48.7%. A codon usage table was constructed for the B. caldotenax icd gene (table 5.2). 
Codon usage was quite different from that of E. coli as in B. caldotenax there was higher 
use of codons with either G or C as their third letter. For the B. caldotenax icd gene the 
G+C content in the third letter of the codon is 67.7% whereas in the E. coli gene it is only 
52.5%.
The gene for ICDH from the extreme thermophile Thermus thermophilus has recently 
been cloned and sequenced (Miyazaki et al., 1992). The nucleotide sequence of B. 
caldotenax ICDH showed 62% identity to that of T. thermophilus. The G+C content of 
the coding region of T. thermophilus ICDH is 65.6% and that in the third nucleotide of 
the codon is 90.3%. These values are higher than those obtained for the B. caldotenax 
ICDH coding region.
A testcode computer analysis (section 2.20) was performed on the nucleotide sequence 
obtained (figure 5.11). Testcode identifies a protein coding sequence by plotting a measure 
of the non-randomness of the composition at every third base. The plot is divided into
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Figure 5.10 Nucleotide sequence and derived amino acid sequence 
of the first 1555 nucleotides of the pCWl insert
The nucleotide sequence is shown with the derived amino acid sequence below. The 
putative ribosome binding site, -10 and -35 regions are indicated in bold print. The 
start and stop codons of ORFs are also shown in bold.
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121
181
241
301
361
421
481
541
601
NGTTTAGGAATCGATCATGATTTGTTTACGCCGATTTTTGCCGTCAGCCGCACCTCGGGA
60
7 L G I D H D L F T P  I F A V S R T S G
TGGTTGGCTCACATCTTGGAACAATACGACAACAACCGTCTCATCCGTCCGCGCGCTGAG
120
W L A H I L E Q Y D N N R L I R P R A E
TACACCGGCCCAGGCAAGCGGGCGTACGTGCCGATCGACGAGCGCGGCCAAAACAAGTGG
180
Y T G P G K R A Y V P  I D E R G . Q N K W
ACAAGGCGGTGAAGGCGCGCCTTCACGCCTTTTTATAAAAAAACTGCATTGGGGGTTTTG
240
T R R *
CTCGTGACGCAAGGAGAAAAAATTACAGTCCAAAATGGTGTGCTCAACGTTCCGAACAAC
300
T Q G E K I T V Q N G V L N V P N N
CCGATCATTCCGTTCATCGAGGGGGATGGAACCGGCCCGGACATTTGGGCGGCCGCTTCG
360
P I I P F I E G D G T G P D I W A A A S
CGCGTGCTCGAAGCAGCGGTGGAAAAAGCGTACAAAGGTGAGAAAAAAATCGTCTGGAAG
420
R V L E A A V E K A Y K G E K K  I V W K
GAAGTGCTCGCTGGTGAAAAAGCGTACAAGCTGACGGGCAGCTGGCTTCCGGATGAAACG
480
E V L A G E K A Y K L T G S W L P D E T
CTTGAGACGATCCGCGAATACATAATCGCCATTAAAGGGCCGTTGACGACGCCGGTCGGC
540
L E T I R E Y I I A I K G P L T T P V G
GGCGGCATCCGCTCGCTGAACGTAGCGCTCCGCCAAGAGCTCGACCTGTTTGTCTGCTTG
600
G G I R S L N V A L R Q E L D L F V C L
CGCCCGGTTCGCTACTTCCCAGGCGTTCCGTCGCCGGTGAAACGCCCGGAAGACACCGAT
660
R P V R Y F P G V P  S P V K R P E D T D
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ATGGTCATTTTCCGGGAAAACACGGAAGACATCTACGCTGGCATTGAATATGCCAAAGGC 
661  720
M V I  F R E N T E D I Y A G I E Y A K G
ACGCCGGAAGTGAAAAAAGTCATCGACTTTTTGCAAAACGAAATGGGCGTGCGCAAAATC 
721  780
T P E V K K V I D F L Q N E M G V R K I
CGCTTCCCGGAAACGTCCGGCATCGGCATTAAACCGATTTCCGAACAAGGGACGAAACGG 
781  840
R F P  E T S G I G I K P  I S E Q G T K R
CTTGTGCGCGCGGCGATCAACTACGCGATCGAACACGGCCGCAAGTCGGTGACGCTCGTT 
841  900
L V R A A I N Y A I E H G R K S V T L V
CATAAAGGAAACATTATGAAATTCACCGAAGGCGCGTTTAAAAACTGGGGTTATGAATTG 
901 960
H K G N  I M K F T E G A F K N W G Y E L
GCGGAGGAAGAATTCGCCGACAAAGTGTTCACGTGGGCGCAATACGACCGAATCGTTGAA 
961 1020
A E E E F A D K V F T W A Q Y D R I V E
ACGGAAGGCAAGGAAGCGGCGAACAAAGCGCTTGCTGATGCGGAAGCGTCCGGCAAAATC 
1021  1080  
T E G K E A A N K A L A D A E A S G K I
ATTATCAAAGATGTCATCGCCGACATCTTCCTGCAACAAATTTTGACGCGTCCGCGCGAA 
1081  1140
I I K D V I A D I F L Q Q I L T R P R E
TTTGACGTCATCGCGACGATGAACTTAAACGGCGACTACATTTCCGACGCGCTGGCCGCT 
1141  1200
F D V I A T M N L N G D Y I S D A L A A
CAAGTCGGCGGCATCGGCATCGCGCCGGGGGCCAACATCAACTACGAAACCGGCCACGCG 
1201  1260  
Q V G G I G I A P G A N I N Y E T G H A
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ATTTTCGAAGCGACGCACGGCACGGCGCCGAAATACGCAGGGCTTGACAAAGTCAACCCG 
1261  1320
I F E A T H G T A P K Y A G L D K V N P
TCGTCCGTCATTCTCTCGGGCGTCATGATGTTTGAGCATCTTGGTTGGAACGAAGCAGCG 
1321  1380
S S V I L S G V M M F E H L G W N E A A
AAATTGATCATCAAAGCGATGGAGAAAACCATCGCCGCGAAAATCGTCACGTATGACTTC 
1381  1440
K L I  I K A M E K T  I A A K I V  T Y D F
GCCCGCCTGATGGAAGGGGCGACGGAAGTGAAATGCTCCGAATTTGCTGATGCGCTCATC 
1441  1500
A R L M E G A T E V K C S E F A D A L I
CGCAATATGGACTAACCTTTGAAGGAAAGGGATGGCAAACGATGGCGATGAAACG 
1501  1555
R N M D *
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Table 5.2 Codon usage in the B. caldotenax icd gene
G A T C
G Gly 17 Glu 18 Val 39 Ala 60 G
Gly 8 Glu 82 Val 3 Ala 7 A
Gly 14 Asp 30 Val 16 Ala 13 T
Gly 61 Asp 70 Val 42' Ala 20 C
A Arg 0 Lys 13 Met 100 Thr 76 G
Arg 0 Lys 88 lie 2 Thr 4 A
Ser 0 Asn 11 lie 34 Thr 0 T
Ser 8 Asn 89 He 63 Thr 20 C
T Tip 100 Stop 0 Leu 22 Ser 46 G
Stop 0 Stop 100 Leu 4 Ser 0 A
Cys 0 Tyr 23 Phe 38 Ser 0 T
Cys 100 Tyr 77 Phe 63 Ser 46 C
C Arg 11 Gin 0 Leu 22 Pro 95 G
Arg 6 Gin 100 Leu 0 Pro 5 A
Arg 6 His 40 Leu 22 Pro 0 T
Arg 78 His 60 Leu 30 Pro 0 C
Codon usage in the B.caldotenax icd gene was calculated using the WGCG program 
codon frequency (section 2.20). The frequency with which each codon is used to code a 
particular amino acid is expressed as a percentage.
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Figure 5.11 TESTCODE plot of nucleotides 1-1555 of the pCW l insert
The top region of the plot predicts coding regions to a 95% level of confidence. The bottom 
region predicts non-coding regions to the same level of confidence. The middle region is 
the "window of vulnerability" for the method where the statistic can make no significant 
prediction. Above the curve, there are markings that identify the start and stop codons for 
each reading frame of the sequence. Starts are indicated by short vertical lines and stops by 
small diamonds.
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three regions, the top region predicts coding regions to a 95% level of confidence and the 
bottom region predicts non-coding regions with the same level of confidence. The middle 
region is termed the "window of vulnerability" and makes no significant prediction. 
Testcode of the nucleotide sequence obtained predicted an open reading frame of 
approximately 1200 nucleotides with only one small "vulnerable" region. No conclusions 
could be drawn regarding testcode analysis of the region upstream of the icd gene. 
Testcode uses a window of 200 nucleotides to make predictions and there was not this 
much upstream sequence available.
5.2.11 Analysis of the predicted amino acid sequence of B. caldotenax 
ICDH
The nucleotide sequence of the B. caldotenax icd gene predicted a protein of 422 amino 
acid residues. This predicted sequence was compared to the sequence of 15 amino acid 
residues determined by Edman degradation (section 3.2.). This comparison confirmed, as 
previously suggested, that the sequence of 15 residues established by protein sequencing 
was in fact N-terminal. The two sequences were in complete agreement.
Bestfit computer analysis (section 2.20) was used to compare B. caldotenax and E. coli 
ICDH amino acid sequences (figure 5.12). The sequences aligned with 70.1% identity and 
83.9% similarity. Comparison of the amino acid sequence of B. caldotenax ICDH with 
that of T. thermophilus showed 42% identity and 62% similarity (also shown in figure 
5.12). Several stretches of amino acids present in B. caldotenax ICDH were absent from 
that of T. thermophilus. In addition T. thermophilus ICDH possessed a region of 140 
amino acids at its C terminus which was not found in B. caldotenax ICDH. Miyazaki et 
al. (1992) compared the amino acid sequence of T. thermophilus ICDH to that of E. coli. 
The two sequences exhibited 33% identity and 37% similarity. B. caldotenax ICDH is 
much more closely related to ICDH of E. coli than that of T. thermophilus. Although
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Figure 5.12 Comparison of the B. caldotenax ICDH derived amino
acid sequence with the known sequences of other ICDHs
The derived amino acid sequence of B. caldotenax ICDH was compared to the 
derived amino acid sequences of E. coli (Thorsness and Koshland, 1987) and 
T.thermophilus (Miyazaki et al., 1992). The sequences were aligned using the 
LINEUP program of the UWGCG package (section 2.20).
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AASRVLEAAV EKAYKGEKKI VWKEVLAGEK AYKLTG. . SW LPDETLETIR 
AMLKWDAAV EKAYKGERKI SWMEIYTGEK STQVYGQDVW LPAETLDLIR 
ATLKVLEAA....................... KAP LAYEVREAGA SVFRRGIASG V PQ ETIESIR
101  150
E Y IIA IK G PL  TTPVGGGIRS LNVALRQELD LFVCLRPVRY FPGVPSPVKR 
EYRVAIKGPL TTPVGGGIRS LNVALRQELD LYICLRPVRY YQGTPSPVKH 
KTRWLKGPL ETPVGYGEKS ANVTLRKLFE TYANVRPVRE FPNVPTPYAG
1 5 1  200
PEDTDMVIFR ENTEDIYAGI EYAKGTPEVK KVIDFLQNEM GVRKIRFPET
PELTDMVIFR ENSEDIYAGI EWKADSADAE KVIKFLREEM GVKKIRFPEH
R G I.D L V W R  ENVEDLYAGI EHMQTPSVAQ ..................................................
2 0 1  250
S G IG IK P IS E  QGTKRLVRAA INYAIEHGRK SVTLVHKGNI MKFTEGAFKN 
CGIGIKPCSE EGTKRLVRAA IEYAIANDRD SVTLVHKGNI MKFTEGAFKD 
...T L K L IS W  KGSEKIVRFA FELARAEGRK KVHCATKSNI MKLAEGP..K
2 5 1  300
WGYELAEEEF ADKVFTWAQY DRIVETEGKE AANKALADAE ASGK IIIK D V
WGYQLAREEF GGELIDGGPW LKV......................................KNPN TGKEIVIKDV
RAFEQVAQEY P D ..............................................................................................IEAVHI
3 0 1  350
IA D IFLQ Q IL TRPREFDVIA TMNLNGDYIS DALAAQVGGI GIAPGANINY 
IADAFLQQIL LRPAEYDVIA CMNLNGDYIS DALAAQVGGI GIAPGANIGD 
IVDNAAHQLV KRPEQFEVIV TTNMNGDILS DLTSGLIGGL GFAPSANIGN
3 5 1  400
ETGHAIFEAT HGTAPKYAGL DKVNPSSVIL SGVMMFEHLG WNEAAKLIIK 
E C ..A L FE A T  HGTAPKYAGQ DKVNPGSIIL SAEMMLRHMG WTEAADLIVK 
E V . . AIFEAV HGSAPKYAGK NVINPTAVLL SAVMMLRYLE EFATADLIEN
4 0 1  450
AMEKTI.AAK IVTYDFARLM EGATEVKCSE FADALIRNMD .........................
GMEGAI. NAK TVTYDFERLM DGAKLLKCSE FGDAIIENM ...............................
ALLYTLEEGR VLTGDWGYD RGA. . .KTTE YTEAIIQNLG KTPRKTQVRG
4 5 1 500
YKPFRLPQVD GAIAPIVPRS RRWGVDVFV ETNLLPEALG KALEDLAAGT 
5 0 1  550
PFRLKMISNR GTQVYPPTGG LTDLVDHYRC RFLYTGEGEA KDPEILDLVS 
5 5 1  5 8 0
RVASRFRWMH LEKLQEFDGE PGFTKAQGED
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B.caldotenax and E.coli ICDHs show significant identity to the N-terminal region of 
that of TJhermophilus ICDH the C termini are considerably different For this reason 
most comparisons were made between the B. caldotenax and E. coli enzymes.
The activity of ICDH in E. coli is controlled by phosphorylation of a serine residue. The 
position of the phosphorylated serine residue and the sequence of surrounding amino acids 
has been determined in E. coli (Borthwick et a l 1984b; Malloy et al., 1984) to be as 
follows;
104-Thr Thr Pro Val Gly Gly Gly lie Arg Ser Leu Asn Val Ala-117
This sequence of amino acids is completely conserved in B. caldotenax ICDH between 
* positions 94 and 107.
A consensus sequence for a nucleotide binding site in ICDH/IMDH type dehydrogenases 
has been defined in the computer analysis program MacPattem on the evidence of Hurley 
et al. (1991). This motif was identified in B. caldotenax ICDH between positions 341 and 
351.
C o n s e n s u s  ICDH/IM DH E [A /P ]  X H G [ S /T ]  A P X X [A /P ]
B. c a l d o t e n a x  ICDH E A T H G  T A P K Y  A
The amino acid composition of B. caldotenax ICDH was calculated and is shown in table
5.3 together with that of E. coli ICDH for comparison. Generally there is little difference 
between the overall amino acid compositions of the two types of ICDH. However B. 
caldotenax ICDH does exhibit a slight increase in the overall number of polar residues and 
a decrease in cysteine residues. These differences may have implications in increasing the 
thermostability of the protein; the additional polar residues might be involved in stabilising 
hydrogen bonds.
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Table 5.3 The amino acid compositions of B.caldotenax and E.coli
ICDH s
Amino acid B.caldotenax ICDH E.coli ICDH
Ala 10.7 9.1
Cys 0.5 1.4
Asp 4.7 6.0
Glu 9.0 8.4
Phe 3.8 2.4
Gly 8.5 9.6
His 1.2 1.2
lie 9.7 8.9
Lys 7.6 7.5
Leu 6.4 7.5
Met 2.1 3.1
Asn 4.3 3.6
Pro 4.5 4.8
Gin 2.1 2.6
Arg 4.3 4.1
Ser 3.1 3.1
Thr 5.9 4.3
Trp 1.4 1.4
Tyr 3.1 3.6
Val 7.1 7.2
The amino acid compositions of B.caldotenax and E.coli ICDH s were calculated from 
their amino acid sequence using the WGCG computer program Pepsort (section 2.20).
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B. caldotenax ICDH lacks the first 8 amino acids at the N-terminus which are present in 
E. coli ICDH, these residues are also absent in T. thermophilus ICDH although the 
reason for this is unclear. In addition B. caldotenax ICDH contains an extra stretch of 13 
amino acids between residues 257 and 270 which has no corresponding sequence in the 
E.coli enzyme. The region of nucleotides encoding these additional amino acids 
corresponded to the 'Vulnerable" coding region identified by testcode analysis (section 
5.2.10). This region of unusual DNA was sequenced independently on the second ICDH 
clone, pCW2. The nucleotide sequence of this region was found to be identical in both 
clones, indicating that it is genuine and not an artefact resulting from a re-arrangement of 
the DNA during cloning. Examination of the structure of E. coli ICDH showed the 
position of this extra region. The region forms a loop on the surface of the smaller domain 
of the ICDH subunit. It is possible that this extra region of DNA has implications in 
enhancing the thermostability of the enzyme.
5.2.12 Analysis of DNA peripheral to the icd  gene
a) Analysis of upstream DNA
In addition to determination of the complete nucleotide sequence of the icd gene the 
sequence of approximately 300 nucleotides upstream and 40 nucleotides downstream was 
also established. These flanking regions of DNA have been examined for evidence of 
ribosome binding sites and other upstream transcriptional elements, and searched for the 
presence of other open reading frames.
Moran et al. (1982) examined ribosome binding sites (RBS) o f B.subtilis and showed the 
nucleotide sequence of these sites to be very similar to those for E. coli genes. Several 
genes from thermophilic bacilli have been cloned and potential RBSs identified for these
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genes. In all cases the sequence of the RBS was similar to the consensus RBS defined for 
E. coli genes.
The RBS for the B. caldotenax ICDH gene would be expected to lie within 7-14 
nucleotides of the GTG start codon (Moran et al., 1982). This region of DNA was 
examined for a sequence of nucleotides similar to the consensus RBS sequence. The 
sequence most likely to be a RBS was found between positions -6 and-14 and is shown 
highlighted in figure 5.10. This potential RBS bears little similarity to the RBS consensus 
sequence. A putative transcriptional promoter has been identified, the -35 and -10 regions 
show considerable sequence homology to the E. coli -35 (TTGACA) and -10 (TATAAT) 
consensus sequences. The -35 and -10 regions for the putative B. caldotenax icd gene 
promoter are highlighted in figure 5.10.
Computer analysis of the upstream nucleotide sequence revealed the end of another open 
reading frame, just 50 nucleotides upstream to the icd gene and in the same reading frame. 
This ORF was translated and used to search the GenEmbl database for evidence of 
homology to other proteins of known sequence. The translated sequence was found to 
have 50% identity and 76 % similarity to the C-terminal end of the amino acid sequence of 
citrate synthase from the thermophile Thermus acidophilum. Similarly it showed 50% 
identity (74% similarity) to citrate synthase from the facultative thermophile B. coagulans 
and between 40% and 44 % identity with the C-terminus of citrate synthase from 6 other 
micro-organisms. An alignment of these sequences with the translated upstream ORF is 
shown in figure 5.13. It seems very likely from this alignment that the gene which 
encodes citrate synthase in B. caldotenax lies just upstream to the gene for ICDH.
b) Analysis of downstream DNA
The sequence of approximately 40 nucleotides after the TAA stop codon of the icd gene 
have been determined. This region of DNA contained a sequence of nucleotides which
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TAACCTTTGAAGGAAAGGGATGGCAAACGATGGCGATGAAACG 
1 5 1 3  1 5 5 5
M A N D G D E T
M A M K R
Figure 5.14 Analysis of nucleotide sequence downstream to icd
The sequence of 40 nucleotides downstream to the gene for ICDH are shown. Translation 
of the sequence in all reading frames (section 2.20) showed the start of two possible 
ORFs. A potential ribosome binding site was identified for one of these ORFs and is 
indicated in bold. The derived amino acid sequences of these two ORFs are also shown.
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resembled the consensus RBS sequence and was closely followed by two possible ATG 
start codons in two different open reading frames. The downstream region of DNA was 
translated in all 6 possible reading frames and the resulting peptide sequences (figure 5.14) 
used to search the GenEmbl database. None of the translated peptides showed significant 
similarity with any known protein sequences.
5.3 Discussion
A 35mer oligonucleotide probe was designed to B. caldotenax ICDH amino acid sequence 
and was found to hybridise to a 4.5kb Sal I fragment of B. caldotenax genomic DNA.
The strength of the signal obtained from probing B. caldotenax genomic DNA was 
sufficient, at high stringency, to represent genuinely specific hybridisation. Strength and 
specificity of the signal depend on hybridisation and washing conditions. It is possible to 
calculate the Tm, melting temperature of a DNA duplex, (Suggs et al., 1981; Anderson 
and Young, 1985; Albretsen et al., 1988) and hybridisation temperatures of 5-10°C below 
Tm are recommended (Binnie, 1990). However in practice conditions are usually defined 
empirically.
A low stringency hybridisation wash is used initially and then the stringency increased 
progressively. The more stringent the hybridisation and washing conditions, the less likely 
the chance of mismatches between the oligonucleotide and target DNA. In this manner a 
set of conditions are determined which result in a single specific hybridisation signal being 
retained. In this case a single specific signal was obtained when filters were hybridised at 
50°C in 6xSSC and washed with lxSSC at 55°C.
The 35mer oligonucleotide probe was used to isolate a clone from a sub-library of 
B.caldotenax genomic DNA. The clone contains the complete coding sequence for the 
B.caldotenax icd gene. The gene consists of an open reading frame of 1266 base pairs
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which encodes a protein of 422 amino acid residues with a molecular weight of 46,437 
daltons. This value agrees well with that obtained for the subunit molecular weight 
determined by SDS PAGE (section 3.2.2).
A comparison was made of the inferred amino acid sequence with that obtained by protein 
sequence analysis (section 3.2.6). The two sequences were in complete agreement and 
confirmed the previous suggestion that the protein sequence was N-terminal.
It has been suggested that the ability of thermophiles to grow at elevated temperatures is a 
result of differences in the macromolecules which they contain, in comparison to 
mesophiles. Studies have shown DNA from thermophiles to possess greater thermal 
stability than that from mesophiles and investigations have been carried out to see how this 
increased thermostability is achieved (Stenesh et al., 1968). Stenesh's group compared 
DNA from several strains of B. stearothermophilus with that from a number of 
mesophilic Bacillus species. They found thermophilic DNA contained an increased G+C 
content in comparison to mesophiles. Kagawa et al. (1984) studied the IMDH gene of 
Thermus thermophilus and showed thermophiles not only have an increased G+C content 
within their coding regions but more specifically to have high G+C in the third letter of 
codons. The results obtained for the G+C content within the B. caldotenax gene for 
ICDH support these observations. The G+C content in the coding region of this gene was 
54.8% and in the third letter of codons to be 67.7%. These values were compared to those 
calculated from the ICDH coding regions of the extreme thermophile, T. thermophilus, 
and the mesophile, E. coli (table 5.4). A general trend was observed in which the more 
thermophilic the organism the higher the total G+C content in the coding region and in the 
third letter of the codon. This trend was also observed by Sekiguchi et al. (1986b) when 
comparing the G+C content of the IMDH coding regions from a variety of thermophilic 
and mesophilic organisms (table 5.4).Values for the G+C content in both B. caldotenax 
genes was found to be very similar.
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Table 5.4 Comparison of the total G+C content and G+C content in
the third letter of the codon in the coding region of ICDH 
and IMDH from different organisms
Micro-organism Protein
(%)
G+C 
content 
codon (%)
G+C content 
in 3rd letter
Study
E.coli ICDH 48.7 52.5 Thorsness and 
Koshland (1987)
S.cerevisiae IMDH 43.5 39.6 Andreadis et al. (1984)
S.cerevisiae ICDH 42 44.8 Haselbeck and 
McAlister-Henn (1990)
B.coagulans IMDH 53.1 56.3 Sekiguchi et al. (1986b)
B.caldotenax IMDH 56..7 65.2 Sekiguchi etal. (1987)
B.caldotenax ICDH 54.8 67.7 this study
T.thermophilus IMDH 70.1 89.4 Kagawa et al. (1984)
ICDH (isocitrate dehydrogenase)
IMDH (3-isopropylmalate dehydrogenase)
Any nucleic acid is stabilised by increasing its G+C content Thermophiles utilise this 
property in order to gain increased thermostability of their DNA. In addition the increased 
G+C content in the third letter of the codon will help to stabilise dynamic structures 
formed during transcription and translation at high temperatures. A result of this is that the 
codon usage of thermophiles is quite different from that of mesophiles. Comparison of the 
nucleotide sequences of the B. caldotenax icd gene with that of E. coli showed 69% 
identity. Although significant, a high identity at the nucleotide level is less significant than 
at the amino acid level.
At the amino acid level the sequence of B. caldotenax had 70.1% identity and 83.9 % 
similarity to that of E. coli ICDH (figure 5.12). This is remarkable similarity considering 
that these are two quite different micro-organisms. Presumably this extreme level of 
conservation reflects the importance of the enzyme in central metabolism. In E. coli ICDH 
certain regions are known to be of functional importance to the enzyme, e.g. the sites for 
nucleotide binding and phosphorylation. The amino acid sequence of these regions are 
conserved in their entirety in B. caldotenax ICDH. The complete conservation of the 
phosphorylation site is further evidence that the activity of B. caldotenax ICDH may be 
controlled by phosphorylation as was originally suggested in chapter 4. B. caldotenax 
ICDH showed less identity (42%) with ICDH from T. thermophilus. B. caldotenax 
ICDH seems to be much more closely related to the E. coli enzyme than that of the 
extreme thermophile.
A number of workers in the past have tried to identify thermostabilising amino acid 
residues within thermophilic proteins by comparing them to a mesophilic form of the same 
protein. Several features of interest arose from comparisons of the amino acid composition 
and sequences of E. coli and B. caldotenax ICDHs. B. caldotenax ICDH contained only 2 
cysteine residues whereas that of E. coli contained 6. It was suggested by Saiki et al. 
(1978) that non-essential cysteine residues might be replaced in thermophilic enzymes so 
as to prevent oxidative inactivation of the enzymes under aerobic conditions at high
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temperatures. This may explain the reduced number of cysteine residues observed in 
B.caldotenax.
It is believed that an increase in the internal hydrophobicity of a protein will increase its 
thermostability (Yutani et al., 1987). No significant differences in the number of 
hydrophobic residues present in E. coli and B. caldotenax ICDH were observed. Certain 
other amino acid replacements have been reported in thermophilic enzymes when 
compared to those of mesophiles. Zuber (1978) reported an increase in arginine residues 
in thermophilic enzymes at the expense of lysine residues. Zuber hypothesised that 
thermostabilty was gained by a difference in the arrangement of ionic bonds. Three such 
substitutions were apparent within B. caldotenax ICDH at residues 38,177 and 255. 
Other similar thermostabilising substitutions have been suggested by Argos et al. (1979) 
who reported changes in thermophiles of Gly to Ala, Ser to Ala, Ser to Thr and Asp to 
Glu. At least one or more examples of all these substitutions can be identified in 
comparisons of the E. coli and B. caldotenax ICDH amino acid sequences. However it 
was suggested by Zuber (1978) that when carrying out such comparisons it was advisable 
to compare proteins from closely related bacteria with very similar metabolism, as 
thermophilic-mesophilic differences in amino acid sequence would be most visible when 
other differences were small. As a result of comparative studies on the amino acid 
sequences of mesophilic and thermophilic ferredoxins Zuber also advised that at least 2-3 
thermophilic proteins must be compared with 2-3 mesophilic proteins in order to establish 
any critical thermostabilising residues. This being the case it is not possible to draw any 
firm conclusions, regarding thermostability, from similar comparisons between the amino 
acid sequences of B. caldotenax and E. coli ICDHs as phylogenetic differences will be 
large.
Examination of DNA upstream to the gene for ICDH has shown the presence of a second 
ORF in very close proximity to the icd gene. It seems very likely that this ORF codes for 
citrate synthase, another enzyme of the TCA cycle. The two ORFs are separated by only 51
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nucleotides. The close proximity of the two genes might suggest that they form part of an 
operon. In addition it would seem logical for the genes of these two TCA cycle enzymes 
to be transcribed together. In contrast in E. coli none of the TCA cycle enzymes constitute 
an operon. Some of the TCA cycle genes are clustered together but this is not the case 
with the icd gene. It is thought that the genes do not form an operon possibly because of 
the cycle's dual role in anabolism and catabolism.
If the B . caldotenax icd gene does form part of an operon we would not expect to see 
distinct transcription initiation sites for this gene, however putative sites were identified. It 
is possible that icd is within an operon but under certain circumstances ICDH needs to be 
expressed separately from CS. Genes which are differentially expressed have been 
identified in E. coli. For example the genes for the component enzymes of the pyruvate 
dehydrogenase (PDH) complex (aceE, aceF and Ipd) can be expressed as a single 
transcript from one promoter, or Ipd can be transcribed singly from a different promoter 
(Spencer and Guest, 1985). The manner in which the genes are expressed is dependent on 
the growth conditions.
The hypothesis that the genes for CS and ICDH form an operon in B. caldotenax could be 
tested by the use of SI nuclease transcriptional mapping. This approach was used by 
Spencer and Guest (1985) to analyse the organisation of the genes encoding components 
of the pyruvate and 2-oxoglutarate dehydrogenase complexes in E. coli. This method 
allows the size of transcripts to be established and it is possible to determine whether or 
not genes are transcribed singly or together. This approach and other methods of 
confirming the existence of a CS/ICDH operon are discussed further in the general 
discussion.
Chapter 6
General discussion
General discussion
It has been firmly established in E. coli that the division of flux at the branch point between 
the TCA cycle and the glyoxylate bypass is controlled by the reversible phosphorylation and 
inactivation of ICDH. It is generally accepted that, during growth on acetate, 
phosphorylation of ICDH renders the enzyme rate limiting in the TCA cycle thus allowing 
the intracellular concentration of isocitrate, the common substrate of the competing 
pathways, to increase to a level that facilitates flux through the glyoxylate bypass.
The control of isocitrate dehydrogenase by phosphorylation in E. coli was the first example 
of prokaryotic phosphorylation to be well characterised, and both the physiological role and 
the molecular details of phosphorylation are well understood. During the elucidation of this 
control mechanism ICDH was intensively studied in many aspects. The gene for ICDH was 
cloned and sequenced and the 3-dimensional structure of the protein determined. No such 
comparable study has been carried out on ICDH from any other micro-organism.
The work of Bennett and Holms (1975) provided evidence that ICDH may be controlled in 
some other gram negative bacterial strains (,Serratia, Salmonella and Klebsiella) in a similar 
manner to that of E. coli. However these workers provided no evidence for the existence of 
such a mechanism in any gram positive strains. It was the lack of knowledge in this area 
together with the desirability of learning more about central metabolism in thermophiles that 
prompted this study on ICDH from B. caldotenax. I have purified B. caldotenax ICDH, 
characterised some of its properties and investigated the possibility that the enzyme might be 
controlled by phosphorylation. In addition I have cloned and sequenced the gene for this 
enzyme. The results of these studies have allowed comparisons to be drawn between ICDH 
of E. coli and ICDH from a moderate thermophile B. caldotenax.
B. caldotenax ICDH was shown to be very similar in size and composition to E. coli 
ICDH. The similarity of the two enzymes led us to investigate the possibility that
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B.caldotenax ICDH is controlled by phosphorylation. This led to the discovery that it was 
possible to phosphorylate and inactivate purified B. caldotenax ICDH using E. coli ICDH 
kinase/phosphatase in vitro. This was the first indication that phosphorylation might be 
used to control ICDH activity in a gram positive bacterium. However, initial attempts to look 
for evidence of ICDH phosphorylation in vivo proved unsuccessful.
Further support for the idea that B. caldotenax might be controlled by phosphorylation was 
provided when the complete amino acid sequence of the protein was determined. The 
sequence of the amino acids around the phosphorylation site in E. coli ICDH were 
established by Borthwick et al. (1984c) and Malloy et al. (1984). In this study, it was found 
that this sequence of amino acids is entirely conserved in B. caldotenax ICDH. Similarly the 
amino acid sequence of ICDH from the extreme thermophile Thermits thermophilus was 
recently determined (Miyazaki et al., 1992). These workers reported the sequence of amino 
acids found at the E. coli phosphorylation site to be conserved within T. thermophilus 
ICDH. As a result of this finding, coupled with the knowledge that T. thermophilus is able 
to grow on acetate as sole carbon source, this group proposed that ICDH from this micro­
organism may also be controlled by phosphorylation.
Many eukaryotic kinases have been shown to recognise and phosphorylate short linear 
sequences of amino acids. It might be thought therefore that the sequence conservation itself 
explains why B. caldotenax ICDH is a substrate for the E. coli kinase. However McKee et 
al. (1989) demonstrated that E. coli ICDH kinase/phosphatase was unable to phosphorylate 
a short synthetic peptide, the sequence of which corresponded to the ICDH phosphorylation 
site. In addition the kinase was unable to phosphorylate chymotryptic peptides of ICDH. 
E.coli ICDH kinase recognises the overall 3-dimensional structure of the protein and 
recognition cannot be achieved by the phosphorylation site alone. The B. caldotenax and 
E.coli ICDH amino acid sequences share 71% identity and the structures of these two 
enzymes are therefore likely to be similar. The 3-dimensional structure together with the 
presence of the serine residue at the correct site would allow phosphorylation of the enzyme.
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The serine residue could have been conserved for two possible reasons, either to maintain 
the activity of the enzyme or for control by phosphorylation. The 3-dimensional structure of 
E. coli ICDH was determined by Hurley et al. (1990). The structure showed serl 13 to form 
a hydrogen bond with the substrate isocitrate. These workers made mutants of ICDH in 
which serl 13 was converted to other amino acids. The replacement of serine with similar 
sized amino acids, such as threonine or alanine resulted in enzymes which were still active, 
thus showing that serl 13 is not essential for ICDH activity. The question arises as to why 
this serine residue is highly conserved even though it is not absolutely essential for activity. 
It is possible that it has been retained in order to maintain the ability of the enzyme to be 
controlled by phosphorylation.
It will only be possible to confirm the use of phosphorylation, as a regulatory mechanism, in 
the control of B. caldotenax ICDH by carrying out detailed in vivo phosphorylation studies, 
comparable to those performed by Borthwick et al. (1984b) in E. coli. These studies 
involved labelling a culture of B. caldotenax, grown on acetate, with 32Pi and then looking 
for the incorporation of 32P into ICDH together with a decrease in enzyme activity. This 
work was based on many years study of ICDH activity in E. coli under different growth 
conditions. An initial attempt to look for evidence of B. caldotenax ICDH phosphorylation 
in vivo produced negative results and, within the course of this project, there was 
insufficient time to repeat this work under different experimental conditions. Prior to any 
further attempts to look for ICDH phosphorylation in vivo it would be useful to carry out 
growth physiology studies on B. caldotenax. It would be necessary to monitor ICDH 
activity in B. caldotenax under different growth conditions in particular looking for changes 
in ICDH activity which correspond with changes in the growth conditions. In this way it 
should be possible to establish the most appropriate conditions in which to carry out future 
experiments to investigate the phosphorylation of B. caldotenax ICDH in vivo.
During the course of this study the gene encoding B. caldotenax ICDH (icd) was cloned 
and sequenced, together with the flanking regions of DNA. Determination of the nucleotide
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sequence upstream to the gene for ICDH produced possibly the most interesting finding of 
this study. Analysis of the nucleotide sequence upstream to icd showed it to contain the 3' 
end of the gene encoding citrate synthase (CS). It seems likely from the extreme proximity 
of the two genes that they might constitute an operon.
Genes coding for functionally related proteins are sometimes found clustered together on the 
genome. For example it is generally accepted that the biosynthetic genes for each 
actinomycete antibiotic are clustered together.
One well characterised example of this concerns the genes encoding the enzymes involved in 
the biosynthesis of the antibiotic actinorhodin in |streptomycetes. Malpartida and Hopwood 
(1986) determined the physical and transcriptional organisation of the set of genes involved 
in actinorhodin production. All the biosynthetic genes and at least one regulatory gene were 
shown to be clustered together in a region of approximately 26 kb. The genes were found to 
be organised in at least four transcriptional units, some of the genes being transcribed as 
polycistronic mRNA.
Similar gene clusters have been identified in Bacillus species. The genetics of B. subtilis 
have been well studied and the genes controlling development and sporulation extensively 
characterised. Some genes have been shown to be polycistronic as in the case of the spoIIA 
locus which encodes genes involved in sporulation (Piggot et al., 1985). Other operons 
have also been identified in B. subtilis, Fujta et al. (1985) showed the genes for gluconate 
kinase and gluconate permease to form an operon. The enzymes coded for by these genes 
are necessary for the cell to utilise gluconate.
A few examples of gene clusters in thermophiles have been reported. The genes for the 
glycolytic enzymes phosphoglycerate kinase and GAPDH were found clustered together in 
B. stearothermophilus (Davies et al., 1991) and T. thermophilus (Bowen et al., 1988). 
This cluster is not unique to thermophiles but has also been identified in mesophiles
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including E. coli (Alefounder and Perham, 1989). Mallinder et al. (1992) recently cloned a 
4.2 kb EctfRI fragment from B. stearothermophilus. The fragment contains the gene 
encoding glycerol kinase, two other complete ORFs and two incomplete ORFs. The start 
and stop codons of two complete ORFs and one incomplete ORF are located appropriately 
so as to allow translational coupling and it was proposed that the genes could constitute a 
single operon. It is unclear what the genes encode.
In E. coli the genes of the TCA cycle enzymes do not constitute a single operon. This is 
probably a reflection on the cycle's dual role in anabolism and catabolism, and the 
complexity of its regulation. In addition it is thought possible that the cycle evolved from 
diverse segments of earlier metabolic pathways. If this is the case one would not expect the 
genes to constitute a single operon. However, some of the genes, including the gene for CS 
do form clusters. The genes for CS (gltA), succinate dehydrogenase (sdhCDAB) and the 2- 
oxoglutarate dehydrogenase complex (sucCD) form a large cluster at 17 min on the E. coli 
chromosome. The gene for ICDH {icd) does not form part of the cluster but is positioned 
on its own at 25 min.
CS catalyses the condensation of oxaloacetate with acetyl-CoA to form citrate at the start of 
the TCA cycle. The next enzyme of the cycle is aconitase which catalyses the 
interconversion of citrate to isocitrate, the substrate for ICDH. In this way CS and ICDH act 
in relatively close succession and it is likely that a requirement for the synthesis of both 
enzymes would occur simultaneously. It would therefore be logical for the genes of these 
two enzymes to form an operon. As the enzyme aconitase links the CS and ICDH reactions 
one might expect the gene for this enzyme present in the proposed operon. It is possible that 
the aconitase gene could lie upstream to the gene for CS, as this region of DNA has not yet 
been studied. Some nucleotide sequence of DNA downstream to the icd gene was obtained. 
The translated sequence showed no homology to any other known protein sequences 
including that of aconitase. It seems likely therefore that the aconitase gene does not lie
144
downstream to that of ICDH, though this possibility cannot entirely be ruled out as so little 
downstream sequence was available.
The arrangement of genes in B. caldotenax is quite different from that of E. coli and the 
question arises as to how this particular arrangement has developed. The most likely 
explanation seems to be that at some time during the evolution of this micro-organism a 
rearrangement of genetic material has occurred possibly a result of intrachromosomal 
recombination or a transposable element. The resulting order of the genes encoding CS and 
ICDH genes must have proved advantageous to the organism for it to be maintained within 
the species. No similar CS/ICDH operon has previously been identified in any other 
organism. The idea that CS and ICDH form an operon is proposed only on locational 
evidence and obviously further research is required in this area before any firm conclusions 
regarding such an operon can be made. However, it is possible to conclude that B. 
caldotenax exhibits clustering of the genes for CS and ICDH.
Future work
Further research on this project could concentrate on two main areas. Firstly, we need to 
determine conclusively if phosphorylation of B. caldotenax ICDH is genuinely of 
physiological significance. As mentioned previously further in vivo research is required. 
However an alternative approach to addressing this question would be to look for evidence 
of an ICDH kinase in B. caldotenax. In this study we showed that E. coli ICDH 
kinase/phosphatase was able to recognise and phosphorylate B. caldotenax ICDH as a 
substrate. It would be fairly reasonable to assume from this that any putative B. caldotenax 
ICDH kinase will be very similar to that of E. coli. It was also demonstrated that B. 
caldotenax ICDH cross-reacts with an antibody raised to E. coli ICDH, there apparently 
being little variation between the two species. A comparatively simple method of looking for
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a B. caldotenax ICDH kinase would be to use an antibody raised to purified E. coli ICDH 
kinase/phosphatase. It is likely that such an antibody would then cross-react with the 
putative B. caldotenax ICDH kinase. The antibody could be used in Western blots of crude 
extracts and immunoprecipitation experiments. (We might expect to see a protein of 
approximately 66,000 daltons, the size of E. coli ICDH kinase, either lighting up' on a 
Western blot or being immunoprecipitated).
Attempts could also be made to look for a gene encoding an ICDH kinase/phosphatase 
within the B. caldotenax genome. The nucleotide sequences of B. caldotenax and E. coli 
ICDH showed appreciable similarity, (70% identity). The E. coli ICDH kinase gene and the 
putative B. caldotenax ICDH kinase genes might be expected to share similar identity. 
Genomic digests of B. caldotenax DNA could be screened using the complete gene for E. 
coli ICDH kinase, labelled with 32P, as a probe. A strong, specific hybridisation signal 
would not conclusively prove the presence of a B.caldotenax kinase gene but would 
strongly indicate this.
The second main area for future work would involve studies of the proposed CS/ICDH 
operon. The clone obtained in this study (pCWl) contained the complete gene for ICDH but 
only the 3' end of the gene for citrate synthase. Prior to any studies to determine the 
existence of a CS/ICDH operon it would be necessary to clone a stretch of DNA containing 
both genes in their entirety. This procedure will be facilitated by using pCWl as a probe. It 
is possible that the proposed operon could consist of more than two genes. By sequencing 
further upstream to the gene for CS and also downstream from the gene for ICDH this could 
be clarified.
Several approaches could be used to establish the existence of a CS/ICDH operon. Firstly 
transposon insertional mutations could be constructed within one or other of the two genes. 
If the two genes do form an operon an insertional mutation in the gene for ICDH would only 
inhibit expression of icd having no effect on the synthesis of CS. However a similar
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mutation in the gene for CS would prevent expression of both genes. If the genes do not 
constitute an operon any insertional mutation would only effect transcription of the mutated 
gene.
Insertional mutations could provide indirect evidence for the existence of a CS/ICDH 
operon. Direct evidence for the proposed operon could be provided by S1 nuclease 
transcriptional mapping. The method involves the purification of RNA followed by the 
production of DNA/RNA hybrids, using single stranded DNA of interest, in this case DNA 
encoding CS and ICDH. Treatment with S1 nuclease results in the digestion of any single 
stranded DNA, unprotected by bound RNA.In this manner the size of RNA transcripts can 
be deduced. From the size of the transcripts it should be possible to determine whether or 
not the genes for CS and ICDH are transcribed as a single unit, as in the case of an operon, 
or as individual genes.
Finally, it would be interesting to achieve expression of the gene for ICDH and also CS. 
Barstow et al. (1986) successfully expressed the B.stearothermophilus gene for lactate 
dehydrogenase in E. coli. The gene was cloned into an expression vector, expression 
proceeding from the vector’s promoter. It should therefore be feasible to express the genes 
for caldotenax CS and ICDH in E. coli.
The main objectives set out at the start of this work have been achieved. ICDH has been 
purified from B. caldotenax, its regulatory properties have been studied and its gene has 
been cloned and sequenced. This represents a significant advance in our knowledge of the 
enzyme in thermophiles. In addition the work has led to a number of possibilities for further 
experiments, some of which are outlined above. It is hoped that at least some of these ideas 
will be followed up in the future.
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